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The mammary gland is a branched epithelial organ comprised of myoepithelial, 
ductal and alveolar cells that are derived from resident stem and progenitor cells. The 
progression from mammary gland stem cell(s) to the differentiated mammary gland 
cell types is poorly understood. Here, I describe the identification and 
characterization of two luminal progenitor cell populations in the mouse mammary 
gland, and investigate the role of the transcription factor C/EBPβ in their 
development. In Chapter 2, I describe the isolation of two luminal progenitor cell 
populations (Sca1+ and Sca1- luminal cells) and show that they are differentially 
primed in their gene expression towards ductal and alveolar cell fates, respectively. 
Furthermore, I show that in vivo genetic priming affects the in vitro differentiation 
potential of Sca1+ and Sca1- luminal cells. In Chapter 3, I show that C/EBPβ is 
required for the appropriate specification of ductal and alveolar lineages, and in its 
absence, alveolar lineage priming is lost, and ductal lineage priming is up-regulated 
in both Sca1+ and Sca1- cells. Preliminary data also shows that in addition to severe 
proliferation defects, the changes in in vivo lineage priming in Cebpb-/- mice also 
affect the in vitro differentiation potential of Cebpb-/- Sca1+ and Sca1- luminal 
progenitors. Lastly, in Chapter 4, I describe the genome-wide binding characteristics 
of C/EBPβ in Sca1+, Sca1- and P16.5 alveolar cells. These experiments reveal that 
genome-wide C/EBPβ occupancy is correlated with alveolar cells fate, and that 
C/EBPβ target genes perform distinct cellular functions in alveolar cells (Sca1- cells 
and P16.5). Furthermore, I show that Elf5 is directly regulated by C/EBPβ, and posit 
that direct regulation of Elf5 by C/EBPβ may be one mechanism through which 
C/EBPβ exerts its alveolar cell fate programming.………...………………………….
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1.1 The mouse mammary gland 
 




The mouse mammary gland begins to form during embryonic development from a 
small number of ectoderm-derived epithelial cells (Sakakura, 1987). Between 
embryonic day 10 (E10) and E11, these cells form two tracks, often referred to as the 
milk or mammary line, that extend from the thoracic to the inguinal region along the 
ventral body surface. Over the next 24 hours, five pairs of lens-shaped epithelial 
thickenings, known as placodes, form along the mammary line at the future sites of 
the glands (Veltmaat et al., 2003; Robinson, 2007). These placodes, attached to the 
epidermis by a narrow stalk, slowly increase in size between E13 and E15, and 
invaginate the underlying dermis to form bulb-shaped buds. Between E16 and E18, 
the buds elongate and form a primitive ductal system by branching into the 
developing subcutaneous fat pads. These rudimentary structures persist unchanged 
until puberty. Also around E16, specialized mesenchymal cells condense into 
concentric layers around the rudimentary mammary glands, and begin to express 
steroid receptors (Heuberger et al., 1982; Robinson et al., 1999). Concomitantly, the 
surface epithelia associated with the glands differentiates into specialized nipple skin 
cells (Foley et al., 2001). Mouse mammary gland development is indistinguishable 
between males and females before E13. On E13, the male testes begin to secrete 
androgens, which, over the next two days, cause the mammary epithelium to 
degenerate and detach from the nipple (Richert et al., 2000). These developmental 
steps are discussed in more detail below and summarized in Figure 1.1 [adapted from 
(Robinson, 2007)]. 
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Figure 1.1 Key developmental stages in the embryonic mammary gland. 
The top schematic diagram depicts the formation of the embryonic mammary 
ductal tree. The first specification of the mammary gland occurs around 
embryonic day 10.5 (E10.5) with the formation of two lateral tracks along the 
ventral body surface, referred to as the milk line. By E11.5, mammary 
placodes form at precise positions along these tracks, and grow to form 
mammary buds (E12.5-E14.5). The mammary buds sprout into the 
underlying dermis between E15.5 and E16.5, and branch into the 
subcutaneous mammary fat pad by E18.5. The bottom schematic diagram 
shows the positioning of the mammary buds in the developing mouse 
embryo. Two milk lines (ML) form on the rostral-caudal axis along the ventral 
body surface. Five pairs of precisely positioned mammary placodes (P) form 
along the milk lines, each of which develops into a mammary bud (MB). This 
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Initiation of mammopoiesis 
 
The first steps of mammopoiesis in the mouse embryo are initiated by the activation 
of WNT (wingless-related mouse mammary tumor virus (MMTV) integration site), 
FGF (fibroblast growth factor) and HH (hedgehog) signalling pathways (Chu et al., 
2004; Veltmaat et al., 2004). The earliest marker of the mammary line, appearing at 
E10.25, is the WNT and FGF target gene T-box transcription factor 3 (Tbx3) 
(Eblaghie et al., 2004). TBX3 was first noted for its involvement in mammary gland 
development in patients with ulnar mammary syndrome (UMS) (Bamshad et al., 
1999). UMS patients suffer from hypoplasia in the mammary glands, as well as in 
other organs, and mutations in the deoxynucleic acid (DNA) binding domain of the 
Tbx3 gene have been associated with this disease (Bamshad et al., 1999). In mouse 
development, deletion of Tbx3 leads to complete absence of prenatal mammary 
epithelium (Davenport et al., 2003). Canonical WNT activity can also be detected in 
the mesenchymal cells along the mammary line from E10.5, with increased 
expression in and around the placodes as they form (DasGupta and Fuchs, 1999). In 
this study, canonical WNT activity was detected using the TOP-Gal reporter mouse, 
which contains the lacZ gene under the control of the c-Fos minimal promoter. Upon 
WNT stimulation, the lacZ gene product, beta galactosidase, is expressed and its 
activity can be detected using an X-gal assay (DasGupta and Fuchs, 1999). In the 
E11.25 embryo, expression of Wnt10b and Wnt6 can be found along the whole 
mammary line, while Wnt10a is found only in the placodes (Veltmaat et al., 2004). 
As well, another WNT target gene, Lef1 is dynamically expressed along the milk line 
from E10.5 (Mailleux et al., 2002). Over-activation of WNT signalling accelerates 
the formation of placodes in their normal location, as well as induces the formation 
of ectopic placode-like structures (Chu et al., 2004), while keratin 14 (K14)-driven 
expression of the WNT inhibitor Dickkopf (Dkk1) leads to complete absence of any 
mammary gland structures (Andl et al., 2002; Chu et al., 2004). LEF1 and TBX3 
have been identified as the most likely effectors of early mammopoiesis due to the 
absence of placode formation upon deletion of each of these factors (van Genderen et 
al., 1994; Davenport et al., 2003; Renard et al., 2007). Using Lef1 as a marker of 
placode formation also revealed that the mammary placodes form in an 
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asynchronous way (Mailleux et al., 2002). Between E11 and E11.5, placode 3 begins 
to form first, followed by placode 4, then 1 and 5, and finally by placode 2.  
 
Mammary placode formation 
 
Unique and complex signalling interactions are involved with the formation of each 
placode pair (Mailleux et al., 2002; Veltmaat et al., 2006). For example, genetic 
deletion of Fgf10 or its receptor Fgfr2b prevents the development of placodes 1,2,3 
and 5, but not placode 4 (Mailleux et al., 2002). Deletion of Gli3, a hedgehog 
signalling pathway inhibitor, prevents the formation of placodes 3 and 5, while the 
other placodes develop normally (Hatsell and Cowin, 2006; Veltmaat et al., 2006). 
On the other hand, deletion of the hedgehog signalling pathway activator 
Smoothened (Smo) leads to ectopic mammary gland formation on the ventral skin of 
the mouse embryo (Gritli-Linde et al., 2007). In the absence of neuroregulin 3 
(Nrg3), a ligand for ERBB4 receptor tyrosine kinase (HER4), development of 
placode 3 is inhibited and ectopic placode formation on the dorsal side of placode 4 
occurs (Howard et al., 2005). Another level of complexity is added to the 
development of the placodes through the regulation of dorso-ventral positioning. For 
example, precise positioning of placode 3 is initiated on E10.5 by reciprocal 
expression of Tbx3/15 and Bmp4 in the mesenchymal cells surrounding the 
mammary epithelium (Cho et al., 2006). High Tbx3/15 and low Bmp4 expression 
mark the ventral boundary of placode 3, while high Bmp4 and low Tbx3/15 
expression mark the dorsal boundary. TBX3, TBX15 and BMP4 each regulate the 
regional expression of Lef1 and specify the boundaries of this placode. Although our 
understanding of the spatial regulation of placode formation is not complete, it is 
clear that this process requires a complex cooperation and coordination of signals. 
 
Mammary bud formation 
 
Morphologically distinct epithelial buds, formed by E13.5, initiate the reorganization 
of the proximal mesenchyme into tightly packed, concentric layers of cells around 
the mammary epithelium. At this time point in development, these specialized cells, 
	   5	  
referred to as the primary mammary mesenchyme, begin to express hormone 
receptors and the matrix protein tenascin C (TNC) (Heuberger et al., 1982; Dunbar et 
al., 1999; Robinson et al., 1999). The epithelial signal that induces reorganization of 
the proximal mesenchyme is parathyroid hormone-related peptide (PTHLH) (Dunbar 
et al., 1999), a peptide hormone more commonly known for its role in calcium 
homeostasis (Mannstadt et al., 1999). Pthlh is expressed from E11.5 in the mammary 
epithelium, whereas its receptor, Pthr1 is expressed in all of the epidermis (Dunbar 
et al., 1999). In the absence of PTHLH or its receptor, the mammary placodes 
progress into mammary buds, but the buds are unable to elongate and push through 
the underlying mesenchyme into the subcutaneous fat pads (Wysolmerski et al., 
1998). The absence of PTHLH signalling also affects cytokeratin expression in the 
mammary buds, where it changes from a mammary-specific pattern (Asch and Asch, 
1985; Sun et al., 2010) to a skin-cell specific pattern (Foley et al., 2001). As well, the 
expression of androgen receptor in the primary mammary mesenchyme is lost. On 
the other hand, ectopic expression of PTHLH induces androgen receptor expression 
and reorganization of the underlying mesenchyme, and leads to differentiation of the 
surrounding epidermis into specialized nipple cells (Dunbar et al., 1999; Foley et al., 
2001). Taken together, these data show that PTHLH signalling is required for the 
formation of the primary mammary mesenchyme and for the androgen-mediated 
growth of the mammary bud.  
 
Embryonic branching morphogenesis 
 
Induction of mammary bud elongation, branch initiation and nipple skin 
specialization are also dependent on PTHLH signalling (Hens et al., 2007). PTHLH 
is secreted by the mammary epithelium, and promotes the expression of bone 
morphogenic protein (BMP) receptor 1A (Bmpr1a) in the primary mammary 
mesenchyme. In turn, BMP4 binds BMPR1A in the mesenchymal cells and initiates 
branching of the elongated mammary epithelial buds (Hens et al., 2007). This 
mechanism was elucidated through the observations that addition of BMP4 to 
mammary bud explant cultures rescues the defect in ductal morphogenesis in 
PTHLH-deficient mice, and conversely, that addition of Noggin, a BMP antagonist, 
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reduces ductal branching by 50 % in wild type mammary buds (Hens et al., 2007). 
Concurrent to branch initiation of the mammary epithelium is the synergistic 
activation of muscle segmentation homeobox 2 (Msx2) by PTHLH and BMP in the 
adjacent epidermis (Hens et al., 2007). MSX2 inhibits hair follicle formation and 
induces the specialization of the nipple cells. Taken together, the activation of 
mesenchymal BMP signalling by the secretion of PTHLH from the mammary 
epithelium stimulates mammary bud elongation and branching into the underlying 
mammary fat pads, as well as mediates nipple formation by MSX2-dependent 
inhibition of hair follicle development. Development of the mammary gland arrests 
on E18.5, and will not resume until puberty (at ~3 weeks of age in mice).   
 




In the first three weeks after parturition, the small ductal trees that developed in the 
embryo grow allometrically (Watson and Khaled, 2008). From the onset of puberty 
(from ~3 weeks of age in mouse), the development of the mammary gland is 
regulated primarily by the sequential actions of growth hormone (GH), oestrogen, 
progesterone and prolactin (Figure 1.2) (Brisken and O'Malley, 2010). During 
puberty, the cyclic release of oestrogen and progesterone stimulate the ducts to grow 
and branch. Most hormone responsive cells are located in specialized structures at 
the ends of the ducts called terminal end buds (TEBs) (Fendrick et al., 1998; Joshi et 
al., 2012). Proliferation in the TEBs leads to ductal elongation, while clefting of 
TEBs generates branches. Over the next few weeks, the virgin mammary gland 
continues to develop into a regularly branched epithelial tree that completely fills the 
mammary fat pad, and is ready for the next stage of development, terminal 
differentiation of the secretory alveolar cells. 
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Figure 1.2 Hormone actions during postnatal mammary gland 
development. The mammary gland becomes hormone responsive at 
puberty, and its subsequent development is regulated by the sequential 
actions of growth hormone (GH), oestrogen, progesterone and prolactin. 
Terminal end bud (TEB) development and ductal morphogenesis are 
regulated primarily by indirect GH signalling in early postnatal mammary 
gland development. At puberty, oestrogen signalling promotes further 
development of the ductal epithelium by regulating ductal elongation and 
branching. The cyclical release of oestrogen and progesterone in the adult 
virgin mammary gland leads to the proliferation and apoptosis of a subset of 
mammary epithelial cells with each oestrous cycle. During early pregnancy, 
progesterone promotes further ductal side-branching, whereas during mid-
late pregnancy, increased levels of oestrogen and prolactin promote alveolar 
proliferation and differentiation. The cessation of suckling leads to a sharp 
drop in prolactin levels and remodelling of the mammary gland, known as 
involution, to a state that resembles its pre-pregnancy state. This figure is 
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Development of the terminal end buds 
 
TEBs form shortly after the onset of puberty, and are comprised of several layers of 
body cells that are surrounded by an outer layer of cap cells (Sternlicht, 2006). 
Elongation of the ducts results from proliferation within the TEBs, where cap cells 
contribute to the growth of the basal myoepithelial cell layer, and body cells 
contribute to the growth of the luminal cell layer (Hennighausen and Robinson, 
2005). A high rate of apoptosis occurs in the body cells of TEBs (~2x that observed 
in the mature ductal epithelium), which is posited to be the mechanism for lumen 
formation (Humphreys et al., 1996; Richert et al., 2000; Watson and Khaled, 2008). 
Clefting in the TEBs leads to bifurcation of the ducts that generate additional 
branches (Watson and Khaled, 2008). The formation of TEBs at the onset of puberty 
is essential for the rapid, hormone-dependent growth of the mammary gland. 
Interactions between the mammary epithelium and the fat pad are important for TEB 
development (Couldrey et al., 2002). In mice lacking white adipose tissue, ductal 
development is severely disrupted and TEBs do not form (Couldrey et al., 2002). 
Interestingly, these mice are still capable of producing milk, suggesting that although 
adipocytes are necessary for ductal growth and branching, they are not required for 
the terminal differentiation of alveolar cells. The expression of Rras2 within the 
mammary epithelium is also necessary for normal TEB formation and ductal 
development. R-RAS2, a member of the RAS GTPase superfamily, is expressed at 
low levels in the mammary gland, with increased expression observed during puberty 
and pregnancy (Larive et al., 2012). Mammary gland development is normal until 
puberty in Rras2-/- mice. However, at puberty, fewer TEBs develop, which leads to 
a delay in ductal elongation and branching (Larive et al., 2012). Another important 
factor for TEB formation is GATA3, a zinc-finger transcription factor that is 
normally expressed in the body cells of TEBs. MMTV-Cre driven excision of Gata3 
leads to defects in ductal elongation and branching during puberty (Asselin-Labat et 
al., 2006; Kouros-Mehr et al., 2006). GATA3 is also critical for the development of 
alveolar cells, and its absence leads to a block in the differentiation of alveolar 
progenitor cells into milk producing cells (Asselin-Labat et al., 2006). Loss of 
GATA3 is further associated with reduced expression of oestrogen receptor alpha 
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(ESR1) in the mammary epithelium. Kouros-Mehr proposed that forkhead box 
protein A1 (FOXA1), a transcription factor recently shown to regulate the DNA 
binding activity of ESR1 (Lupien et al., 2008; Hurtado et al., 2011), is a direct target 
gene of GATA3, and thereby may mediate the cross-talk between GATA3 and 
oestrogen signalling (Kouros-Mehr et al., 2006).  
 
Growth hormone signalling 
 
Growth Hormone (GH) signalling is primarily important for TEB development and 
ductal morphogenesis. Historically, GH was thought to mimic the lactogenic effects 
of prolactin due to their structural similarity (Kleinberg et al., 1990). However, 
Lyons was the first to hypothesize that GH may play an important role during 
puberty (in TEB formation and branching), whereas prolactin is mostly involved in 
lactogenesis (Lyons et al., 1958). The first study to demonstrate this compared the 
effects of oestrogen, oestrogen and GH, and oestrogen and prolactin on the 
mammary glands of hypophysectomised rats (Kleinberg et al., 1990). These 
experiments showed that oestrogen and GH, but not oestrogen alone, nor oestrogen 
and prolactin, can increase pubertal mammary gland development, as evidenced by 
increased TEB formation and ductal branching. Also, treatment with GH, or its 
downstream effector insulin-like growth factor 1 (IGF1), led to a 2-fold increase in 
the size of the mammary epithelium in rhesus monkeys (Murphy et al., 1987; Ng et 
al., 1997). More recently, through the transplantation of GH receptor (GHR) null 
mammary epithelia into wild type stroma, it was demonstrated that growth hormone 
signalling is not directly involved in the development of the mammary epithelium 
(Gallego et al., 2001). Rather, GH must interact through an intermediate messenger 
in the stroma to cause the GH-associated changes in mammary gland development.  
 
The suggestion that IGF1 may be the downstream effector of GH signalling in the 
mammary epithelium originates from observations that Igf1 messenger RNA 
(mRNA) is increased in response to GH administration in the mammary epithelium, 
and that IGF1 can initiate mammary gland differentiation and development in male 
rats (Ruan et al., 1992). Furthermore, mammary gland development is severely 
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disrupted in Igf1-/- rats, even in the presence of GH (Ruan and Kleinberg, 1999). 
Administration of IGF1 and oestrogen, but not GH and oestrogen, can rescue the 
developmental defects in Igf1-/- mammary glands, as shown by increased numbers of 
TEBs, ducts and percent of fat pad occupied (Ruan and Kleinberg, 1999). IGF1 
signalling through its cognate receptor IGF1R appears to mediate proliferation in the 
TEBs, but not apoptosis (Bonnette and Hadsell, 2001). Together, these studies 
suggest, although they do not conclusively demonstrate, that GH signalling in the 
mammary stroma acts through IGF1 on the mammary epithelium to drive TEB 




Oestrogen signalling is necessary for ductal elongation and branching in the pubertal 
mammary gland, and for alveolar differentiation in the pregnant/lactating mammary 
gland. Oestrogen has two cognate receptors: alpha (ESR1) and beta (ESR2). Esr1 is 
expressed in both the mammary epithelium and surrounding stroma (Daniel and 
Silberstein, 1987). In the absence of ESR1, mammary gland development halts at 
puberty with no further ductal or alveolar development (Bocchinfuso et al., 2000; 
Mallepell et al., 2006; Feng et al., 2007). To investigate whether the developmental 
defects observed in the absence of ESR1 are intrinsic to the mammary epithelium, 
Mallepell transplanted mammary epithelia from Esr1-/- mice and from wild type 
littermates into contralateral cleared fat pads of a single wild type female recipient, 
and assessed the ability of the glands to develop (Mallepell et al., 2006). The 
transplanted wild type glands developed normally and filled the recipient mammary 
fat pad within 10 weeks after transplantation. During pregnancy, transplanted wild 
type mammary glands formed additional side-branches and the alveoli differentiated 
into milk producing cells. On the other hand, the transplanted Esr1-/- mammary 
epithelia failed to develop, and were unable to form differentiated alveolar cells 
during pregnancy. Mallepell also investigated the role of ESR1 signalling in the 
mammary stroma by co-transplanting the fat pad from an Esr1-/- mouse and the 
mammary epithelium from a wild type littermate onto the abdominal muscle of a 
wild type recipient, and assessing the gland’s ability to grow.  
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Figure 1.3 Cellular targets of key hormones during postnatal mammary 
gland development. Activation of growth hormone receptor (GHR) by its 
ligand (GH) in mammary stromal cells induces the expression of Igf1. IGF1, 
in turn, activates its cognate receptor, IGF1R, in luminal cells, and promotes 
TEB formation and ductal morphogenesis. Oestrogen activates ESR1 in 
luminal cells, and regulates ductal elongation and branching during puberty, 
and alveolar differentiation during pregnancy/lactation. Progesterone 
receptor (PR) is activated upon binding of its ligand, progesterone, in luminal 
cells, and promotes ductal side-branching and alveolar development during 
pregnancy. Prolactin activates its receptor (PRLR) in luminal cells, and 
controls the proliferation, terminal differentiation and survival of alveolar cells 
during pregnancy and lactation. Abbreviations: GH, growth hormone; GHR, 
growth hormone receptor; IGF1, insulin-like growth factor 1; IGF1R, insulin-
like growth factor 1 receptor; TEB, terminal end bud; ESR1, oestrogen 
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The transplanted wild type mammary epithelium grew normally in Esr1-/- stroma, 
and showed alveolar differentiation during pregnancy (Mallepell et al., 2006). Cre-
mediated excision of ESR1 from the mammary epithelium further demonstrated that 
defects in ductal morphogenesis (MMTV-Cre) and alveolar differentiation (WAP-
Cre) were intrinsic to the epithelium itself (Feng et al., 2007). As well, through the 
co-transplantation of chimeric mammary epithelium, which contained both Esr1-/- 
and wild type cells, Mallepell demonstrated that Esr1-/- epithelial cells are able to 
contribute to all parts of the mammary tree, including TEBs, ducts and side-
branches, suggesting that paracrine signals from the subset of oestrogen responsive 
WT epithelial cells are sufficient for normal mammary gland development (Mallepell 
et al., 2006). Taken together, these data demonstrate the importance of ESR1-
mediated regulation of mammary gland development. ESR2, on the other hand, does 
not appear to be important in mammary gland development. The mammary glands of 
Esr2-/- females develop normally, albeit with a slight delay in the onset of pubertal 
ductal branching, which has been attributed to decreased progesterone levels in these 




Pregnancy-induced ductal side-branching and alveolar development are regulated in 
part by progesterone signalling. Progesterone acts through two cognate receptors, 
PRA and PRB, which are expressed from a single gene (Pgr) through two alternate 
transcription start sites (Kastner et al., 1990; Brisken et al., 1998). Both receptors are 
expressed in the mammary gland, with PRA more prominently expressed in the 
virgin, while PRB more prominently expressed in the pregnant mammary gland 
(Conneely et al., 2003; Aupperlee, 2005; Brisken and O'Malley, 2010). In the 
absence of PR, the mammary gland develops normally in the virgin mouse. 
However, while wild type mammary glands form additional branches and develop 
distinct alveolar structures in response to injected oestrogen and progesterone (used 
to mimic the increase in these hormones during pregnancy), the mammary glands of 
PR null mice are unable to do so (Lydon et al., 1995).  
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To examine whether the phenotype observed in Pgr-/- mice is intrinsic to the 
mammary epithelium or due, at least in part, to other reproductive defects observed 
in these mice, such as failure to ovulate, Brisken transplanted PR null mammary 
epithelia into wild type mammary fat pads and conversely, PR null fat pads with 
normal mammary epithelium into wild type female recipients (Brisken et al., 1998). 
Through these experiments they demonstrated that PR in the mammary epithelium, 
but not in the stroma, is required for pregnancy-induced side-branching and the 
development of differentiated alveolar cells. As well, through the co-transplantation 
of chimeric mammary epithelium, which contained both Pgr-/- and wild type cells, 
they demonstrated that Pgr-/- epithelial cells are able to proliferate and differentiate, 
suggesting that paracrine signals from a subset of epithelial cells are sufficient for 
normal mammary gland development (Brisken et al., 1998). Mulac-Jericevic later 
demonstrated that receptor activator of nuclear factor (NF) κβ ligand (RANKL), an 
important regulator of osteoclast development, is one such paracrine mediator of 
progesterone signalling (Mulac-Jericevic et al., 2003; Fernandez-Valdivia et al., 
2009). WNT4A was demonstrated to be another paracrine mediator, albeit its 
involvement is in progesterone-driven branching morphogenesis rather than 
alveologenesis (Brisken et al., 2000).  
 
To determine which receptor isoform is responsible for progesterone responsiveness 
in the mammary epithelium, mouse models were generated to selectively ablate 
either PRA or PRB expression (Mulac-Jericevic et al., 2000; 2003). The Pgrb-/- 
mouse displayed defects in pregnancy-associated ductal side-branching and alveolar 
development, whereas the mammary glands of Pgra-/- mouse developed normally. 
These data demonstrate that progesterone signalling through PRB is essential for 




Prolactin (PRL) signalling is essential for the proliferation, terminal differentiation 
and survival of alveolar cells in the mammary gland during pregnancy and lactation. 
Prolactin mediates its signalling through its cognate receptor, PRLR (Boutin et al., 
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1988). PRLR has three isoforms in mouse, which are splice-variants transcribed from 
a single gene (Prlr) (Davis and Linzer, 1989; Bole-Feysot et al., 1998). Several 
studies investigated the role of prolactin signalling in mammary gland development 
using the PRLR knockout mouse (Ormandy et al., 1997a; 1997b; Brisken et al., 
1999; Gallego et al., 2001). The absence of PRLR does not affect development of the 
mammary gland before puberty. After puberty, however, absence of PRLR leads to 
perturbed ductal development, with smaller ducts and fewer branch points, and 
absent alveolar development as evidenced by the persistence of TEBs into adulthood 
(Ormandy et al., 1997a; 1997b). Ormandy’s studies were unable to assess lactation in 
Prlr-/- mice because these females are sterile, while Prlr+/- mice, which are not 
sterile, have severe defects in lactation (Ormandy et al., 1997b). Later studies 
assessed whether the developmental defects in Prlr-/- mice are intrinsic to the 
mammary epithelium or the result of systemic endocrine defects by transplanting 
Prlr-/- mammary epithelia into the cleared mammary fat pads of wild type recipients 
(Brisken et al., 1999). In the presence of wild type stroma, Prlr-/- mammary epithelia 
develop normally at puberty, suggesting that the aberrant side-branching observed in 
Prlr-/- mice in vivo is an indirect effect of prolactin signalling (Brisken et al., 1999). 
During pregnancy, however, Prlr-/- mammary epithelia fail to develop differentiated 
alveolar structures, demonstrating that the defects observed in lactation are the result 
of direct prolactin signalling to the mammary epithelium (Brisken et al., 1999; 
Gallego et al., 2001).  
 
One key effector of prolactin signalling during pregnancy and lactation is the E74-
like factor 5 (ELF5) (Oakes et al., 2008). In Prlr-/- mice, Elf5 expression is down-
regulated, whereas in Elf5-/- mice, Prlr expression is normal, suggesting that PRLR 
is upstream of ELF5 signalling (Zhou et al., 2005). Signal transducer and activator 5 
(Stat5) expression is also reduced in Elf5-/- mammary glands, and ELF5 directly 
binds and regulates the Stat5 promoter (Choi et al., 2009). In the Elf5-/- mammary 
gland, alveolar cells do not differentiate (the phenotype is very similar to the Prlr-/- 
mouse), and conversely, upon over-expression of Elf5, precocious alveolar 
differentiation and milk secretion is observed (Oakes et al., 2008). As well, re-
expression of Elf5 in Prlr-/- mammary epithelia restored normal alveolar 
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development and milk production (Harris et al., 2006). Together, these data 
demonstrate that prolactin-mediated expression of Elf5 specifies the development 
and differentiation of the luminal secretory cells in the mammary gland.  
 
Oestrous cycle and the mammary gland 
 
From the onset of puberty, the cyclical expression of oestrogen and progesterone 
control the development and maintenance of the virgin mammary gland. (Figure 1.4) 
The morphological changes that accompany each oestrous cycle (alveologenesis and 
secondary branching) are driven by the proliferation and apoptosis of a subset of 
mammary epithelial cells, particularly in the alveolar structures (Ankrapp et al., 
1998; Fata et al., 2001a). The highest level of proliferation occurs during late 
proestrous and oestrous (Andres and Strange, 1999), when ESR1 expression is 
highest in the mammary epithelium. Oestrogen promotes the elongation of the ducts, 
and induces the expression of PR in the mammary epithelium (Haslam and 
Shyamala, 1979), which in turn promotes alveolar development (Brisken et al., 
1998). Epidermal growth factor (EGF) induces the expression of PR through 
activation of oestrogen signalling, thus providing a possible mechanism for initiating 
the proliferation observed during oestrous, and fundamentally, for the development 
of hormone responsiveness in the mammary epithelium at the onset of puberty 
(Ankrapp et al., 1998).  
 
In the absence of pregnancy, the levels of ovarian hormones drop and diestrous 
(menses) proceeds. The drop in oestrogen and progesterone levels is closely 
correlated with a peak in apoptosis in the mammary gland, particularly in the alveoli 
(Andres and Strange, 1999). This process requires degradation and restructuring of 
the epithelial and stromal networks, which is carried out primarily by matrix 
metalloproteinases (MMPs) and their inhibitors (TIMPs), whose expression is 
closely correlated with the cyclical turnover of mammary epithelial cells during the 
oestrous cycle (Ankrapp et al., 1998; Fata et al., 2001a). MMP2 and MMP3 have 
been shown to be required for TEB invasion of the fat pad and branching 
morphogenesis  (Wiseman et al., 2003). Mmp2-/-  mammary  glands  are defective in  
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Figure 1.4 Oestrous cycle and the mammary gland. From the onset of 
puberty, the cyclical expression of oestrogen/oestrogen receptor and 
progesterone/progesterone receptor (top row) control the development and 
maintenance of the virgin mammary gland. The morphological changes of 
alveologenesis and secondary branching that accompany each oestrous 
cycle (middle row) are driven by the proliferation and apoptosis of a subset of 
mammary epithelial cells (bottom panel), particularly in the alveolar 
structures. The highest level of proliferation occurs during late proestrous 
and oestrous, when ESR1 expression is highest in the mammary epithelium. 
Oestrogen promotes the elongation of the ducts, and induces the expression 
of PR in the mammary epithelium, which in turn promotes alveolar 
development. Abbreviations: E2, oestrogen; ESR1, oestrogen receptor 
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TEB invasion and have excess secondary branches, whereas MMP3 null mammary 
glands are defective in secondary branching, but have normal TEB invasion. 
Inhibition of MMPs by TIMP1 leads to defective TEB invasion, but has little effect 
on secondary branching (Wiseman et al., 2003), whereas Timp3-/- mammary glands 
display accelerated luminal collapse and loss of alveolar structures (Fata et al., 
2001b). These data demonstrate that tightly controlled spatial and temporal 
expression of ovarian hormones, as well as specific MMPs and TIMPs, are required 
for the cyclical remodelling of the virgin mammary gland to maintain tissue 
homeostasis. 
 




With each pregnancy, the mammary gland undergoes a cycle of proliferation, 
differentiation and apoptosis. The ducts form additional side-branches in response to 
progesterone and prolactin. These side-branches contain alveolar buds, which 
functionally differentiate into secretory cells capable of milk production during 
pregnancy (Robinson et al., 1995). At parturition, prolactin induces the alveoli to 
produce milk, and suckling stimulates the release of oxytocin, causing the 
myoepithelial cells surrounding the alveoli to contract, and expel the milk into the 
primary ducts connected to the nipple. Significant structural remodeling, known as 
involution, is initiated upon the termination of suckling. Over a 2-week period, the 
alveoli collapse as a result of apoptotic cell death, and the mammary gland returns to 
a state that resembles a mature, virgin gland. 
 
Epithelial proliferation during early pregnancy 
 
The first phase of epithelial proliferation and differentiation is initiated early in 
pregnancy by the synergistic actions of progesterone and prolactin (Brisken, 2002). 
As described in the previous section, not all luminal epithelial cells are responsive to 
hormonal cues, therefore mammary epithelial proliferation during early pregnancy is 
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mediated in part by paracrine signals (Brisken et al., 1998; 2000; Mulac-Jericevic et 
al., 2003). One such mediator of progesterone (and PRL) signalling is RANKL, 
which activates the NF-κβ pathway in neighbouring epithelial cells, and in turn 
activates cyclin D1 (Ccnd1) expression (Cao et al., 2001; Srivastava et al., 2003). 
CCND1 is an important regulator of the cell cycle, and is critical for pregnancy-
associated proliferation in normal mammary gland development. In its absence, 
proliferation is blocked in a cell-autonomous way, particularly in alveoli (Sicinski et 
al., 1995; Fantl et al., 1999), whereas over-expression of Ccnd1 is implicated in the 
proliferation in mammary tumors (Jesselsohn et al., 2010). Another paracrine factor 
that is important for cell proliferation during early pregnancy is WNT4 (Brisken et 
al., 2000). Transplantation of Wnt4-/- mammary epithelium into wild type stroma 
demonstrated that in the absence of WNT4, ductal side-branching during pregnancy 
is greatly reduced. However, by parturition, the number of differentiated alveolar 
structures is indistinguishable between Wnt4-/- and wild type littermates, 
demonstrating that WNT4 is required by the ductal epithelium during a short time 
window in early pregnancy.  
 
Polarization of alveolar cells  
 
During mid to late pregnancy, alveolar cells differentiate into polarized pre-secretory 
cells, and start to highly express genes associated with milk and lipid synthesis 
(Richert et al., 2000; Anderson et al., 2007). Activation of STAT5 through 
PRL/JAK2 and ERBB4 is primarily responsible for this transition (Han et al., 1997; 
Liu et al., 1997; Hennighausen and Robinson, 2005). STAT5 was originally 
identified as a prolactin-responsive transcription factor responsible for the activation 
of milk protein genes, such as whey acidic protein (Wap) and beta casein (Csn2) 
(Wakao et al., 1994). Two highly homologous isoforms exist, STAT5A and 
STAT5B (Teglund et al., 1998). Stat5a is expressed more highly in the mammary 
gland, and it is this isoform that is biologically relevant in mammary gland 
development, as its absence blocks alveolar differentiation into milk-producing cells 
(Liu et al., 1997). Similar defects in mammary gland development exist upon 
deletion of Prlr, Jak2, Erbb4, or Stat5, underscoring the importance of these 
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signalling cascades in alveolar cell proliferation and differentiation during pregnancy 
(Ormandy et al., 1997b; Shillingford et al., 2002b; Long et al., 2003).  
 
Cell adhesion molecules, such as connexins and claudins, are also important in the 
polarization of alveolar cells, as they regulate and stabilize interactions between the 
epithelial cells (Streuli et al., 1995; Monaghan and Moss, 1996; Ormandy et al., 
2003). Connexins are a component of gap junctions, whose function is to regulate the 
exchange of small ions and metabolites between cells (Ormandy et al., 2003). 
Connexin 26 (Cx26), a direct STAT5 target gene, is upregulated during pregnancy 
and lactation in alveolar cells, and loss of Cx26 (using Cre-loxP based 
recombination) during early pregnancy leads to increased alveolar cell death (Tu et 
al., 1998; Ormandy et al., 2003; Bry et al., 2004). Also important for alveolar 
differentiation are claudins, a major component of tight junctions, which function as 
barriers to solute transport and the diffusion of molecules, thus helping to maintain 
cell polarity (Ormandy et al., 2003). In mid to late pregnancy, tight junctions 
between the luminal epithelial cells close in response to decreased levels of 
progesterone and increased levels of prolactin (Nguyen et al., 2001). Prolactin 
signalling not only facilitates closure of tight junctions during pregnancy, but also 
directs their formation by regulating transcription of their components, such as 
Claudin-3 and -7 (Ormandy et al., 2003). Closure of the tight junctions prepares the 
mammary gland for the transport of milk towards the lumen, rather than towards the 
basement membrane, during lactation.  
 
Interactions with the basement membrane are also required for complete alveolar 
differentiation (Streuli and Bissell, 1990; Fata et al., 2004). Within each alveolar 
structure, the luminal cells are surrounded by a discontinuous layer of myoepithelial 
cells, which allows some of the luminal cells to make direct contact with the 
basement membrane (Streuli and Bissell, 1990). The basement membrane is created 
principally from myoepithelial secretion of fibronectin, laminin, collagen, and 
heparan sulfate (Barcellos-Hoff et al., 1989; Streuli and Bissell, 1990; Dickson and 
Warburton, 1992; Adams and Watt, 1993). Epithelial interactions with the basement 
membrane are dependent on β1 integrin (cluster of differentiation [CD] 29), which 
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dimerizes with alpha integrins to form cell surface receptors for laminins and 
collagens (Zutter et al., 1998; Fata et al., 2004). In the absence of β1 integrin, 
alveolar cells become disorganized due to alterations in their associations with the 
basement membrane, including invasion into the lumen by the epithelium, and 
proliferation of luminal cells is significantly reduced (Li et al., 2005). Conditional 
deletion of β1 integrin during early pregnancy demonstrated that it is important in the 
formation of alveoli, whereas deletion in late pregnancy showed that it is also 




Secretory differentiation of polarized alveolar cells occurs at parturition as a result of 
a rapid drop in circulating progesterone and concomitant increase in prolactin 
(Nguyen et al., 2001; Anderson et al., 2007). High prolactin leads to activation of 
STAT5-mediated transcription of milk protein genes. However, active lactation is 
not initiated until progesterone levels are sufficiently low (Kuhn, 1969; Neville et al., 
2002). Secretory activation is also associated with a dramatic increase in the 
cytoplasmic machinery required for lipid and protein synthesis, as well as the 
disappearance of large lipid droplets that accumulated during pregnancy (Mather and 
Keenan, 1998; Anderson et al., 2007). Secretion of lipid droplets, which contain milk 
proteins, is essential for lactation, and defects in its components, for example 
xanthine dehydrogenase (Xdh), lead to accumulation of milk in the luminal cells and 
the inability to lactate (Vorbach et al., 2002).  
 
The myoepithelium that surrounds the alveolar cells is also actively involved in 
lactation (Haaksma et al., 2011). By contracting in response to suckling-induced 
oxytocin stimulation, the myoepithelium reduces the diameter of the alveolar lumen, 
thereby ejecting the milk into the ductules that connect to the nipple (Gimpl and 
Fahrenholz, 2001). Although oxytocin is also associated with uterine contractions 
during birth, females that lack oxytocin have normal gestation and parturition 
(Nishimori et al., 1996). As well, although oxytocin null females display normal 
maternal behaviours, all pups die shortly after birth due to the mother’s inability to 
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nurse, demonstrating the essential role of oxytocin in milk ejection during lactation 
(Nishimori et al., 1996). 
 
Lactation occurs in two phases: the colostral phase and the mature secretion phase 
(Anderson et al., 2007). During the colostral phase, which is short-lived in the 
mouse, the milk contains high levels of immunoglobulins and other immune defense 
proteins, which provide passive immunity for the newborn against pathogens that the 
mother has been exposed to, and facilitates the establishment of the gut flora 
(Kelleher and Lönnerdal, 2001; Anderson et al., 2007). During the mature secretion 
phase, which lasts approximately 3 weeks, milk contains high levels of proteins     
(12 %), lipids (30 %), and lactose (5 %), which provide the nutrients required to 
support rapid growth (Anderson et al., 2007). Lactose is a disaccharide unique to 
milk, and its synthesis is considered a marker for secretory activation of the alveoli 
(Anderson et al., 2007). In the absence of alpha lactalbumin, an essential cofactor for 
lactose synthesis, lactation is disrupted and mice cannot sustain their offspring 
(Stacey et al., 1995). 
 
Microarray studies investigating the temporal changes in gene expression from 
pregnancy to involution led to the development of a model whereby the activation of 
metabolic genes required for milk synthesis and secretion is achieved, in part, 
through prolactin-mediated activation of AKT1 (Rudolph et al., 2003). AKT1 is a 
serine-threonine kinase that is highly up-regulated by the PRLR/JAK2/STAT5 
pathway in late pregnancy (Creamer et al., 2010), and has been shown to be an 
important regulator of the metabolic pathways involved in milk synthesis (Boxer et 
al., 2006; Maroulakou et al., 2008). The absence of AKT1 leads to defects in milk 
production, which result in reduced pup weight and increased pup mortality (Boxer 
et al., 2006). In addition to its metabolic functions, AKT1 is also a potent anti-
apoptotic factor, and its absence is marked by accelerated post-lactational involution 
(Maroulakou et al., 2008). The exact mechanism by which AKT1 regulates lipid 
biosynthesis remains unclear. This pathway has been linked to the regulation of the 
sterol regulatory element binding protein 1 (SREBP1), which is an important 
regulator of genes involved in fatty acid and cholesterol biosynthesis (Anderson et 
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al., 2007). However, the direct targeting of SREBP1 by AKT1 signalling has not 
been demonstrated convincingly, as the expression of Srebp1 is unchanged in Akt1-/- 




The cessation of suckling initiates rapid remodelling in the mammary gland, known 
as involution. Most of the studies investigating this process used forced weaning of 
the pups (removal of the pups after a specified number of days of suckling), rather 
than natural weaning, which would occur more slowly (Richert et al., 2000). It is 
therefore assumed that forced weaning recapitulates natural weaning, but in a 
controlled manner that allows for specific time points to be assessed (Richert et al., 
2000). During the first two days after sucking stops (post-suckling), milk 
accumulates in the alveoli and the levels of lactogenic hormones begin to fall (Li et 
al., 1997). The expression of milk protein genes drops in response to reduced levels 
of prolactin; however, lactation can be reinitiated with suckling during this time 
period (Li et al., 1997; Marti et al., 1999). To identify the mechanisms that regulate 
this initial stage of involution, Li used three models (sealing of teats, mammary 
gland transplants, and inactivation of oxytocin) to disrupt milk secretion while 
maintaining normal systemic hormonal regulation (Li et al., 1997). These studies 
demonstrated that local factors, rather then systemic hormones, are required for the 
induction of programmed cell death that result primarily from changes in the 
phosphorylation of STAT3 (Li et al., 1997). While STAT5 was required for alveolar 
development and differentiation, STAT3 is essential for the initiation of apoptosis 
during involution (Chapman et al., 1999; Humphreys et al., 2002). Leukemia 
inhibitory factor (LIF) and transforming growth factor beta 3 (TGFβ3) activate Stat3 
(Nguyen and Pollard, 2000; Kritikou et al., 2003; Schere-Levy et al., 2003), which in 
turn activates the transcription of key pro-apoptotic genes, such as Igfbp5 and Cebpd 
(Tonner et al., 2002; Thangaraju et al., 2005). Apoptosis can be suppressed by 
AKT/protein kinase B (PKB), a cell survival complex that is negatively regulated by 
STAT3-mediated expression of its inhibitor, phosphatidylinositol 3 kinase (PI3K) 
(Ormandy et al., 1997b; Schwertfeger et al., 2001; Shillingford et al., 2002b; Long et 
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al., 2003; Abell et al., 2005). Another pathway that is important for regulating 
apoptosis during involution is the NF-κβ/Iκβ kinase (IKK)- death receptor (DR) 
pathway. Upon conditional deletion of Ikk from the mammary gland, a delay in 
apoptosis and remodelling is observed, as well as reduced expression of NF-κβ 
targets, such as tumour necrosis factor (Tnf) and its cognate receptor (Tnfr1) 
(Sakakura, 1987; Ormandy et al., 2003; Baxter et al., 2006). 
 
Removal of the large number of apoptotic epithelial cells from the mammary lumen 
is achieved through efferocytosis (phagocytosis of apoptotic cells) by both epithelial 
cells and macrophages (Tu et al., 1998; Ormandy et al., 2003; Bry et al., 2004; 
Monks et al., 2005; 2008; O'Brien et al., 2012). Monks observed that viable 
epithelial cells engulfed nearby apoptotic cells using many of the same receptors as 
macrophages, including the cell surface receptors CD36, CD91 and the vitronectin 
receptor (Monks et al., 2005), as well as the phosphatidylserine receptor (PSR), the 
activation of which causes rapid cytoskeletal reorganization and macropinosis 
(Hoffmann et al., 2001). Macrophages also participate in the rapid clearance of 
apoptotic epithelial cells. Conditional deletion of macrophage colony stimulating 
factor 1 receptor (Mcsf1r) leads to delayed involution, as well as lack of alveolar 
regression or adipocyte repopulation (O'Brien et al., 2012). Injection of M2-polarized 
macrophages into Mcsf1r-/- mammary epithelium was sufficient to rescue these 
defects, demonstrating their importance in remodelling the postpartum mammary 
gland (O'Brien et al., 2012). 
 
1.2 Mouse mammary gland stem and progenitor cells 
 
1.2.1 Stem cells in the mammary gland 
 
Foundations for the mammary stem cell hypothesis 
 
The ability of the mammary gland to undergo repeated cycles of proliferation, 
differentiation and involution suggests that mammary epithelial stem cells exist. In 
the 1950s and ‘60s, DeOme and Daniel’s seminal work showed that the serial 
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transplantation of epithelial fragments isolated from different areas of the mammary 
gland was able to reconstitute a complete and functional mammary tree in recipient 
mice (Deome et al., 1959; Daniel et al., 1968). They developed a technique of de-
epithelializing the recipient mammary stroma prior to transplantation, yielding a 
cleared mammary fat pad, which has become a cornerstone assay in the field of 
mammary gland biology. Subsequent experiments using mammary gland tissue from 
young and old female mice further demonstrated that the capacity to regenerate a 
functional mammary gland is maintained throughout life (Young et al., 1971). The 
identity of mammary stem cell(s) remained elusive because transplantation of any 
portion of the mammary tree from any aged mouse during any developmental stage 
gives rise to functional mammary epithelial outgrowths (Smith and Medina, 1988). 
To determine whether a single cell could generate a functional mammary gland, 
Kordon and Smith transplanted MMTV-infected cells into cleared fat pads, and 
assessed the number of integration sites in each outgrowth using Southern blotting 
(Kordon and Smith, 1998). MMTV is a murine milk-transmitted retrovirus that 
inserts DNA copies of its genome randomly into the host genome, but expresses 
itself only in the mammary epithelium (Bittner, 1936; Matsuzawa et al., 1995). 
Kordon and Smith hypothesized that if an outgrowth originated from a single cell, 
then only one pattern of integration would be observed through Southern blotting 
from different regions of the MMTV-infected outgrowth. However, if an outgrowth 
originated from several cells, then different patterns of integration would be 
observed. Their observation that each outgrowth contained only one pattern of viral 
genome integration supported the hypothesis that a single cell could give rise to a 
functional mammary gland. Through serial transplantation experiments, they further 
demonstrated that these cells had the potential to self-renew, as the secondary 
outgrowths were of the same clonal origin as the first (Kordon and Smith, 1998). 
Although these experiments strongly suggested that mammary stem cells exist, they 
did not prove that a single cell gave rise to a complete and functional organ, because 
one could not rule out that a small number of lineage-restricted progenitor cells 
together gave rise to the different cell types observed in the outgrowths.  
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The mammary gland side population 
 
Based on recent discoveries concerning other tissue stem cells, such as those in the 
hematopoietic system (Goodell et al., 1996), Welm and Alvi identified and isolated 
the first putative mammary stem cell population, termed mammary gland side 
population (MG-SP) (Welm et al., 2002; Alvi et al., 2003). SP cells are identifiable 
through flow cytometry due to their ability to expel Hoechst 3342 dye, thereby 
forming a distinct population of cells off to the side of the main cell population 
(hence the term ‘side population’) (Goodell et al., 1996). In the hematopoietic 
system, SP cells have greater than 1000-fold higher in vivo reconstitution activity 
than non-SP cells, and are multi-lineage, as demonstrated by their contribution to 
both myeloid and lymphoid lineages (Goodell et al., 1996). However, the use of 
Hoechst dye to identify stem cells is problematic because Hoechst dye interferes with 
DNA replication during cell division. Therefore, it is possible that the difference 
observed in the in vivo reconstitution activity between hematopoietic SP and non-SP 
cells is due to Hoechst toxicity to the cells that are unable to efflux the dye, rather 
than a biological difference in their repopulating potential. In the mammary gland, 
SP cells are bromo deoxyuridine (BrdU)-label retaining and form approximately 3 % 
of the mammary epithelium (Welm et al., 2002). It was first assumed that cells 
retaining BrdU are quiescent (Welm et al., 2002), but a later study by Smith 
demonstrated that a high percentage (~83 %) of BrdU retaining cells are actively 
dividing through asymmetric cell divisions, which leads to their label retaining 
property (Smith, 2005). Upon in vitro culturing, MG-SP cells form epithelial 
colonies that express classical mammary epithelial cell markers, such as K14, K18 
and K19. Upon in vivo transplantation at limiting dilutions, MG-SP cells give rise to 
both ductal and alveolar structures, albeit with varied frequency between different 
research groups (Welm et al., 2002; Alvi et al., 2003; Liu et al., 2004). MG-SP cells 
also express cell surface markers that are associated with stem cell activity, such as 
stem cell antigen 1 [Sca1; (Spangrude et al., 1988; Welm et al., 2002)] and alpha-6 
integrin [CD49f; (Li et al., 1998; Stingl et al., 2006)], and are responsive to growth 
factors, such as WNT3A and EGF (Liu et al., 2004).  
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However, later studies (reviewed in the next section) revealed that Sca1 is not 
expressed in a multipotent stem cell in the mammary gland (Shackleton et al., 2006; 
Stingl et al., 2006), but is highly expressed in at least one progenitor population 
(Sleeman et al., 2007; Li et al., 2009). Together, these data demonstrate that the SP 
phenotype is associated with stem cell activity, however, since non-SP cells are also 
able to reconstitute a cleared fat pad upon transplantation, albeit with variable 
efficiency, additional markers are needed to specifically label mammary stem cells. 
 
Transplantation studies identify a multipotent mammary stem cell 
 
Another population of mammary stem cells was identified by three independent 
groups (Shackleton et al., 2006; Sleeman et al., 2006; Stingl et al., 2006). Sleeman 
first demonstrated that the cell surface antigen CD24 can be used to isolate three cell 
populations in the mammary gland: CD24negative (neg), CD24low (lo) and CD24high (hi), 
marking non-epithelial, myoepithelial, and luminal epithelial compartments based on 
keratin expression, respectively (Sleeman et al., 2006). Transplantation experiments 
demonstrated that the CD24lo compartment contains the highest repopulating 
activity, with lower repopulating activity observed in the CD24hi population, 
suggesting that the mammary stem cell has a basal (myoepithelial-like) position in 
the cellular hierarchy.  
 
Stingl further refined the purification of the mammary stem cell, which they termed 
mammary repopulating unit or MRU, with the inclusion of additional cell surface 
markers (Stingl et al., 2006). By first using negative selection to remove unwanted 
cell lineages (Lin: CD31-endothelial & CD140a-mesencymal cells; CD45 & Ter119-
hematopoietic cells), and then by assessing CD24 and CD49f expression, Stingl 
isolated three distinct cell populations, and determined that the MRUs were enriched 
in the population with the cell surface phenotype: LinnegCD24loCD49fhi. These cells 
also expressed K5, K14, smooth muscle actin (SMA), smooth muscle myosin, 
vimentin and laminin, all of which are characteristic markers of the 
basal/myoepithelial lineage. Transplantation of a mixture of green fluorescent protein 
(GFP) and cyan fluorescent protein (CFP)-labeled MRUs generated single-colored 
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outgrowths, suggesting that a single stem cell, rather than several lineage restricted 
progenitor cells, gave rise to each gland. This was formally demonstrated by 
performing single cell transplantation of the MRU, which allowed Stingl to 
determine its frequency to be 1:1400 total epithelial cells, or 1:200 in the 
LinnegCD24loCD49fhi population. These outgrowths contained both myoepithelial and 
luminal cells, demonstrating that the MRU has multi-lineage potential. Over 90 % of 
MRUs were in the G1 or S/G2/M phase of the cell cycle, suggesting that these cells 
are actively dividing. As well, less than 10 % of the MRUs were found in the SP 
compartment, further confirming that non-SP cells contain a significant proportion of 
mammary gland stem cells.  
 
Concurrent to this work, Shackleton used another staining strategy to isolate the 
mammary stem cell (Shackleton et al., 2006). He first selected against the lineage 
markers CD31, CD45 and Ter119, and then assessed the expression of CD29 (β1 
integrin) and CD24 (Shackleton et al., 2006). CD29 was chosen based on its 
association with stem cell activity in the skin (Jones et al., 1995). This gating 
strategy allowed for the isolation of four distinct cell populations, each of which was 
assessed for repopulating activity through transplantation experiments. Repopulating 
activity was highly enriched in the LinnegCD24posCD29hi population, with 1:64 cells 
giving rise to a new gland. The clonality of the outgrowths was demonstrated 
through mixing experiments, in which wild type and LacZ-marked cells were co-
transplanted. Almost all of the outgrowths (95/97) were either wild type or LacZpos, 
suggesting that each outgrowth is the result of one transplanted stem cell. Single-cell 
transplantation experiments confirmed this, and revealed that the stem cell frequency 
within the LinnegCD24posCD29hi population is between 6-12 %. In agreement with 
Stingl, Shackleton observed high expression of CD49f and K14 in the MRU 
population with multi-lineage contribution to the outgrowths. Self-renewal of these 
stem cells was demonstrated by serial transplantations, in which third generation 
transplants achieved functional outgrowths. Also, the transplantation of a single 
outgrowth achieved repopulation in several recipients, indicating that the original 
stem cell that gave rise to the first outgrowth has divided symmetrically to generate 
more stem cells.  
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Lineage tracing identifies multipotent and uni-lineage stem cells 
 
Van Keymeulen posited that transplantation studies, although important for defining 
the differentiation potential of stem cells, may not accurately recapitulate the normal 
behaviour of stem cells in vivo, because in a transplantation setting, stem cells may 
be forced to differentiate into lineages to which they would not normally contribute 
(Van Keymeulen et al., 2011). For example, hair follicle bulge stem cells contribute 
to all epidermal lineages following transplantation, but only to hair follicle 
regeneration under physiological conditions (Blanpain et al., 2004; Blanpain and 
Fuchs, 2009). To determine whether the mammary gland is maintained by a 
multipotent stem cell population, as suggested by transplantation studies, or by 
lineage-restricted stem or progenitor cells, Van Keymeulen performed lineage-
tracing experiments using different keratin reporter lines (K14, K5, K18, K8; 
generated by using the Cre/loxP system) and assessed the contribution of each 
marked cell population to the different cell lineages in the mouse mammary gland 
(Van Keymeulen et al., 2011). In E17 embryos, all mammary epithelial cells (MECs) 
express K14. At birth, however, K14 expression becomes restricted to the 
myoepithelial lineage, which also expresses K5 and SMA, whereas the luminal cells 
are K14neg, and instead express K8 and K19. To determine whether embryonic 
K14pos cells are precursors to all mammary gland cell lineages in the postnatal 
mouse, including the K14neg luminal cells, K14-expressing cells were labeled with 
yellow fluorescent protein (YFP) at E17, and their lineage-contribution was assessed 
in the pubertal mammary gland. YFPpos cells contributed to both myoepithelial and 
luminal lineages in the embryo, and this multi-lineage contribution was maintained at 
puberty, suggesting that embryonic K14pos cells are multipotent.  
 
To investigate if postnatal K14pos cells contained multipotent stem cells, lineage 
tracing was performed at puberty and in adulthood. Postnatal YFPpos cells 
contributed only to the myoepithelial lineage, and interestingly approximately 30 % 
were maintained over time, including during pubertal proliferation and after several 
cycles of pregnancy/involution, suggesting that postnatal K14pos cells contain a long-
term uni-lineage stem cell population. To rule out that their strategy targeted a 
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subpopulation of quiescent myoepithelial cells rather than unilineage stem cells, Van 
Keymeulen repeated these experiments with a K5 reporter mouse line, and obtained 
similar results, confirming that the myoepithelial lineage is maintained by a 
unilineage stem cell population that expresses K14 and K5.  
 
Evidence from Smith’s laboratory using the WAP-Cre mouse model demonstrated 
that alveolar stem/progenitor cells are present in the virgin and lactating mammary 
gland (Wagner et al., 2002). To assess whether or not these luminal stem cells exist 
under physiological conditions, K8-expressing cells were marked with YFP at birth, 
puberty and adulthood, and their contribution to the different lineages was assessed 
(Van Keymeulen et al., 2011). YFPpos cells only contributed to the luminal lineage, 
regardless of when during development the marking occurred. Approximately 40 % 
of YFPpos cells appeared to be mature luminal cells, as they were lost over time. 
Approximately 4 % of YFPpos cells, however, were able to proliferate and produce 
mature secretory cells upon pregnancy and lactation, and were maintained over time, 
including after several cycles of pregnancy/involution, suggesting that these cells are 
long-term uni-lineage stem cells. To further demonstrate that K8 marked luminal 
stem cells, and not a subpopulation of mature luminal cells, Van Keymeulen used 
another luminal marker, K18. Although K18-YFP marked only luminal cells, and 
YFPpos cells did not proliferate during pregnancy, suggesting that they may be 
terminally differentiated cells, rather than stem or progenitor cells. 
 
The theory that the mammary gland is maintained by two uni-lineage stem cell 
populations is inconsistent with the data from transplantation experiments, which 
demonstrated that a single basal stem cell can give rise to both luminal and 
myoepithelial lineages. To address this, Van Keymeulen transplanted postnatal K14-
expressing (YFPpos) cells into cleared recipient fat pads and showed that these cells 
were also able to generate a fully functioning mammary gland, with YFPpos cells 
contributing to both luminal and myoepithelial lineages. However, when K14 
(YFPpos) cells were co-transplanted with unlabeled luminal cells, very little YFP 
contribution was seen in the luminal lineage. When K8 (YFPpos) cells were 
transplanted alone, they were not able to reconstitute a cleared fat pad; however, 
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when co-transplanted with unlabeled myoepithelial cells, they generated a functional 
mammary gland, with YFP contribution observed only in the luminal compartment. 
These data demonstrate that the conditions used for the transplantation of stem cells 
can affect their differentiation potential. However, it remains unclear how 
myoepithelial stem cells can give rise to the luminal lineage. Van Keymeulen 
hypothesized that either luminal stem cells restrict the differentiation potential of 
myoepithelial stem cells in vivo, or that the differentiation of myoepithelial stem 
cells towards the luminal fate is a very rare event; a notion that she could not address 
within her experimental conditions.  
 
1.2.2 Progenitor cells in the mammary gland 
 
Luminal progenitor cells 
 
In the hematopoietic system, the progression from a multipotent stem cell to each of 
the differentiated cell types occurs through a series of progenitor cells with defined 
lineage potentials. In the mammary gland, some evidence exists that distinct 
progenitor cells serve as intermediates between mammary gland stem cells and their 
differentiated progeny (Asselin-Labat et al., 2006; Shackleton et al., 2006; Stingl et 
al., 2006; Sleeman et al., 2007; Li et al., 2009). A mammary gland progenitor 
population (mammary colony forming cell or Ma-CFC) was identified by Stingl and 
Shackleton (Shackleton et al., 2006; Stingl et al., 2006). These cells have the cell 
surface phenotype LinnegCD24hiCD49flo or LinnegCD24hiCD29lo and are more 
numerous than MRUs, with an estimated frequency of 1:63 epithelial cells. They also 
express luminal cell markers, such as K6, K8, K18, K19 and casein genes. In in vitro 
colony forming assays, these cells form uniform, round structures composed of 
cuboidal epithelium. In contrast, MRUs form dense, irregularly-shaped colonies 
under the same culturing conditions. When cultured under lactogenic conditions,    
85 % of Ma-CFCs form alveolar-like structure that produce milk proteins, whereas 
MRUs form a heterogeneous mix of colonies, including branched colonies and 
spheroid bodies (Shackleton et al., 2006). Inclusion of an additional cell surface 
marker, CD61 (β3 integrin), allowed for the isolation of a cell population with 
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increased proliferative activity (Asselin-Labat et al., 2006). Approximately 1:3 
LinnegCD24hiCD29lo cells express CD61. CD61pos cells form larger colonies in 
colony forming assays, and approximately 10-fold more colonies than CD61neg cells 
when embedded in Matrigel. The colonies are uniform, round structures, and express 
K18, a luminal cell marker. In vivo, the percentage of CD61pos progenitor cells 
decreases by approximately 30 % from puberty to adulthood, and by a further 15-
fold by day 18 of pregnancy. The progressive loss of progenitor cells during 
pregnancy is compatible with an increase in the differentiation of secretory cells. A 
block in the differentiation of luminal cells due to the loss of GATA3 leads to the 
accumulation of CD61pos cells, providing further evidence that these cells are 
precursors to the differentiated cell types of the lumen.  
 
Sleeman used two different cell surface markers, Sca1 and prominin1 (CD133), in 
addition to CD24, to isolate two luminal progenitor populations (Sleeman et al., 
2007). Sca1 and prominin1 expression were almost completely overlapping. Both 
CD133pos and CD133neg cell populations express K18, with the CD133pos population 
expressing higher levels than the CD133neg population. The CD133pos progenitors 
also express genes involved in hormone sensing, such as Esr1, Pr and Prlr, while the 
CD133neg progenitors express genes associated with alveolar function, such as Csn2 
and Wap. In colony forming assays, CD133neg cells displayed higher proliferative 
activity, with more than 40 % of cells plated giving rise to colonies, whereas only   
15 % of CD133pos cells yielded colonies. Neither population is efficient in 
reconstituting cleared mammary fat pads following transplantation. Further 
subdivision of Sca1pos and Sca1neg progenitor cell populations based on their 
expression of the cell surface marker alpha 2 integrin (CD49b) also showed that the 
CD49bpos compartment is enriched in progenitor cell activity (Li et al., 2009).  
 
Myoepithelial progenitor cells 
 
Myoepithelial progenitor cells have thus far been defined as the in vitro counterparts 
of MRUs. Stingl defined the myoepithelial progenitor as LinnegCD24loCD49fhi; 
Shackleton as LinnegCD24loCD29hi; and Sleeman as CD24loSca1negCD133neg 
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(Shackleton et al., 2006; Stingl et al., 2006; Sleeman et al., 2007). In in vitro colony 
forming assays, all three populations generated large, irregular-shaped colonies, and 
expressed K14 and SMA, markers of the myoepithelium. The frequency of colony 
forming activity varied from 5 % to 25 % between the studies, as well, some 
differences were observed between the in vivo and in vitro potential of the cells. The 
reasons behind the observation that the CD24lo population displayed high in vivo 
repopulating activity and low in vitro colony forming activity in Sleeman’s studies 
was not determined.  
 
1.3 CCAAT enhancer binding proteins 
 
1.3.1 The CCAAT enhancer binding protein family 
 
The first CCAAT enhancer binding protein (C/EBP), later termed C/EBPα, was 
described as a heat stable protein in rat liver nuclei capable of interacting with the 
CCAAT box of the herpes virus thymidine kinase promoter (Graves et al., 1986). 
Subsequent studies identified five additional genes (Cebpb, Cebpd, Cebpg, Cebpe 
and Cebpz) that were named in the order of their discovery  (Chang et al., 1990; Cao 
et al., 1991; Descombes and Schibler, 1991; Williams et al., 1991; Ron and Habener, 
1992).  This family of transcription factors plays key regulatory roles in a number of 
tissues, including the blood, liver, adipose tissue, brain, and the mammary gland 
(Descombes and Schibler, 1991; Sterneck et al., 1997; Seagroves et al., 1998; 
Kowenz-Leutz and Leutz, 1999; Porse et al., 2001; Benavides et al., 2005). C/EBPs 
share a modular domain architecture with a variable N-terminus and a highly 
conserved C-terminus (Figure 1.5) (Ramji and Foka, 2002). The N-terminus of each 
C/EBP contains a unique combination of transactivation domains (AD) and repressor 
domains (RD), leading to its distinct biological role, which can range from a strong 
transcriptional activator, such as C/EBPα, to a dominant negative repressor, such as 
C/EBPγ (Cooper et al., 1995; Nerlov, 2007). The C-termini of C/EBPs encode the 
DNA-binding (DBD) and dimerization (bZIP) domains, and display greater than 90 
% conservation between family members (Ramji and Foka, 2002). The dimerization 
domain contains a  heptad repeat of  four or five leucine  residues that  form an alpha  
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Figure 1.5 The CCAAT enhancer binding protein (C/EBP) family. C/EBPs 
are transcription factors that have key regulatory roles in diverse cellular 
processes, such as cell proliferation and differentiation. The two isoforms of 
C/EBPα (p42 and p30) and the three isoforms of C/EBPβ (LAP* [p38], LAP 
[p35] and LIP [p21]) arise from alternate translation start site from a single 
RNA transcript for each gene. Whereas the four C/EBPε isoforms arise from 
differential RNA splicing (p27), alternate promoters (p29, p14 and 
p33/p30/p27) and alternate translation start sites (p32 & p30). The six C/EBP 
family members share a modular domain architecture with a variable N-
terminus (green and red) and a highly conserved C-terminus (blue and 
yellow). The N-terminus of each C/EBP contains a unique combination of 
transactivation domains (AD-green) and repressor domains (RD-red), leading 
to its distinct biological role, which can range from a strong transcriptional 
activator, such as C/EBPα, to a dominant negative repressor, such as 
C/EBPγ. The C-termini of C/EBPs encode the DNA-binding (DBD-blue) and 
dimerization (BZIP-yellow) domains, and display greater than 90 % 
conservation between family members. This figure is adapted from Ramji 
and Foka, 2002. 
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helix (Landschulz et al., 1989; Vinson et al., 1989). Dimerization, a prerequisite for 
DNA binding, results from the formation of a coiled-coil structure when two such 
leucine repeats, each from a C/EBP monomer, come into close proximity (i.e., 
leucine zipper or bZIP) (Vinson et al., 1989). C/EBPs can form homo- or 
heterodimers with other C/EBP family members, or other transcription factors, such 
as C-FOS, cyclic adenosine monophosphate  (cAMP)  response  element binding 
protein (CREB),  and activating transcription factor (ATF) (Lekstrom-Himes and 
Xanthopoulos, 1998). The amino acid residues in the basic regions of the protein 
dimer determine the specificity of DNA binding (Osada et al., 1996). The consensus 
binding sequence for C/EBPs is a dyad symmetrical repeat (A/GTTGCGC/TAAC/T) 
(Osada et al., 1996). Heterodimers with other bZIP proteins are unable to bind 
canonical C/EBP sites, and either bind to other regulatory sequences, or sequester 
and repress C/EBP transcriptional activity (Takiguchi, 1998). C/EBPs are also able 
to interact with non-bZIP transcription factors and co-activators, such as NF-κβ p50 
subunit (LeClair et al., 1992), glucocorticoid receptor [GR, (Nishio et al., 1993)], PR 
(Christian et al., 2002), and CREB binding protein [CBP, (Mink et al., 1997)]. 
C/EBPα and C/EBPβ have also been shown to inhibit the cell cycle and promote 
terminal differentiation through their interaction with the E2F complex (Porse et al., 
2001; Sebastian et al., 2005). 
 
1.3.2 Mouse C/EBPβ  
 
Regulation of Cebpb gene expression 
 
The Cebpb gene is located on mouse chromosome two, and is comprised of a single 
exon that is transcribed into a 1.4 kb mRNA. The gene and its promoter have been 
characterized in human, mouse, rat, chicken and Xenopus laevis (Grimm and Rosen, 
2003). The expression of Cebpb, also known as Lap or Crp2, is transcriptionally 
controlled by an auto-feedback loop, as well as by CREB/ATF, C-JUN and SP1 in 
response to diverse extracellular stimuli (Chang et al., 1995; Niehof et al., 1997; 
Berrier et al., 1998; Niehof, 2001; Ruffell et al., 2009) (Figure 1.6). For example, in 
the liver, Cebpb expression is upregulated in response to inflammatory stimuli by  
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Figure 1.6 Transcriptional regulation of Cebpb expression. The 
expression of Cebpb is regulated by a number of factors, including CREB, 
ATF, C-JUN and SP1, KLF4 and IL1/6. Regulation by some of these factors 
is tissue specific. For example, IL1 and IL6 regulate Cebpb expression in the 
liver in response to inflammation. Cebpb expression in fat cells, on the other 
hand, is primarily regulated by KLF4.  Other factors, such as CREB, ATF,   
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lipopolysaccharides, interleukins (IL) 1 and 6, gamma interferon and turpentine 
(Akira et al., 1990; Ray, 1994). In fat cells, the adipogenic response to insulin and 
glucocorticoids is regulated by Krüppel-like factor 4 (KLF4)-mediated expression of 
Cebpb (Birsoy et al., 2008). In contrast, in the ovaries, Cebpb expression is 
controlled by luteinizing hormone (LH)-mediated EGF/RAS/ERK signalling, the 
activation of which leads to granulosa cell differentiation (Fan et al., 2009; 2011). 
The Cebpb promoter contains two CREB binding sites that have been shown to 
mediate Cebpb response to cAMP via the protein kinase A (PKA) pathway (Niehof 
et al., 1997; Ruffell et al., 2009). Hormones and other signals that lead to CREB 
phosphorylation via the mitogen-activated protein kinase (MAPK) pathway can 
target these binding sites as well to induce Cebpb expression. 
 
C/EBPβ has three protein isoforms 
 
Three different proteins are produced from the single Cebpb transcript by using 
alternate translation initiation codons (Descombes and Schibler, 1991). The full-
length isoform, known as liver-enriched transcriptional activator protein (LAP*; 38 
kilodaltons [kDa]), is translated from the first AUG codon. LAP* contains three AD 
and two RD domains. LAP (35 kDa) is translated from the second AUG codon. LAP 
lacks the first 21 N-terminal amino acids, but retains two of the three ADs and both 
RD domains. Although almost identical in sequence and structure, LAP* and LAP 
are functionally distinct (Kowenz-Leutz and Leutz, 1999). For example, only LAP* 
is able to interact with MYB to induce transcription of the granulocyte-specific gene 
Mim1 (Kowenz-Leutz and Leutz, 1999). This specificity may be due to an interaction 
between the 21 N-terminal amino acids of LAP* and the SWI/SNF complex 
involved in chromatin remodeling (Kowenz-Leutz and Leutz, 1999; Eaton et al., 
2001).  
 
Liver-enriched transcriptional inhibitor protein (LIP; 21kDa) is translated from the 
third AUG codon, and lacks all three AD and one of the two RD domains, while the 
bZIP and DBD domains remain intact. Retention of the dimerization and DNA-
binding capacity allows LIP to interact with other C/EBPs and bind to target DNA 
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sequences. However, because of the absence of the AD domains, LIP homo- and 
heterodimers are unable to initiate transcription, and therefore are considered to be 
dominant negative repressors (Descombes and Schibler, 1991). The ratio of LAP to 
LIP also appears to be important, because a moderate increase in this ratio leads to a 
significant increase in transcriptional activation of target genes (Gomis et al., 2006).  
 
As well, phosphorylation plays a key role in C/EBPβ regulation (Takiguchi, 1998). 
Several serine and threonine residues are targets of phosphorylation by a number of 
signalling pathways. C/EBPβ exists in a repressed state because the negative 
regulatory domains interact with, and thereby inhibit, the transactivation and DNA 
binding domains (Kowenz-Leutz and Leutz, 1999; Mo et al., 2004). Upon RAS 
activation, MAPK phosphorylates C/EBPβ (the site of phosphorylation is species-
specific) and leads to the release of this intramolecular repression (Kowenz-Leutz et 
al., 1994). Other kinases known to phosphorylate C/EBPβ include PKA (Trautwein 
et al., 1994), protein kinase C [PKC, (Trautwein et al., 1993; 1994)], calcium 
calmodulin-dependent kinase [CaMK, (Wegner et al., 1992)], ribosomal S6 kinase 2 
[RSK2, (Xing et al., 1996)] and PI3K (Guo et al., 2001). In addition to relieving the 
repression of C/EBPβ, phosphorylation is also important for trafficking activated 
C/EBPβ to the nucleus (Ford et al., 1996). 
 




Three C/EBP family members are expressed in the mammary gland: C/EBPα, -β, 
and -δ. Cebpa is present at constant levels throughout mammary gland development, 
except during lactation, when Cebpa expression increases (Gigliotti and DeWille, 
1998; Robinson et al., 1998; Seagroves et al., 1998). To determine if C/EBPα is 
important for the development of the mammary epithelium, Cebpa-/- mammary 
glands from newborn mice were transplanted into cleared mammary fat pads and the 
outgrowths were assessed at different developmental time points (Seagroves et al., 
1998). The Cebpa-/- outgrowths were comparable to controls, with no overt defects 
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observed in the virgin, pregnant, lactating or involuting gland. These data suggest 
that C/EBPα is not required for normal development of the mammary epithelium. 
However, its role in the mammary stroma, which is primarily composed of 
adipocytes, a cell type in which C/EBPα is known to serve an important 
developmental function (Porse et al., 2001), has not been directly investigated. Mice 
in which C/EBPα is deleted in the liver do not develop white adipose tissue (Linhart 
et al., 2001). The mammary fat pads, however, appear normal in these mice, 




Expression of Cebpb is low in the virgin gland, increases during pregnancy, declines 
during lactation, and increases again 24 to 48 hours after the onset of involution 
(Gigliotti and DeWille, 1998; Robinson et al., 1998; Sabatakos et al., 1998). Because 
a single transcript can give rise to three protein isoforms, the expression and LAP1 
and LIP was assessed (Raught et al., 1995; Dearth et al., 2001). LAP is expressed 
throughout mammary gland development, with a modest (3-fold) increase during 
pregnancy, and a small decrease during lactation (Raught et al., 1995; Gigliotti and 
DeWille, 1998; Sabatakos et al., 1998; Dearth et al., 2001). LIP, historically 
considered as the dominant negative isoform of C/EBPβ, is present at low levels 
throughout development, except during pregnancy, when a greater than 100-fold 
increase in expression is observed (Raught et al., 1995). The robust increase in LIP 
expression during pregnancy coincides with the proliferation and differentiation of 
alveolar cells. High levels of LIP are also observed in mouse mammary tumours and 
in human ductal carcinomas, whereas the normal tissue that surrounds these tumours 
contains almost undetectable levels of LIP (Raught et al., 1996; Zahnow et al., 1997). 
The expression of LIP appears to be controlled at the translational level by EGF 
receptor (EGFR) signalling (Baldwin et al., 2004). EGFR leads to the 
phosphorylation of an RNA-binding protein called CUG binding protein 1 (CUG-
BP1), which in turn binds to the Cebpb transcript, and increases the selective 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
1 A distinction was not made between LAP* and LAP in these studies; therefore, LAP refers to both 
activating isoforms. 
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expression of the LIP isoform (Baldwin et al., 2004). The differential expression of 
LAP and LIP led several groups to posit that the LAP/LIP ratio may be important for 
mammary gland development, and has since been shown to play a role in the 
regulation of the expression of milk protein genes during pregnancy and lactation 
(Raught et al., 1995; Robinson et al., 1998; Seagroves et al., 1998; Dearth et al., 
2001). The LAP/LIP ratio is low (<5) during early pregnancy, when low milk protein 
gene expression is observed. At parturition, the LAP/LIP ratio increases more than 
100-fold, and this increase is correlated with the up-regulation of milk protein genes, 




The expression of Cebpd is low in the virgin mammary gland, increases during 
pregnancy, and decreases again during lactation (Clarkson et al., 2004). Cebpd 
expression increases by more than 100-fold at the onset of involution (Gigliotti and 
DeWille, 1998; Clarkson et al., 2004), and this rise precedes the expression of pro-
apoptotic genes, such as testosterone repressed prostate message 2 [Trpm2, (Guenette 
et al., 1994)], interleukin-1β converting enzyme [Casp1, (Boudreau et al., 1995)] and 
tissue transglutaminase (Strange et al., 1992), as well as genes encoding tissue 
remodeling proteins, such as metalloproteinases and their inhibitors (Talhouk et al., 
1992; Li et al., 1994). These data suggest that C/EBPδ may be involved in the 
regulation of early apoptotic genes that are required for mammary gland involution. 
Later studies confirmed that Cebpd is directly upregulated by STAT3 at the onset of 
involution (Thangaraju et al., 2005). C/EBPδ then induces the expression of pro-
apoptotic genes, such as p53, Bak and Igfbp5, while concomitantly repressing anti-
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1.3.4 C/EBPβ  in the mouse mammary gland 
 
General phenotype of three C/EBPβ null mice 
 
The first two C/EBPβ knockout mice were generated by Kishimoto’s group and 
Poli’s group to assess the role of C/EBPβ in macrophage-dependent bactericidal and 
tumoricidal processes (Tanaka et al., 1995) and in hematopoiesis (Screpanti et al., 
1995). Both groups generated the Cebpb null allele by substituting the bZIP domain 
with an MC1-Neo poly(A)+ cassette, which inactivates all three isoforms of C/EBPβ 
(Screpanti et al., 1995; Tanaka et al., 1995). The vector containing the mutant Cebpb 
gene was then used to mutate the endogenous Cebpb gene in mouse embryonic stem 
(ES) cells through homologous recombination. Clones which had undergone correct 
targeting were injected into recipient blastocysts, and the resultant mutant mice were 
screened for germline transmission of the mutant allele (Screpanti et al., 1995; 
Tanaka et al., 1995). The third Cebpb-/- mouse was generated by Johnson’s group, 
who replaced a 1.2 kb genomic fragment containing the entire Cebpb coding region 
and some additional promoter sequences with a pGKneobpA cassette (Sterneck et 
al., 1997). Correctly recombined ES cells clones were injected into blastocysts, and 
the resultant mutant mice were screened for germline transmission of the mutant 
allele (Sterneck et al., 1997). Cebpb-/- mice were viable, however, homozygous 
mutants were born at a lower-than-expected Mendelian ratio (Sterneck et al., 1997). 
Overt defects included sterility in females, splenomegaly, peripheral lymph node 
enlargement, high susceptibility to infections from microorganisms such as Candida 
albicans and Listeria monocytogenes, and a reduction in brown adipose tissue 
(Screpanti et al., 1995; Tanaka et al., 1995; Darlington et al., 1998). A subset of 
Cebpb-/- mice also exhibited profound hypoglycemia and died shortly after birth 
(Croniger et al., 1997).  
 
The mammary gland in C/EBPβ  null mice 
 
In the mammary gland, Cebpb-/- mice exhibit defects in ductal morphogenesis and 
alveolar development similar to those in the PR, PRLR, GATA3 and STAT5 
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knockout mice (Lydon et al., 1995; Liu et al., 1997; Ormandy et al., 1997b; 
Robinson et al., 1998; Seagroves et al., 1998). Mammary gland development is not 
affected in prepubescent females, with a comparable number of TEBs present at 5 
weeks of age in the wild type and mutant mice, albeit a small delay in ductal growth 
is observed in the mutant mice (Robinson et al., 1998; Seagroves et al., 1998). 
However, by 8-12 weeks, the ducts become abnormally distended, appearing 
‘bloated’, and fewer side-branches are present when compared to wild type 
littermates (Robinson et al., 1998; Seagroves et al., 1998). The absence of ovarian 
hormones in Cebpb-/- mice may contribute to the mammary developmental defects, 
therefore to address this, Robinson transplanted wild type ovaries into Cebpb-/- 
females (Robinson et al., 1998). Ductal morphogenesis was partially restored 
following ovarian transplants, suggesting that C/EBPβ mediates some of its 
developmental effects on the mammary gland through indirect mechanisms 
(Robinson et al., 1998). To demonstrate that the defects observed in ductal 
development are, at least in part, intrinsic to the mammary epithelium, Cebpb-/-, 
Cebpb+/- and wild type mammary glands were transplanted into 3-week old 
recipients, and the outgrowths were analyzed 6 weeks after transplantation 
(Robinson et al., 1998; Seagroves et al., 1998). The outgrowths from the Cebpb-/- 
mammary epithelium exhibited defects in ductal branching, similar to the phenotype 
in vivo, whereas the wild type glands were normal. The Cebpb+/- outgrowths had an 
intermediate phenotype, with some ductal distension and reduced branching. To 
investigate whether C/EBPβ also affects alveolar development, Cebpb-/- females 
were either treated with oestrogen and progesterone to mimic pregnancy (Seagroves 
et al., 1998), or were mated after receiving a wild type ovary (Robinson et al., 1998). 
In both experiments, the mammary glands of Cebpb-/- mice displayed significant 
impairment in alveolar development and pregnancy-induced ductal side-branching. 
Cebpb-/- mice developed fewer alveoli than wild type littermates, although the 
alveoli that were present appeared histologically normal, and displayed a significant 
reduction in the number of side-branches. Robinson also assessed the role of C/EBPβ 
in the stroma by co-transplanting wild type mammary epithelium and Cebpb-/- 
stroma into wild type recipients (Robinson et al., 1998). The mammary outgrowths 
developed normally, including normal ductal branching during puberty, and normal 
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alveolar development during pregnancy. These data demonstrate that the absence of 
C/EBPβ in the stroma is not essential for mammary gland development. 
 
C/EBPβ  target genes in the mammary gland 
 
To date, no direct in vivo target genes have been identified for C/EBPβ in the 
mammary gland. Through in vitro studies, however, the mammary genes Id2, Csn2, 
Xdh and Prlr were shown to be directly regulated by C/EBPβ. Id2 is a negative 
regulator of basic helix-loop-helix (bHLH) proteins. Deletion of Id2 leads to 
impaired alveolar development due to defects in both the proliferation and survival 
of alveolar cells during pregnancy (Mori et al., 2000). In Cebpb-/- mice, Id2 
expression is reduced, whereas over-expression of Cebpb in NIH3T3 cells leads to 
up-regulation of Id2 expression (Karaya et al., 2005). These data suggested that Id2 
may be a direct C/EBPβ target gene, and this was subsequently confirmed through 
ChIP experiments in NIH3T3 cells, where C/EBPβ binding was observed in the Id2 
proximal promoter (Karaya et al., 2005). Csn2 and Xdh are prominent components of 
milk, and their expression is directly regulated by C/EBPβ in HC11 cells (a 
mammary epithelial cell line) (Kim et al., 2002; Seymour et al., 2006). More 
recently, Prlr was also identified as a direct C/EBPβ target gene in a human breast 













	   43	  
 
2 Two lineage-primed luminal progenitor cell 





Many questions remain regarding the organization of the cellular hierarchy in the 
mouse mammary gland. Stingl, Shackleton and Asselin-Labat identified a luminal 
progenitor population (Ma-CFC) using slightly different cell surface markers: 
LinnegCD24hiCD49flo, LinnegCD24hiCD29lo, LinnegCD24hiCD29loCD61pos, 
respectively (Asselin-Labat et al., 2006; Shackleton et al., 2006; Stingl et al., 2006). 
These cells express luminal keratins (e.g., K8, K18) and form smooth, round 
colonies when cultured in vitro. Shackleton also showed that Ma-CFCs produce milk 
proteins when cultured under lactogenic conditions (Shackleton et al., 2006). 
Together, these studies demonstrated that the adult mammary gland contains 
luminal-lineage specific progenitor cells. However, they did not address how the 
ductal and alveolar lineages develop from within this population. It therefore remains 
unclear whether the two luminal cell types (ductal and alveolar cells) are maintained 
by one bipotent luminal progenitor population, or by two unipotent progenitor 
populations within the Ma-CFC.  
 
Sleeman demonstrated that CD45negCD24hi luminal cells can be divided into two 
populations based on Prom1 (CD133) expression, and that CD133 and Sca1 
expression are concordant in luminal epithelial cells (Sleeman et al., 2007). CD133pos 
luminal cells express five hormone-sensing genes: Esr1, Prlr, Pgr, Cited1 and 
S100a6, whereas CD133neg luminal cells express three milk protein genes: Csn2, 
Wap and Ltf. Both populations have poor repopulating capacity in vivo, but high 
clonogenic activity in vitro. These data suggest that the CD133pos and CD133neg 
luminal epithelial cell populations contain precursors to the ductal and alveolar 
lineages, respectively. However, a subsequent study by Kendrick found higher 
expression of some alveolar genes (e.g., Csn2, Csn1s2a) in the Sca1pos population 
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(Kendrick et al., 2008). Therefore, it is presently unclear whether the Sca1pos and 
Sca1neg luminal progenitor populations are lineage-biased. 
 
2.2 Aims of this chapter 
 
The first aim of this chapter is to describe the development and optimization of a 
staining strategy that enabled a more precise isolation of Sca1pos and Sca1neg luminal 
progenitor cells. First, the relationship between the different progenitor populations 
published in the studies mentioned previously was evaluated by direct comparison of 
the gating strategies. To achieve this, cells from dissociated adult (10-12 weeks old) 
virgin mammary glands were stained with a combination of the antibodies used in 
the above publications, and the different gating strategies were compared directly. 
Based on these analyses, we developed a new staining strategy that incorporated 
many of the cell surface markers used in the previous studies.  
  
The second aim of this chapter is to describe the gene expression profile and in vitro 
differentiation potential of the two luminal progenitor cell populations we identified. 
The populations we isolated are similar to Sleeman and Kendrick’s (Sleeman et al., 
2007; Kendrick et al., 2008), as they differentially express Sca1. To clarify the 
difference they observed in alveolar gene expression in the Sca1pos luminal cells, as 
well as to determine whether Sca1pos and Sca1neg luminal cells are biased in their 
gene expression towards ductal and alveolar cell fates, respectively, we performed 
quantitative reverse transcriptase polymerase chain reaction (qRT-PCR) and 
microarray analysis. We expected that if differential lineage priming is observed in 
the two luminal progenitors, then upon in vitro differentiation, each would generate 
colonies with a gene expression pattern and morphology that reflects their lineage 
priming. We therefore performed in vitro colony forming assays and assessed the 
gene expression patterns of the colonies generated by Sca1pos and Sca1neg luminal 
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2.3 Collaborators 
 
The work described in this chapter was performed in collaboration with by Dr. 
Susana Garcia-Silva. Dr. Silva developed the fluorescence-activated cell sorting 
(FACS) staining strategy, prepared virgin luminal cells for microarray, and 
performed qRT-PCR and colony assays. Figures 2.7-2.9 were generated from Dr. 
Silva’s experiments. I helped Dr. Silva develop the mammary gland staining 
strategy, performed qRT-PCR and colony assays, analyzed the microarray data, and 
generated all of the figures. Figures 2.1-2.6, and 2.10 were generated from my own 




2.4.1 Comparison of flow cytometric strategies used to isolate luminal 
progenitors  
 
To directly compare the different staining strategies used in the studies described in 
the introduction, flow cytometric analysis of fresh mammary tissue isolated from 10-
week old virgin wild type females was performed. The published studies performed 
on adult virgin females (age 10-12 weeks old) used different combinations of lineage 
markers, and these differences may affect the direct comparison of the gating 
strategies. Therefore, a common strategy was used in these analyses, whereby non-
singlets, dead cells (7-aminoactinomycinD [7-AAD]pos) and lineage positive cells 
were first excluded. Lineage is defined in this thesis by the markers CD45, CD31 and 
Ter119. Inclusion of the lineage marker CD140a was tested by Dr. Mario Buono, 
who noted that the frequency of luminal and myoepithelial cells did not change upon 
addition of this marker (data not shown). The fluorescence minus one (FMO) 









Figure 2.1 Comparison between the flow cytomteric strategies of Stingl 
and Shackleton. (A&B) Stingl’s staining strategy (A) and Shackleton’s 
staining strategy (B). Dot plots were first gated on viable singlets and Lin 
(CD45, CD31, Ter119) cells (not shown). The four quadrants created with 
black lines were set using fluorescence minus one controls to indicate 
negative & positive positions within the graph (C&D) Shackleton’s Ma-CFCs 
(green) analyzed in Stingl’s gating strategy (black). (E&F) Stingl’s Ma-CFC 
(black) analyzed in Shackleton’s gating strategy (green). These plots show 
that the Ma-CFC population identified by the two staining strategies marks 
the same population of cells. Abbreviations: Ma-CFC, mammary colony 
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Comparison between Stingl and Shackleton’s staining strategy is shown in Figure 2.1 
(Shackleton et al., 2006; Stingl et al., 2006). Stingl’s staining divides the Linneg 
compartment into three populations based on CD24 and CD49f expression (Fig. 
2.1A). The luminal compartment (Ma-CFC) is defined as CD24hiCD49flo and forms  
23 % of the Linneg gate. Shackleton’s staining divides the Linneg compartment into 
four populations based on CD24 and CD29 expression (Fig. 2.1B). The luminal 
compartment (Ma-CFC) is defined as CD24hiCD29lo and forms 58 % of the Linneg 
gate. Stingl’s Ma-CFC population (black) assessed for CD29 expression includes all 
of Shackleton’s Ma-CFCs (green), albeit Stingl’s Ma-CFCs are restricted to the 
CD29med population, and do not include the CD29lo cells (Fig. 2.1C,D). Conversely, 
Shackleton’s Ma-CFCs (green) assessed for CD49f expression include all of Stingl’s 
Ma-CFCs (black), although Shackleton’s gating also includes some CD49f 
negative/low cells not included in Stingl’s gating strategy (Fig. 2.1E,F). These cells 
form a part of the same cell population, therefore this discrepancy is due to the 
stringency in the cutoff for CD49f expression used by Stingl. These analyses show 
that the Ma-CFCs investigated by Stingl and Shackleton are overlapping populations, 
and have the combined cell surface phenotype of LinnegCD24hiCD49floCD29lo. 
 
Asselin-Labat’s gating strategy was then compared with Stingl and Shackleton’s 
(Fig. 2.2) (Asselin-Labat et al., 2006). Asselin-Labat first gated on LinnegCD24pos 
cells, and then compared the expression of CD61 and CD29 (Fig. 2.2A). Both the 
CD29loCD61pos and CD29loCD61neg populations (green) co-localize with Stingl’s 
(Fig. 2.2B,C) and Shackleton’s (Fig. 2.2D,E) Ma-CFCs (black).   
 
Sleeman used the cell surface markers CD24, CD133 and Sca1 to distinguish 
between three cell populations (Fig. 2.3) (Sleeman et al., 2007). The CD24hi cells can 
be divided into two cell populations based on CD133 expression. However, Sleeman 
also noted that Sca1 and CD133 expression are concordant. Therefore, Sca1 was 
substituted for CD133 in these analyses (Fig. 2.3A). When compared with Stingl’s 
(Fig. 2.3B,C) and Shackleton’s (Fig. 2.3D,E) staining, both the CD24hiSca1pos (upper 
panel in Fig. 2.3B-E) and CD24hiSca1neg cells (lower panel in Fig. 2.3B-E) co-
localize with the Ma-CFCs (black).  
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Figure 2.2 Comparison between the flow cytometric strategy of Asselin-
Labat, Stingl and Shackleton. (A) Asselin-Labat’s gating strategy. The dot 
plot was first gated on viable singlets, lineage (CD45, CD31, Ter119) 
negative cells and CD24 positive cells (not shown) prior to evaluating CD61 
and CD29 expression. The two CD29lo quadrants (progenitor cells-top panels 
in B-E, and mature cells-bottom panels in B-E) from (A) were then compared 
to Stingl’s (B&C in black) and Shackleton’s (D&E in black) staining. Both 
compartments (in green) co-localize with the mammary colony forming cell 



















Figure 2.3 Comparison between the flow cytometric strategy of 
Sleeman, Stingl and Shackleton. (A) Sleeman’s gating strategy. The 
original gating used by Sleeman was based on CD133 and CD24 
expression. However, he also noted that Sca1 and CD133 expression are 
concordant, therefore, Sca1 was substituted for CD133 in these analyses. 
The dot plot in (A) was first gated on viable singlets and lineage (CD45, 
CD31, Ter119) negative cells (not shown) prior to evaluating Sca1 and CD24 
expression. Sca1pos (top panel in B-E, green) and Sca1neg (bottom panel in 
B-E, green) were compared with Stingl’s (B&C) and Shackleton’s (D&E) 
mammary colony forming cells. Both cell populations co-localize with Ma-
CFCs, and a portion also co-localize with MRUs (CD49fhi in B and CD29hi in 
D). Abbreviations: MYO, myoepithelial cells; CFC, colony forming cells; Ma-
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A small portion of CD24hiSca1neg cells also appear to mark a subset of myoepithelial 
cells, which express intermediate levels of CD24 and CD29. 
 
Lastly, Li first gated on CD24hi cells, and then assessed Sca1 and CD49b expression 
(Fig. 2.4) (Li et al., 2009). Li observed that the two CD49bpos populations (Sca1pos 
and Sca1neg) are enriched in progenitor activity when compared to the CD49bneg 
cells. All three populations co-localize with Ma-CFCs (Fig. 2.4B-E). However, 
similar to Sleeman’s staining, some of the Sca1neg luminal cells also contain a subset 
of cells from the myoepithelial compartment. 
 
To achieve the highest possible purity of Sca1pos and Sca1neg luminal cells, we 
developed a staining strategy that combined the cell surface markers employed by 
the above research groups (Fig. 2.5). First, non-singlets, dead cells and lineage 
positive cells were excluded. Next, cells were gated based on CD29 expression 
(CD29pos), which included two distinct cell populations: CD29lo and CD29hi. The 
CD29lo population co-localizes with the Ma-CFCs described by Stingl and 
Shackleton, and the CD29hi population corresponds to the myoepithelial/MRU 
(mammary repopulating unit or stem cell) population. Next, we assessed CD24 and 
CD49f expression, where we obtain the same three groups of cells as Stingl (Fig. 
2.5B,D). In our staining, the Ma-CFCs (marked in solid green color in Fig. 2.5A, 5th 
panel from the left) make up 57 % of the Linneg population, similar to Shackleton’s 
gating (58 %) (Fig. 2.5C,E). Using these gates in addition to the assessment of Sca1 
and CD49b expression in the luminal compartment allowed us to remove the small 
subset of myoepithelial cells that were included in Sleeman’s and Li’s isolation 
strategy (Fig. 2.3 & Fig. 2.4). These myoepithelial cells would fall into the Sca1neg 
gate in the subsequent plot (Appendix 1). In the representative plot in Figure 2.5, the 
Sca1pos and Sca1neg luminal cells are 27 % and 21 % of the Linneg population, 
respectively. In Sleeman’s gating, the Sca1pos cells are 27 % and the Sca1neg cells are 
25 % of the Linneg population. Of note is that the frequency of the two populations 
varies between 10-week old, wild type virgin females from 20-32 % of Linneg, with 
an average of 24.55 ± 5.11 % (mean ± standard deviation (SD); n=4) for Sca1pos 
cells, and 27.65 ± 1.64 % (n=4) for Sca1neg cells. To verify that the two cell  
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Figure 2.4 Comparison between the flow cytometric strategy of Li, 
Stingl and Shackleton. A) Li’s gating strategy. The dot plot was first gated 
on viable singlets, lineage (CD45, CD31, Ter119) negative cells and CD24 
high cells (not shown) prior to evaluating Sca1 and CD49b expression. The 
three panels in (A) were compared to Stingl’s (B&D) and Shackleton’s (C&E) 
gating strategies, and shows that all three populations co-localize with the 
mammary colony-forming cell population. Abbreviations: CFC, colony-
forming cells; Max, maximum. 
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Figure 2.5 Comparison between the flow cytometric strategy developed 
by Garcia-Silva and Zay (this thesis), Stingl and Shackleton.  
(A) Schematic diagram (top row) and representative dot plots (bottom row) 
depicting the gating strategy used to isolate Sca1pos and Sca1neg luminal 
progenitor cells from adult (10-12 week old) virgin mice. Cells were first gated 
on scatter to obtain singlets. Then lineage (CD31, CD45, Ter119) positive 
cells were excluded, and Linneg cells were selected based on CD29 
expression (CD29lo correspond to Ma-CFCs and CD29hi cells correspond to 
MYO/MRUs). CD29pos cells were then evaluated for CD24 and CD49f 
expression. CD24hiCD49flo cells were further subdivided based on Sca1 
expression, and both Sca1pos and Sca1neg luminal cells co-localize with the 
mammary colony forming cells identified by Stingl (B&D) and Shackleton 
(C&E). Abbreviations: SSC-A, side scatter area; FSC-A, forward scatter 
area; FSC-H, forward scatter height; CFC, colony forming cell; Max, 
maximum. 
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Figure 2.6 Relative expression of selected ductal and alveolar genes in 
Sca1pos and Sca1neg luminal cells. Quantitative real-time PCR analysis of 
ductal (Nkcc1 & Esr1) and alveolar (Csn2) genes was performed on sorted 
Sca1pos (black bars) and Sca1neg (white bars) luminal cells from 12-week old 
wild type virgin females. The values represent gene expression normalized to 
Gapdh from two biological replicates (Sample 1 and Sample 2), each 
assayed in technical triplicate. The table below each graph shows the 
average value from the two replicates ± standard deviation. Abbreviations: 
SD, standard deviation; n, number. 
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populations we sorted were comparable to Sleeman’s, qRT-PCR was performed on 
Esr1, Csn2, and Nkcc1 (Figure 2.6). The ductal genes Nkcc1 and Esr1 were highly 
expressed in Sca1pos cells when compared to Sca1neg cells. The alveolar gene Csn2 
was more highly expressed in Sca1neg cells, albeit not significantly. The overall 
expression of Csn2 was approximately 100-fold lower than Nkcc1 and 10-fold lower 
than Esr1. 
 
2.4.2 The luminal compartment contains two differentially programmed 
progenitor populations 
 
To address how ductal and alveolar specification might occur in the luminal 
progenitor compartment, the Sca1pos and Sca1neg luminal cells were assessed for gene 
expression by microarray and qRT-PCR. Gene profiling using Affymetrix exon 
arrays identified 936 differentially expressed genes (false detection rate [FDR] ≤ 
0.01) between the Sca1pos (776 genes) and Sca1neg cells (160 genes) (Fig 2.7A). The 
genes with higher expression in Sca1pos luminal cells included the previously 
reported hormone sensing genes Prlr, Pgr and Esr1, as well as other genes 
associated with the ductal epithelium, for example Areg and Foxa1 (Fig. 2.7B). 
Genes that were preferentially expressed in the Sca1neg luminal cells included milk 
protein genes, such as Xdh, Ltf and Csn3, and the gene encoding the alveolar-specific 
transcription factor Elf5 (Fig 2.7B). The calcium binding protein gene S100a6 and 
the milk protein gene Csn1s2a were not differentially expressed between the two 
populations (data not shown). To confirm that the ductal (D-genes) and alveolar (A-
genes) genetic programs were enriched in the Sca1pos and Sca1neg luminal cells, 
respectively, microfluidics-based real time PCR was performed. The expression of 
the five selected ductal genes (Prlr, Pgr, Areg, Esr1, Foxa1) was enriched in the 
Sca1pos cells, whereas the four alveolar genes (Csn3, Xdh, Ltf, Elf5) were enriched in 
the Sca1neg cells (Fig. 2.7C). Common luminal genes (L-genes), such as Krt18, Sox9, 
Klf5 and Gata3, were highly but not differentially expressed in the two populations 
(Fig. 2.7B-C). Functional annotation clustering analysis using the DAVID 
bioinformatics resource (Anderson et al., 2007; Huang et al., 2008) showed that the 
overall D-gene signature is enriched in genes associated with hormone response,  
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Figure 2.7 Differentially expressed genes in Sca1pos and Sca1neg luminal 
cells. (A) Differentially expressed genes between Sca1pos and Sca1neg 
luminal cells that were identified from the microarray analysis (FDR ≤0.01) 
are represented as the ratio of Sca1pos to Sca1neg values. The RMA-
normalized, annotated, and quality-filtered expression values were tested for 
differential expression using Limma in the BioConductor framework, and the 
values shown are the ratio between the average Sca1pos cells (n=3) and 
Sca1neg cells (n=3) expression values after log2 transformation. (B) Selected 
genes from (A) showing that hormone sensing genes (Prlr, Pgr, Esr1) are 
enriched in Sca1pos luminal cells, whereas milk genes (Csn3, Xdh) are 
enriched in Sca1neg luminal cells. Highly but not differentially expressed 
genes are shown for comparison (Krt18, Sox9, Klf5, Gata3). (C) Quantitative 
real-time PCR validation of microarray data. Gene expression was 
determined by quantitative real-time PCR on Fluidigm 48.48 dynamic arrays. 
For each gene, 4 biological replicates were analyzed in triplicate for each 
population, and the value shown is the ratio of the average Sca1pos and 
Sca1neg values after log2 transformation. 
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mammary gland morphogenesis, branching and tube formation (Fig. 2.8A). Whereas 
the overall A-gene signature is enriched in genes associated with secretion, cell 
motility, extracellular matrix interactions and ion transport (Fig. 2.8B). Comparison 
between the small population of Sca1posCD49bneg and the Sca1posCD49bpos cells 
identified only 19 differentially expressed genes (FDR ≤ 0.01) (not shown), 
indicating that these two cell populations are the same. Together, these data suggest 
that the Sca1pos and Sca1neg luminal populations contain functionally distinct 
progenitors biased towards ductal and alveolar differentiation, respectively. 
 
To determine whether upon in vitro differentiation the Sca1pos and Sca1neg luminal 
cells would generate colonies that reflect their in vivo lineage priming with respect to 
gene expression pattern and colony morphology, freshly sorted cells were cultured in 
semi-solid medium in the presence of PRL and RANKL (Fig. 2.9), or heparin and 
EGF (Figure 2.10). PRL and RANKL promote the differentiation of alveolar and 
ductal cells. In Figure 2.9, Sca1pos and Sca1neg luminal cells were cultured for 15 
days, with the medium supplemented with PRL and RANKL for the last 7 days to 
promote differentiation in the colonies. While both Sca1pos and Sca1neg progenitors 
formed smooth, round colonies in the absence of PRL/RANKL, only the Sca1pos 
luminal progenitors formed irregular shaped colonies that resemble branching (Fig. 
2.9A). Gene expression analysis of the colonies after PRL/RANKL treatment 
showed that the A-signature was maintained in the Sca1neg progenitors, whereas the 
D-signature was maintained in the Sca1pos progenitors (Fig. 2.9B). These data 
suggest that the Sca1pos and Sca1neg luminal cells exhibit distinct responses to PRL 
and RANKL, consistent with their in vivo transcriptional identity. To further 
demonstrate that in vitro branching morphogenesis was specific to the Sca1pos 
luminal cells, both Sca1pos and Sca1neg populations were cultured with EGF, FGF and 
heparin (Fig. 2.10). After 21 days in culture, the Sca1pos cells formed branched 
colonies, whereas the Sca1neg cells formed smooth, round colonies (Fig. 2.10A,C). 
The frequency of colony forming cells was approximately 2-fold higher and the 
frequency of branching was approximately 9-fold higher in Sca1pos cells when 
compared with the Sca1neg cells (Fig. 2.10B,C).  
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Figure 2.8 Functional annotation clustering analysis of differentially 
expressed genes in Sca1pos and Sca1neg luminal progenitor cells. (A) 
Functional clusters generated by enriched genes in Sca1pos luminal 
progenitors. The transcript cluster IDs of differentially expressed genes (from 
Fig. 2.7) were analyzed using the DAVID Bioinformatics Resource using 
default parameters. Functional clusters were included in the figure if they had 
an enrichment score of ≤2. (B) Functional clusters were generated by 
enriched genes in Sca1neg luminal cells using the same analysis as in (A). 
Supplementary information related to this figure (complete list of functional 
clusters) is shown in Appendices 2&3. 
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Figure 2.9 In vitro colony forming assay of Sca1pos and Sca1neg luminal 
cells. (A) Representative images of Sca1pos and Sca1neg colonies embedded 
in Matrigel, and cultured over a layer of irradiated NIH3T3 fibroblast cells for 
15 days. On the left, colonies were cultured without PRL/RANKL for 15 days, 
and on the right, colonies were cultured with PRL/RANKL for the last 7 days 
of the 15-day culture period. Scale bar=100 µm. (B) Gene expression in 
colonies generated by Sca1pos and Sca1neg luminal cells after 15 days in 
culture, with the addition of PRL/RANKL for the last 7 days. Gene expression 
was determined by quantitative real-time PCR on Fluidigm 48.48 dynamic 
arrays. For each gene, 4 biological replicates were analyzed in triplicate for 
each population, and the value shown is the ratio of the average Sca1pos and 
Sca1neg values after log2 transformation. Abbreviations: PRL, prolactin; 
RANKL, RANK ligand, N.D., not determined. 
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Figure 2.10 In vitro colony forming assay of Sca1pos and Sca1neg luminal 
cells. (A) Representative images of Sca1pos and Sca1neg colonies embedded 
in Matrigel, and cultured over a layer of mitomycin-C treated NIH3T3 cells in 
the presence of EGF, FGF and heparin for 21 days. Scale bar=100 µm. (B) 
Quantification of colony forming activity by Sca1pos and Sca1neg luminal cells. 
Values represent the number of colonies as a frequency of the total number 
of cell plated from two biological replicates plated in duplicate. (C) 
Quantification of branching in Sca1pos and Sca1neg colonies after 21 days of 
culture. Values represent the number of branched colonies divided by the 
total number of colonies. Abbreviations: CFC, colony-forming cells. 
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Together, the gene expression analyses and in vitro colony forming assays 
demonstrate that the Sca1pos luminal compartment contains ductal-primed luminal 
progenitors (termed ductal luminal progenitors or DLPs), whereas the Sca1neg 
luminal compartment contains alveolar-primed luminal progenitors (termed alveolar 




2.5.1 Isolation of two luminal progenitor populations  
 
The development of the mammary gland requires the specification of myoepithelial, 
ductal and alveolar lineages from mammary stem and progenitor cells. Others have 
previously shown that the luminal epithelial compartment contains progenitors (Ma-
CFCs) that express luminal keratins and have high clonogenic activity in vitro 
(Asselin-Labat et al., 2006; Shackleton et al., 2006; Stingl et al., 2006). Furthermore, 
it has been demonstrated that the luminal cells can be divided into a hormone-
sensing population (CD24hiCD133pos) that co-expresses the prolactin, progesterone 
and oestrogen receptors, and a CD24hiCD133neg population that expresses the 
alveolar-specific lactoferrin (Ltf), β-casein (Csn2) and whey acidic protein (Wap) 
genes (Sleeman et al., 2006; 2007). However, CD133 and Sca1 are concordantly 
expressed in luminal epithelial cells, and a subsequent study by Kendrick found that 
some alveolar genes (Csn2, Csn1s2a) were enriched in the CD24hiSca1pos population, 
rather than the CD24hiSca1neg cells (Kendrick et al., 2008). To clarify whether the 
Sca1pos and Sca1neg luminal cells were lineage-primed towards the ductal and 
alveolar cell fates, respectively, we characterized their global gene expression and in 
vitro differentiation potential. 
 
The flow cytometric strategy we developed incorporated many of the cell surface 
markers used by different research groups (Fig. 2.1-2.5). The strategy of gating on 
Lin, CD29, CD49f and CD24 expression prior to analyzing Sca1 and CD49b 
expression allowed us to exclude contamination from other compartments, 
particularly from the myoepithelium, which was observed in our analysis of the 
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published gating strategies (Fig. 2.3 & 2.4). The initial validation of the sorting 
strategy was performed by qRT-PCR using three genes with known functions in the 
mammary gland (Fig. 2.6). Nkcc1 encodes a sodium-potassium-calcium co-
transporter that was shown to localize exclusively to the basolateral membrane of 
ductal luminal cells by immunofluorescence staining (Shillingford et al., 2002a). 
Esr1 expression was observed only in CD24hiCD133pos luminal cells, and 
immunofluorescence staining demonstrated nuclear ESR1 only in the ductal 
epithelium (Sleeman et al., 2007). Lastly, Csn2 encodes a milk protein that is 
expressed during pregnancy and lactation by alveolar cells (Moreira et al., 2010). 
The qRT-PCR results from sorted Sca1pos and Sca1neg luminal cells show that 
Nkcc1and Esr1 are highly expressed in the Sca1pos cells (Fig. 2.6), consistent with 
previous observations (Shillingford et al., 2002a; Sleeman et al., 2007), whereas the 
alveolar gene Csn2 is enriched in Sca1neg cells. Csn2 did not pass the FDR filter of 
≤0.01 in the microarray data from 3 biological replicates, demonstrating that it is not 
differentially expressed between Sca1pos and Sca1neg cells. Consistent with its 
biological function as a component of milk, we and others observed that the level of 
expression for Csn2 is very low in the virgin gland, with expression increasing 
during pregnancy and lactation (Shillingford et al., 2002a; Moreira et al., 2010). The 
variability between biological samples and the low level of expression in the virgin 
mammary gland are the likely reasons for the opposing observations by Sleeman and 
Kendrick regarding the relative expression of Csn2 in Sca1pos and Sca1neg luminal 
cells (Sleeman et al., 2007; Kendrick et al., 2008). Of the five casein genes included 
in the microarray (Csn1s1, Csn1s2a, Csn1s2b, Csn2, Csn3), only Csn3 (expressed 
more highly in Sca1neg cells) passed the FDR filter of  ≤0.01. 
 
2.5.2 The luminal compartment contains two lineage-primed progenitors 
 
Following the qRT-PCR validation of the two sorted luminal cell populations, we 
performed microarray analysis to investigate their global gene signatures. The exon 
arrays show that Sca1pos and Sca1neg cells differentially express 936 genes (Fig. 
2.7A). As expected, genes more highly expressed in Sca1pos cells include the genes 
described by Sleeman (Prlr, Pgr, Esr1, Cited1), as well as other genes that are 
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associated with ductal morphogenesis, such as amphiregulin (Areg) and forkhead 
box protein A1 (Foxa1) (Sleeman et al., 2007). The expression profile of these genes 
was confirmed by qRT-PCR (Fig. 2.7C). AREG is an EGFR ligand that is 
upregulated in the mammary gland during ductal elongation (LaMarca and Rosen, 
2007). Ciarloni demonstrated that Areg is directly regulated by ESR1, and is an 
important mediator of oestrogen-induced ductal morphogenesis in the pubertal 
mammary gland (Ciarloni et al., 2007). Similar to the mammary gland of Esr1-/- 
females, Areg-/- mammary glands have significant developmental defects in TEB 
formation, ductal elongation and branching during puberty. However, unlike in Esr1-
/- mice, pregnancy-induced side-branching and alveolar differentiation in Areg-/- 
females are not disrupted. These data demonstrate that the function of AREG is 
restricted to ductal luminal cells. FOXA1 is a transcription factor that is required for 
the interaction of ESR1 with chromatin (Lupien et al., 2008; Hurtado et al., 2011). 
The deletion of Foxa1 leads to early postnatal lethality (Bernardo et al., 2010). 
Therefore, to investigate the effects of Foxa1 deletion in postnatal mammary gland 
development, the mammary rudiments (epithelium and surrounding stroma) from 
postnatal day 1 Foxa1-/- and control mice were grafted onto the kidney capsule of 
wild type recipient females (Bernardo et al., 2010). This grafting technique is used in 
mammary gland biology to study factors whose deletion causes early (embryonic or 
postnatal) death. These experiments demonstrated that FOXA1 is required for TEB 
formation and ductal elongation, because contrary to the grafted wild type mammary 
epithelium, the Foxa1-/- mammary epithelia fail to form TEBs and the rudimentary 
ducts are unable to extend into the mammary fat pad in response to host-derived 
pubertal signals (Bernardo et al., 2010). In the wild type mammary gland, Foxa1 is 
expressed in CD61pos luminal progenitors cells, and is further upregulated in mature 
luminal cells, lending support to the hypothesis that FOXA1 contributes to the 
specification of the luminal lineage (Bernardo et al., 2010). The established role of 
Prlr, Pgr, Esr1, Areg and Foxa1 in ductal morphogenesis, and their enriched 
expression in Sca1pos cells supports the hypothesis that Sca1pos cells contain ductal 
lineage-primed progenitors.  
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Further support for ductal priming in Sca1pos cells is provided by the functional 
annotation clustering analysis of the microarray data (Fig. 2.8). All of the 
differentially expressed genes that passed the FDR cutoff of ≤0.01 (776 genes) were 
used to generate functional clusters using the DAVID Bioinformatics Resource. The 
differentially expressed genes in Sca1pos cells are generally enriched in functions 
related to hormone response, ductal growth, branching and tube formation (Appendix 
2). For example, cluster 1 contains Cd24, which is a known marker of mammary 
luminal epithelial cells (Sleeman et al., 2006), and high expression of CD24 is 
associated with high ESR1 expression (Sleeman et al., 2007). CD24 also regulates 
mammary ductal branching, as in its absence, branching morphogenesis is 
accelerated during puberty and pregnancy (Cremers et al., 2010). Cluster 3 contains 
the gene encoding hypoxia inducible factor 1A (Hif1a). Although a role in mammary 
gland development has not been reported for Hif1a, a role in branching 
morphogenesis was recently demonstrated in the lung, where over-expression of a 
normoxia-stable isoform of Hif1a led to aberrant pulmonary branching, as well as to 
defects in the maturation of epithelial cells (Bridges et al., 2012). Wnt4 is also 
included in cluster 3, and has a known role in progesterone-driven mammary ductal 
branching both during puberty and pregnancy (Brisken et al., 2000).  
 
Interestingly, pleckstrin (cluster 2, e.g., Rasgrf1) and tetraspanin (cluster 6, e.g., 
Tspan13) homology were also highly enriched in the ductal gene set. The pleckstrin 
homology (PH) domain is found in a wide range of proteins involved in intracellular 
signalling and cytoskeletal function (Haslam et al., 1993), such as the Rho GTPase 
RASGRF1 (Buchsbaum et al., 1996). The PH domain allows proteins to associate 
with specific membranes within the cell by binding to phosphatidylinositol lipids, 
thereby positioning them to interact with components of their respective signalling 
pathways. RASGRF1 (also known as P190) is associated with the plasma membrane, 
and functions as a downstream effector of IGF signalling (Heckman et al., 2007). 
Deletion of P190b leads to defects in mammary bud formation during embryonic 
development (Heckman et al., 2007). P190b-/- mammary epithelia also fail to 
express steroid receptors and display defects in TEB formation (Heckman et al., 
2007), whereas over-expression of P190b leads to increased branching, delayed 
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ductal elongation and perturbed organization of the mammary tree (Vargo-Gogola et 
al., 2006). The tetraspanins are four transmembrane domain proteins that are 
associated with laminin-binding integrins (e.g., α6β1), and are known to regulate cell 
proliferation, cell motility and tumour invasiveness (Novitskaya et al., 2010). 
Recently, the tetraspanin family member TSPAN13 was implicated in TGF-β-
mediated mammary tumour progression, with a possible role in tumour-stromal 
interactions during mammary tumour cell migration and invasion (Matise et al., 
2012). As well, the up-regulation of CD151, another tetraspanin family member, was 
associated with advanced stage mammary ductal carcinoma in situ (34 % of 
advanced tumours showed up-regulation of CD151) (Novitskaya et al., 2010). 
Deletion of Cd151 from an in vitro model of ductal carcinoma in situ (HB2 cell line) 
led to the formation of an internal lumen and polarization of the epithelial cells in the 
colonies (Novitskaya et al., 2010).  
 
The exon arrays also show that 160 genes are more highly expressed in Sca1neg cells 
compared to Sca1pos cells. Included in this gene list are the previously reported genes 
encoding lactoferrin [LTF, (Sleeman et al., 2007)], which is an important iron-
binding milk protein, as well as other milk components, such as Csn3 and Xdh. Xdh 
is expressed uniformly in most cell types, and encodes a rate-limiting enzyme in 
purine metabolism (Vorbach et al., 2002). An additional function for XDH was 
demonstrated in the mammary gland, where it is required for the secretion of milk fat 
droplets from alveolar cells during lactation (Vorbach et al., 2002). Some milk genes, 
shown by others to be more highly expressed in Sca1neg luminal cells (Csn2, Mfge8, 
Wap), did not pass the false detection rate filter of ≤0.01 in our experiments. 
Although not significant, qRT-PCR showed that Csn2 is more highly expressed in 
Sca1neg cells (Fig. 2.6), which is consistent with Sleeman’s observations (Sleeman et 
al., 2007). The gene encoding the transcription factor ELF5, an important regulator 
of alveolar development, also displayed higher expression in Sca1neg cells. ELF5 is a 
key mediator of prolactin signalling during pregnancy and lactation, and a block in 
alveolar differentiation is observed in Elf5-/- mammary glands, whereas precocious 
alveolar differentiation and milk secretion is observed when Elf5 is over-expressed 
(Oakes et al., 2008). Overall, enriched expression of the alveolar genes Ltf, Csn3, 
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Xdh and Elf5 in Sca1neg cells supports the hypothesis that this population contains 
alveolar-primed luminal progenitors. 
 
Functional annotation clustering analyses provide further support for the alveolar 
lineage priming in Sca1neg cells. During pregnancy, the mammary gland undergoes 
significant remodeling to form secretory alveolar cells in preparation for lactation. 
Oakes described this process as the ‘alveolar switch’, whereby prolactin and 
progesterone signalling initiate a coordinated change in the genetic programming of 
the mammary epithelium to induce cell proliferation, migration and differentiation 
(Oakes et al., 2006). Consistent with these functions, Sca1neg cells are enriched in 
genes associated with secretion, cell migration, extracellular matrix interactions and 
ion transport (Fig. 2.8B, Appendix 3). For example, cluster 1 and cluster 3 contain 
the gene encoding connective tissue growth factor (CTGF), a matrix-associated 
protein that is required for the lactogenic differentiation of cultured mammary 
epithelial cells (Morrison et al., 2010). Over-expression of Ctgf led to increased 
differentiation of mammary epithelial cells in vitro (using the HC11 mammary 
epithelial cell line) as demonstrated by increased Csn2, AKT and CCND1 expression 
(Wang et al., 2008; Morrison et al., 2010). On the other hand, depletion of CTGF by 
small interfering RNA (siRNA) knockdown led to decreased differentiation of the 
mammary epithelial cells (Wang et al., 2008). The authors posit that the changes in 
the expression of extracellular matrix proteins, integrins and Csn2 due to CTGF 
over-expression/depletion suggest that CTGF is an important mediator of the 
stromal-epithelial communication that regulates alveolar differentiation.  
 
An interesting cluster that emerged from the functional annotation analysis contains 
genes associated with the plexin-semaphorin signalling axis (cluster 7 in Fig. 2.8B). 
Semaphorins are secreted or membrane-associated glycoproteins that bind their 
cognate receptors, the plexins (Janssen et al., 2010). The plexin-semaphorin 
signalling axis is involved in neuronal axon guidance, vascular growth and tumour 
progression, primarily through the regulation of Rho-family GTPases (Kruger et al., 
2005). Met, a gene we found to be enriched in Sca1neg cells, and a member of cluster 
7 in Figure 2.8B, was recently implicated in the regulation of mammary gland 
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growth, repopulating potential, and basal cell-fate commitment (Gastaldi et al., 
2012). Consistent with our findings, Gastaldi also found that Met is more highly 
expressed in ESR1neg luminal progenitors, and further showed that constitutive 
activation of MET leads to de-differentiation of luminal progenitor cells whereby 
they attain enhanced in vitro clonogenic and in vivo repopulating potential (Gastaldi 
et al., 2012). These data demonstrate a mechanism for the observation that basal-like 
breast cancer originates from luminal progenitor cells (Gastaldi et al., 2012). 
 
Interestingly, the expression of the number of genes involved in the alveolar program 
is not as numerous in Sca1neg cells as those in the ductal program in Sca1pos cells, as 
evidenced by the lower level of enrichment of alveolar genes, as well as the lower 
number of genes in the A-gene signature (Fig. 2.7). One explanation for this is that 
the hormone-responsive ductal epithelium develops early in the lifecycle of the 
mammary gland, and therefore a higher basal level of ductal gene expression is 
observed. On the other hand, the alveolar cells mature later in development 
(pregnancy and lactation), and therefore the basal level of alveolar gene expression 
may be lower. This is supported by the observation that Csn2 is expressed at much 
lower levels in luminal cells compared to Nkcc1 and Esr1 (Fig. 2.6).  
 
In summary, the mouse exon arrays and qRT-PCR analyses demonstrate that the 
Sca1pos and Sca1neg luminal compartments contain cells primed towards ductal and 
alveolar cell fates, respectively. The Sca1pos (ductal) gene signature is enriched in 
hormone signalling, ductal morphogenesis and tube formation, whereas the Sca1neg 
(alveolar) gene signature is enriched in secretion, cell motility and extracellular 
matrix interactions.  
 
2.5.3 In vitro functional output reflects in vivo lineage priming of luminal 
progenitor cells  
 
To determine whether the lineage priming we observed in vivo affects the in vitro 
differentiation potential of Sca1pos and Sca1neg cells, they were cultured under 
differentiation conditions. The first culturing conditions included prolactin and 
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RANKL for the last 7 days to promote the differentiation of alveolar and ductal 
progenitor cells (Fig. 2.9). PRL signalling is essential for the proliferation, terminal 
differentiation and survival of alveolar cells (Brisken et al., 1999; Gallego et al., 
2001), whereas RANKL promotes ductal side-branching and alveolar differentiation 
in vivo (Fernandez-Valdivia et al., 2009). Both progenitor populations form smooth, 
round colonies in the absence of differentiation factors (Fig. 2.9A, left panels). After 
culturing the colonies with PRL/RANKL for 7 days, however, Sca1pos colonies 
change shape by forming protrusions that appear to be early stages of branching, 
whereas the morphology of the Sca1neg colonies does not change (Fig. 2.9A, right 
panels). These observations demonstrate that Sca1pos and Sca1neg cells respond 
differently to differentiation signals, and suggest that their lineage priming may 
impact their in vitro differentiation potential. Following the differentiation protocol, 
the D- and A-gene sets were analyzed by qRT-PCR to determine whether the in vivo 
lineage priming is maintained. The results presented in Figure 2.9B show that 
alveolar genes are more highly expressed in cultured Sca1neg cells compared to 
Sca1pos cells, and conversely, ductal genes are more highly expressed in cultured 
Sca1pos cells compared to Sca1neg cells, demonstrating that the initial priming is 
preserved. 
 
To further show that in vitro branching morphogenesis is restricted to Sca1pos cells, 
we cultured Sca1pos and Sca1neg cells using differentiation factors 
(EGF/FGF/heparin) that promote ductal branching (Hung et al., 2005; Pavlovich et 
al., 2011). Consistent with the results we obtained previously by culturing the cells 
with PRL and RANKL, only Sca1pos cells formed branched colonies when cultured 
with EGF/FGF/heparin (Fig. 2.10). The Sca1pos colonies generated using this 
differentiation protocol have elongated, tubular, highly branched projections. Some 
colonies were also completely tubular (top right), whereas others had branched 
projections originating from a round colony (top left). These morphologies may 
reflect progressive stages of differentiation. Sca1pos cells also form more colonies 
(~22 %) than Sca1neg cells (~10 %). This result is consistent with Li’s published 
observation that approximately 20 % of Sca1pos luminal progenitor cells and 12 % of 
Sca1neg luminal progenitor cells have colony forming activity (Li et al., 2009). 
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Approximately 15 % of Sca1pos cells form branched colonies, compared to 1.6 % of 
Sca1neg cells, demonstrating that branching morphogenesis is limited to Sca1pos cells. 
However, 85 % of colonies formed by Sca1pos cells do not generate branches, and 
remain round and smooth despite the addition of tubulogenic factors. Heterogeneity 
within the ductal luminal compartment has been documented based on ESR1 
expression (LaMarca and Rosen, 2008). However, to my knowledge, ductal luminal 
progenitors have not been functionally dissected before. These data demonstrate that 
Sca1pos cells contain (at least) two different progenitor populations: one that engages 
in branching morphogenesis, and one that cannot. These observations are of interest, 
and future investigations will focus on the molecular differences between branching 
and non-branching Sca1pos cells.  
 
In summary, this chapter described the isolation of two luminal progenitor cell 
populations (Sca1pos and Sca1neg cells) and showed that they are differentially primed 
in their gene expression towards ductal and alveolar cell fates, respectively. 
Furthermore, we showed that the in vivo genetic priming affects the in vitro 
differentiation potential of Sca1pos and Sca1neg luminal progenitor cells. Together, 
these findings led to the development of a revised model of the cellular hierarchy that 
maintains the adult mammary gland (Fig. 2.11). As shown by others, the Ma-CFC 
contains a bipotent luminal progenitor/stem cell population, which thus far has been 
described as CD29lo, CD24hi and CD49flo (Stingl et al., 2006; Shackleton et al., 
2006), and additionally as K8+/K19+ (Van Keymeulen et al., 2011). This 
progenitor/stem cell, through one or more undefined intermediates, gives rise to two 
luminal cell lineages: ductal and alveolar (Fig. 2.11A). The characterization of two 
new progenitor cell populations, as described in this chapter, provides a critical link 
between the bipotent luminal progenitor/stem cells and the two differentiated luminal 
cells types in the adult mammary gland (Fig. 2.11B). 
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Figure 2.11 Schematic representation of the cellular hierarchy in the 
mammary gland. A. In this model, the adult mammary gland is maintained 
by a multipotent stem cell population (shown in orange), which, based on 
Stingl and Shackleton’s experiments, resides in the myoepithelial cell 
compartment. This multipotent stem cell gives rise to two lineage-restricted 
stem/progenitor cells (bipotent luminal progenitor/stem cells [referred to as 
Ma-CFC in Chapter 1] and unipotent myoepithelial progenitor/stem cells 
[referred to as MRU in Chapter 1]). These, in turn, give rise to the three 
principal mammary epithelial cell types: myoepithelial cells, ductal cells and 
alveolar cells. In a transplantation setting, the myoepithelial progenitor/stem 
cell generates both primary cell lineages (myoepithelial and luminal), 
whereas the bipotent luminal progenitor/stem cell only generates luminal cell 
types. As indicated by discontinuous arrows, the intermediate cell types 
between the bipotent luminal progenitor/stem cell and differentiated luminal 
cells were not known. B. In this model, the two progenitor cell types identified 
in this chapter (Sca1- ALPs and Sca1+ DLPs) provide a link between the 
bipotent luminal progenitor/stem cell and the differentiated luminal cell types 
(in yellow box). Key: continuous arrows- relationship described; 
discontinuous arrow- relationship unknown; discontinuous line around cell- 
identity contended. 
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The development of the mammary gland requires the specification of myoepithelial, 
ductal and alveolar lineages from mammary stem and progenitor cells. Others have 
shown that the luminal epithelial compartment contains progenitor/stem cells 
(Shackleton et al., 2006; Stingl et al., 2006; Van Keymeulen et al., 2011) that can be 
divided into two populations: one that expresses hormone-sensing genes, and one 
that expresses alveolar genes (Sleeman et al., 2007). In Chapter 2, we have further 
shown that improved separation of luminal progenitor cells using a novel 
combination of cell surface markers can isolate two lineage-primed progenitor 
populations, where Sca1pos luminal cells contain ductal luminal progenitors (DLPs), 
and Sca1neg luminal cells contain alveolar luminal progenitors (ALPs). However, the 
genetic mechanisms that regulate the specification of these luminal cell fates and 
their subsequent differentiation remains poorly understood. 
 
Three CCAAT/enhancer binding protein family members are expressed in the 
mammary gland: C/EBPα, -β, and -δ. C/EBPα is not required for mammary gland 
development, as demonstrated by transplantation experiments (Seagroves et al., 
1998), whereas C/EBPδ is important for the regulation of apoptotic genes during 
involution (Thangaraju et al., 2005). These studies suggested that neither of these 
two C/EBP family members are involved in the early specification of the two 
luminal cell types. Expression of Cebpb, on the other hand, is low in the virgin 
gland, increases during pregnancy, declines during lactation, and increases again   
24-48 hours after the onset of involution (Gigliotti and DeWille, 1998; Robinson et 
al., 1998; Sabatakos et al., 1998). C/EBPβ has also been shown to be an important 
regulator of mammary gland development (Robinson et al., 1998; Seagroves et al., 
1998). In adult Cebpb-/- mice, mammary ducts are morphologically abnormal 
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(distended) with fewer side-branches, and alveolar differentiation is blocked in 
response to lactogenic hormones in transplanted Cebpb-/- mammary epithelia 
(Robinson et al., 1998; Seagroves et al., 1998). Further studies have shown that these 
defects are intrinsic to the mammary epithelium, as a lack of C/EBPβ in the stroma 
does not affect ductal elongation/branching during puberty, or development/ 
differentiation of the alveoli during pregnancy (Grimm and Rosen, 2003). Based on 
these observations, we posited that C/EBPβ may be involved in the specification of 
luminal cells, and subsequently, in regulating the development of alveolar cells.  
 
3.2 Aims of this chapter 
 
This chapter aims to investigate the role of C/EBPβ in the transcriptional 
diversification of ductal and alveolar cell fates in the luminal compartment of the 
mammary gland. To begin, flow cytometric analysis was performed on C/EBPβ-
deficient and control mammary glands to assess the composition of the luminal 
compartment. This was followed by gene profiling using qRT-PCR on C/EBPβ-
deficient Sca1pos and Sca1neg luminal cells to assess any potential changes in the D- 
and A- gene signatures. Lastly, C/EBPβ-deficient Sca1pos and Sca1neg luminal cells 
were cultured in vitro to investigate any changes in proliferative activity and 




The work described in this chapter was performed in collaboration with by Dr. 
Susana Garcia-Silva. Dr. Silva performed the qRT-PCR from which Figure 3.8 was 
generated. I performed the other experiments presented in this chapter, and generated 
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3.4 Results 
 
3.4.1 C/EBPβ affects the cellular organization of the mammary gland 
 
The level of Cebpb expression was previously shown to be low in the virgin 
mammary gland (Sabatakos et al., 1998). However, its expression in specific 
mammary gland cell populations has not been assessed. Therefore, the level of 
Cebpb expression was first determined in wild type Sca1pos and Sca1neg cells by 
qRT-PCR. The level of Cebpb expression in adult (10-12 week old) wild type 
females is approximately 3-fold higher in Sca1neg cells compared to Sca1pos cells 
(Fig. 3.1). This observation suggests that C/EBPβ may be important in priming 
Sca1neg cells towards alveolar development. To test this, I used the flow cytometric 
staining strategy described in Figure 2.5 to assess potential changes in the cellular 
composition of the luminal compartment in Cebpb-/- mice. The total cellularity of 
Cebpb-/- mammary glands (10-12 weeks old) is approximately 5-fold lower than 
littermate controls (p<0.005) (Fig. 3.2), consistent with the proliferative defects in 
Cebpb-/- mammary glands observed by others in vivo (Robinson et al., 1998; 
Seagroves et al., 1998). In the luminal compartment (LinnegCD29pos CD24hiCD49flo), 
a shift from Sca1neg to Sca1pos cells is observed in Cebpb-/- mice when compared to 
Cebpb+/- or Cebpb+/+ littermates (Fig. 3.3). As well, the previously published 
observations that alveolar proliferation and differentiation are significantly affected 
in the absence of C/EBPβ are consistent with these findings. 
 
Absolute quantification of the luminal (Ma-CFC, Sca1pos, Sca1neg), myoepithelial 
(MRU&MYO) and stromal cells shows that all three populations are significantly 
decreased in Cebpb-/- females (Fig. 3.4 & 3.5). Relative quantification, defined here 
as frequency of Linneg, also shows that luminal cells are increased by approximately 
20 %, with a concomitant decrease in myoepithelial (~35 %) and stromal cells (~45 
%) when compared to wild type littermates (Fig. 3.6). The luminal and myoepithelial 
cells are similar in frequency between Cebpb+/+ and Cebpb+/- mice. However, the 
stromal compartment of Cebpb+/- is reduced compared to Cebpb+/+ to a frequency 
more similar to Cebpb-/-, suggesting that C/EBPβ may be important for the 
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Figure 3.1 Relative expression of Cebpb in ductal (Sca1pos) and alveolar 
(Sca1neg) luminal progenitor cells. Quantitative reverse transcriptase PCR 
analysis of Cebpb expression was performed on sorted ductal and alveolar 
luminal progenitor cells from 12-week old wild type virgin females. The 
values represent the average Cebpb expression normalized to Gapdh from 
two biological replicates (Sample 1 and Sample 2), each assayed in technical 
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Figure 3.2 Total cellularity in the mammary gland of Cebpb-/- mice 
compared to littermate controls. Bar graph and accompanying table 
showing the total number of mammary epithelial cells in Cebpb+/+ (n=3), 
Cebpb+/-, (n=4) and Cebpb-/- (n=5) mice. The values in the bar graph 
represent the mean number of cells (x106) calculated from a minimum of 
three biological replicates (precise number is indicated for each genotype in 
the table). The values in the bar graph represent the mean, and error bars 
indicate standard deviation. Significance (p-value) was calculated using an 
unpaired, one-tailed Student’s T-test. The level of significance is shown by 
stars in the graphs, and numerically in the tables. Abbreviations: SD, 
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Figure 3.3 Deletion of Cebpb alters the cellular composition of the 
mammary luminal compartment. (A) A schematic diagram is shown in the 
top row and illustrates the gating strategy used in the representative FACS 
dot plots below. The CD24/CD49f plot was generated by first gating on 
singlets, live cells, lineage (CD31, CD45, Ter119) negative cells, and CD29 
positive cells (not shown). In the histograms, black lines represent control 
samples, and green lines represent Cebpb-/- samples. Comparison between 
Cebpb+/+ and Cebpb-/- is shown in (A), and comparison between Cebpb+/- 
and Cebpb-/- is shown in (B). 
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Figure 3.4 Absolute quantification of the luminal, myoepithelial and 
stromal cell compartments of the mammary gland in Cebpb-/- mice and 
littermate controls. The three cell populations in the CD24/CD49f plots 
generated as in Fig.3.3A were quantified by multiplying the frequency of total 
cells for each population by the average total number of cells for each 
genotype. The bar graph and accompanying tables show the mean number 
of cells for each population. The number of biological replicates used to 
generate each mean is shown in the tables. Error bars indicate standard 
deviation. Significance (p-value) was calculated using an unpaired, one-tailed 
Student’s T-test. The level of significance is shown by stars in the graphs, 
and numerically in the tables below. Abbreviations: SD, standard deviation; 
N.S., not significant; Ma-CFC, luminal cells; MRU&MYO, basal cells 









Figure 3.5 Absolute quantification of Sca1pos and Sca1neg luminal cells 
in Cebpb-/- mice and littermate controls. The two cell populations in the 
Sca1/CD49b plots generated as in Fig.3.3A were quantified by multiplying 
the frequency of total cells for each population by the average total number 
of cells for each genotype. The bar graph and accompanying tables show the 
mean number of cells for each population. The number of biological 
replicates used to generate each mean is shown in the tables. Error bars 
indicate standard deviation. Significance (p-value) was calculated using an 
unpaired, one-tailed Student’s T-test. The level of significance is shown by 
stars in the graphs, and numerically in the tables below. Abbreviations: SD, 
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Figure 3.6 Relative quantification of the luminal, myoepithelial and 
stromal cell compartments of the mammary gland in Cebpb-/- mice and 
littermate controls. The three cell populations in the CD24/CD49f plots 
generated as in Fig.3.3A were quantified as frequency of Lin (CD31, CD45, 
Ter119) negative cells. The bar graph and accompanying tables show the 
mean frequency of cells for each population. The number of biological 
replicates used to generate each mean is shown in the tables. Error bars 
indicate standard deviation. Significance (p-value) was calculated using an 
unpaired, one-tailed Student’s T-test. The level of significance is shown by 
stars in the graphs, and numerically in the tables below. Abbreviations: SD, 
standard deviation; N.S., not significant; Ma-CFC, luminal cells; MRU&MYO, 
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development of the stroma. Within the luminal compartment, the frequency of 
Sca1pos cells is significantly increased in Cebpb-/-, whereas no change is observed in 
the frequency of Sca1neg cells, except that heterozygous mice appear to have a higher 
frequency of Sca1neg cells when compared to Cebpb+/+ (p=0.04) and Cebpb-/- 
(p=0.003) mice (Fig. 3.7). These analyses demonstrate that C/EBPβ is required for 
appropriate specification of the ductal and alveolar lineages, and in its absence, the 
Sca1pos/Sca1neg ratio is increased significantly, suggesting that C/EBPβ may 
specifically promote alveolar development. 
 
3.4.2 C/EBPβ controls luminal progenitor specification 
 
To determine if the perturbed ductal and alveolar specification resulting from genetic 
deletion of Cebpb is caused by changes in the gene expression of Sca1pos and Sca1neg 
cells, qRT-PCR was performed using the D- and A- gene lists that were developed in 
Chapter 2 (Fig. 2.7). Gene profiling of Cebpb-/- Sca1neg cells shows a general 
increase in D-genes with concomitant decrease in A-genes (Fig. 3.8), suggesting a 
loss of alveolar lineage priming in these cells. In Sca1pos cells, the residual alveolar 
programming is depleted, whereas ductal genes further enriched, albeit at low levels. 
Common luminal genes (Krt18, Sox9, Klf5 and Gata3) are slightly down-regulated in 
both populations. 
 
The change in the Sca1pos/Sca1neg ratio in Cebpb-/- mice, and the increase in ductal 
priming in Cebpb-/- Sca1neg cells suggest that the functional program of these cells 
may be affected. To investigate this, Cebpb-/- Sca1pos and Sca1neg cells were cultured 
in semisolid medium under conditions that promote ductal morphogenesis (heparin, 
FGF, EGF) to assess if Sca1neg cells have the ability to form branched structures in 
vitro. Preliminary data (n=1 for mutant and control) presented in Figure 3.9 shows 
that Cebpb-/- Sca1neg cells form irregularly shaped colonies (Fig. 3.9B) compared to 
the smooth, round colonies formed by the wild type control (Fig. 3.9A). However, 
Cebpb-/- Sca1neg cells did not form branches like wild type ductal progenitor cells. 
As well, Cebpb-/- Sca1pos cells did form some irregularly shaped colonies (Fig. 
3.9B), but displayed a reduced level of branching compared to controls.   
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Figure 3.7 Relative quantification of Sca1pos and Sca1neg luminal cells in 
Cebpb-/- mice and littermate controls. The two cell populations in the 
Sca1/CD49b plots generated as in Fig.3.3A were quantified as frequency of 
Lin (CD31, CD45, Ter119) negative cells. The bar graph and accompanying 
tables show the mean frequency of cells for each population. The number of 
biological replicates used to generate each mean is shown in the tables. 
Error bars indicate standard deviation. Significance (p-value) was calculated 
using an unpaired, one-tailed Student’s T-test. The level of significance is 
shown by stars in the graphs, and numerically in the tables below. 
Supplementary information related to this figure (‘frequency of parent’ 
analysis of Sca1pos and Sca1neg luminal cells) is shown in Appendix 4. 
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Figure 3.8 The effect of Cebpb deletion on gene expression in Sca1pos 
and Sca1neg cells. Gene expression analysis comparing ductal (Prlr, Pgr, 
Areg, Esr1, Foxa1), alveolar (Xdh, Ltf, Elf5, Csn3) and common luminal 
genes (Krt18, Klf5, Gata3) from sorted Cebpb-/- and Cebpb+/+ Sca1pos and 
Sca1neg luminal cells. Gene expression was determined from three biological 
replicates for each genotype, and analyzed in triplicate by qRT-PCR using 
Fluidigm 48.48 dynamic arrays. The values shown are the ratio of the 
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Figure 3.9 The effect of Cebpb deletion on in vitro colony morphology. 
Representative images of Sca1pos and Sca1neg colonies embedded in 
Matrigel, and cultured over a layer of mitomycin-C treated NIH3T3 fibroblast 
cells in the presence of EGF, FGF and heparin for 21 days. Scale bar=100 
µm. (A) Colonies generated from sorted Cebpb+/+ (n=1) Sca1pos and Sca1neg 
cells. Sca1pos colonies are irregularly shaped with some colonies forming 
branches, whereas Sca1neg colonies are smooth and round. (B) Colonies 
generated from Cebpb-/- (n=1) Sca1pos and Sca1neg cells. Some Sca1pos 
colonies are irregularly shaped but lack distinct branches, while most are 
round. Most Sca1neg colonies are round, but not smooth, as in (A).  
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These data suggest that deletion of Cebpb affects the functional output of Sca1pos and 
Sca1neg cells, but additional experiments are required to replicate these data, and to 




3.5.1 C/EBPβ is important for alveolar lineage priming 
 
The previous chapter described the isolation of two luminal progenitor cell 
populations (Sca1pos and Sca1neg cells) and showed that they are differentially primed 
in their gene expression towards ductal and alveolar cell fates, respectively. As well, 
in vivo lineage priming was found to affect the in vitro differentiation potential of 
Sca1pos and Sca1neg cells. However, the genetic mechanisms that regulate the 
specification of these luminal cell fates and their subsequent differentiation is not 
well understood. Recently, several studies began to investigate the role of 
transcription factors (e.g., GATA3, ELF5) in mammary gland development. GATA3 
first emerged as an important marker of breast cancers of luminal origins (Charafe-
Jauffret et al., 2005). This finding prompted further investigation into the possible 
roles of GATA3 during normal mammary gland development, and it was 
subsequently shown that GATA3 is an essential regulator of luminal cell 
differentiation (Asselin-Labat et al., 2006). Targeted (K14) embryonic deletion of 
Gata3 blocks the formation of mammary placodes and nipple epithelia. As well, in 
the adult, loss of GATA3 in the luminal compartment leads to reduced ductal 
elongation and branching, as well as reduced alveolar development during 
pregnancy. This decline in differentiated cell types is coupled with an increase in 
CD61pos luminal progenitors, demonstrating that GATA3 is required for luminal cell 
differentiation. ELF5 was also shown to be important for alveolar differentiation 
(Oakes et al., 2008), and more recently, to play a critical role in specifying the 
luminal cell fate and regulating progenitor/stem cell function (Chakrabarti et al., 
2012). Like Gata3, conditional deletion of Elf5 from the mammary gland leads to a 
block in luminal progenitor cell specification, as shown by the loss of CD61pos 
luminal cells and concomitant increase in K14/K8 double positive cells. On the other 
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hand, over-expression of Elf5 causes precocious alveolar development, including 
milk secretion, in virgin females, demonstrating that ELF5 specifies alveolar cell fate 
in luminal progenitor cells. Based on these findings, and the published observations 
that deletion of Cebpb also leads to defects in alveologenesis and ductal 
development, we decided to investigate the role of C/EBPβ in luminal lineage 
specification more closely. Although the expression of Cebpb is low in the virgin 
mammary gland, its expression is higher in alveolar progenitors than in ductal 
progenitors (Fig. 3.1). This observation suggests that C/EBPβ may be involved in the 
priming of alveolar luminal progenitor cells, similar to ELF5, which could be 
important for their subsequent lineage commitment. Similar observations in 
hematopoietic stem/progenitor cells, where genetic priming defines lineage potential 
in later developmental stages, has been described (Mancini et al., 2011). In 
Mancini’s study, for example, FOG1, a cofactor of GATA proteins, was shown to 
prime hematopoietic stem cells (HSCs) towards the megakaryocytic/ erythroid 
(Mk/E) cell fate, and in its absence, HSCs could not generate Mk/E lineage 
committed progenitors. This study demonstrates that early genetic priming by 
transcription/co-factors, which can precede observable changes in gene expression in 
precursor cells, is required for subsequent lineage commitment.  
 
To investigate whether C/EBPβ is involved in lineage priming of luminal 
progenitors, we assessed the composition of the luminal compartment utilizing our 
new staining strategy, which allowed us to specifically assess C/EBPβ function in 
ductal and alveolar-primed progenitor cells. As previously described, C/EBPβ is 
essential for the proliferation and survival of mammary epithelial cells (Robinson et 
al., 1998; Seagroves et al., 1998; 2000), and consistent with these previous studies, 
we also found that the total cellularity of Cebpb-/- mammary glands is greatly 
reduced (Fig. 3.2). The dot plots also revealed a prominent change in the luminal 
compartment of Cebpb-/- mice (Fig. 3.3). Consistent with the known role of C/EBPβ 
in alveolar development, we observed that alveolar-phenotypic cells are greatly 
reduced in Cebpb-/- mice. Also, the reduction of alveolar-phenotypic cells is coupled 
with an increase in ductal-phenotypic cells, suggesting that normal alveolar 
differentiation may occur through specification of ductal cells (Sca1pos) into alveolar 
	   85	  
cells (Sca1neg). The relative increase in the frequency of total luminal progenitor cells 
(Fig. 3.6) suggests that C/EBPβ is important for maintaining the balance between 
luminal and myoepithelial cell fates, as well as for the correct specification of each 
luminal lineage, as deletion of Cebpb leads to alterations in the frequency of Sca1pos 
and Sca1neg luminal cells (Fig. 3.7, Appendix 4). The analysis in Figure 3.7 shows 
that Sca1pos cells increase in Cebpb-/- mice compared to controls, and Appendix 4 
shows more clearly that the relative frequency of Sca1neg cells decreases in Cebpb-/- 
compared to controls. The latter observation is not clear in the analysis in Fig. 3.7, 
because the increase in the frequency of total luminal cells masks the relative 
decrease in Sca1neg luminal cells. The analysis in Figure 3.7 was performed in this 
way, rather than as frequency of the parent population, to ensure consistency across 
all analyses included in this thesis, including those in Chapter 2, and to allow for 
direct comparison across all data sets. In this instance, these data reveal that in the 
whole mammary epithelium, Cebpb-/- Sca1pos cells are more numerous than in 
controls, whereas Sca1neg cells are of similar frequency. However, when the higher 
frequency of total luminal cells is taken into account (Appendix 4), it becomes more 
evident that there is a relative reduction in Sca1neg cells and relative increase in 
Sca1pos cells, which increases the Sca1pos/Sca1neg ratio from approximately 1.1:1 in 
control mice to approximately 2.5:1 in Cebpb-/- mice. When these experiments were 
performed, the effect of Cebpb deletion in luminal progenitor cells was not known. 
However, a study by LaMarca published in 2010 included very similar observations 
to these (LaMarca et al., 2010). Her investigations also demonstrated that deletion of 
Cebpb leads to accumulation of CD24loSca1pos and reduction of CD24loSca1neg 
luminal cells (LaMarca et al., 2010). As well, the block in the differentiation of 
luminal progenitor cells that we observed (Fig. 3.6), as shown by the relative 
increase in Ma-CFCs (luminal cells) and the relative decrease in MRU&MYO 
(myoepithelial/basal cells), was also shown in LaMarca’s study. 
 
To determine if the changes in the organization of the luminal compartment in 
Cebpb-/- mice are accompanied by changes in the lineage gene signatures of 
phenotypic ductal and alveolar cells, the expression of the representative D- and A-
lineage genes was assessed by qRT-PCR. Figure 3.8 shows that all D-lineage genes 
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tested were up-regulated, and all but one (Ltf) A-lineage gene tested were down-
regulated in both Cebpb-/- Sca1pos and Sca1neg cells. As well, expression of the 
common luminal genes were also down-regulated. Further to these results, LaMarca 
showed that the expression of differentiation markers (e.g., Eya1, Notch3) were also 
down-regulated in Cebpb-/- luminal cells, whereas stem cell genes were up-regulated 
(e.g., Pbx1, K15, K5) (LaMarca et al., 2010). When taken together with the 
observation that the relative frequency of phenotypic ductal cells is higher in Cebpb  
-/- mice than controls, these data demonstrate that alveolar lineage programming is 
dependent on the presence of C/EBPβ.  
 
The data presented in Figs. 2.7, 2.9 and 2.10 demonstrated that lineage priming 
affects in vitro differentiation potential. Therefore, to assess the functional impact of 
the changes in the expression of A-lineage and D-lineage genes that were observed 
in Cebpb-/- mice, Cebpb-/- Sca1pos and Sca1neg luminal cells were cultured in 
semisolid medium. The experiment presented in Figure 3.9 is only a preliminary 
finding. However, initial observations suggest that the colony morphology of Cebpb 
-/- Sca1pos and Sca1neg luminal cells is altered when compared to controls. As well, 
although the colony counts are not presented here, the general impression is that the 
number of colonies is greatly reduced in Cebpb-/- cells when compared to Cebpb+/+ 
cells. This observation is consistent with LaMarca’s findings, who noted that while 
approximately 7 % of luminal cells from Cebpb+/+ mice give rise to colonies, only 2 
% of luminal cells from Cebpb-/- are able to do so (LaMarca et al., 2010). LaMarca 
also noted that Cebpb-/- cells generate smaller colonies than Cebpb+/+ cells. In the 
experiment shown in Figure 3.9, an overt difference in colony size is not observed. 
However, additional experiments may reveal similar observations to LaMarca’s. 
Follow-up experiments to this study will also assess the gene expression pattern of 
cultured Sca1pos and Sca1neg cells to determine if the changes in lineage priming are 
maintained in culture, as was seen for wild type cells (Fig. 2.7). 
 
In summary, the changes in the cellular organization of the mammary gland upon 
deletion of Cebpb demonstrate that C/EBPβ is required for appropriate specification 
of the two luminal cell fates. As well, C/EBPβ promotes alveolar lineage priming, as 
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in its absence, alveolar genes are down-regulated and ductal genes are up-regulated 
in both Sca1pos and Sca1neg luminal cells. Lastly, a preliminary in vitro colony 
forming assay shows that in addition to severe proliferation defects, the changes in in 
vivo lineage priming in Cebpb-/- mice may also affect the in vitro differentiation 
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Cebpb-/- mice exhibit mammary gland developmental defects in ductal 
morphogenesis, and alveolar proliferation and differentiation. Overt defects are not 
observed in prepubertal females, however by 8-12 weeks of age, the ducts are 
morphologically abnormal with fewer branches (Robinson et al., 1998; Seagroves et 
al., 1998). Alveolar development is also disturbed, as transplanted Cebpb-/- 
mammary epithelia form significantly fewer alveoli than controls in response to 
lactogenic hormones. However, the alveoli that form appear histologically normal 
(Robinson et al., 1998; Seagroves et al., 1998). Comparison of gene expression 
arrays of luminal cells (LinnegCD24hiCD29lo) in Cebpb-/- and control mice 
demonstrate that Notch and Wnt/β-catenin signalling pathways are significantly 
altered in Cebpb-/- cells (LaMarca et al., 2010). As well, the expression of basal cell 
markers, such as K5, K14, p63, are also increased in Cebpb-/- luminal cells, 
suggesting that specification of the luminal cell fate may be perturbed in the absence 
of C/EBPβ (LaMarca et al., 2010). Data presented in Chapter 3 illustrates that 
C/EBPβ is specifically required for alveolar lineage commitment, and its absence is 
marked by disturbed organization of the luminal compartment, as well as up-
regulation of ductal genes and concomitant down-regulation of alveolar genes in 
both alveolar and ductal luminal progenitor cells. Investigations into the mechanisms 
of C/EBPβ-mediated lineage specification and commitment have been hampered by 
the lack of known target genes in the mammary gland. To date, no direct in vivo 
targets have been identified for C/EBPβ in the mammary gland, and in vitro studies 
have identified only four mammary genes (Id2, Csn2, Xdh and Prlr) as direct 
C/EBPβ targets (Raught et al., 1995; Kim et al., 2002; Karaya et al., 2005; Seymour 
et al., 2006; Goldhar et al., 2011).  
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4.2 Aims of this chapter 
 
The aim of this chapter is to identify direct C/EBPβ target genes in the mammary 
gland in vivo. The data presented in Chapter 3, together with LaMarca’s observations 
(LaMarca et al., 2010), convincingly demonstrate that C/EBPβ is required for 
luminal lineage commitment and subsequent programming towards alveolar cell fate. 
However, the molecular mechanisms underlying C/EBPβ action remain to be 
elucidated, and the lack of known C/EBPβ target genes in the mammary gland has 
hampered further investigations. Therefore, to identify the direct target genes of 
C/EBPβ in vivo, a chromatin immunoprecipitation sequencing (ChIP-Seq) protocol 
was developed and optimized using freshly isolated mammary luminal cells from 




Dr. Simon Tomlinson curated the microarray and ChIP-Seq data, and generated the 
lists of differentially expressed genes. Dr. Susana Garcia-Silva prepared the virgin 
luminal cells and I prepared the pregnant luminal cells for microarray. Susan Moore 
performed the luciferase assay presented in Figure 4.14. I performed all other 
experiments and analyses presented in this chapter. The bioinformatics tool used to 
generate some of the figures (GeneProf) was developed by Florian Halbritter 




4.4.1 Gene expression comparison between differentiated alveolar cells and two 
luminal progenitors 
 
My interest in investigating the role of C/EBPβ in alveolar programming prompted 
me to include a second time point in alveolar development (day 16.5 of pregnancy, 
denoted as P16.5). Choosing this second developmental time point late in late 
pregnancy enabled the investigation of C/EBPβ function in differentiated alveolar 
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cells that have not yet entered the secretory phase. The flow cytometric strategy used 
to isolate mature alveolar cells at P16.5 (LinnegCD29posCD24hiCD49floSca1neg) for 
microarray analysis and ChIP-Seq is shown in Figure 4.1A. In P16.5 mammary 
glands, the Sca1pos luminal cells (last plot to the right) almost completely disappear. 
The loss of Sca1pos luminal cells and concomitant increase in Sca1neg luminal cells is 
consistent with a shift from predominantly ductal to predominantly alveolar cells 
during late pregnancy (Brisken and O’Malley, 2010).  
 
The differentially expressed gene set for P16.5 was generated by selecting the 
common differentially expressed genes from the comparisons between P16.5 and 
virgin Sca1neg cells, and P16.5 and virgin Sca1pos cells (FDR ≤0.01). P16.5 alveolar 
cells differentially express 1198 genes. When the changes in gene expression of the 
selected ductal and alveolar genes (from Chapter 2) are analyzed, they show that 
ductal genes are strongly down-regulated in P16.5 when compared to Sca1pos cells, 
and alveolar genes are strongly upregulated, except for Ltf (Fig. 4.1B). When 
compared to Sca1neg cells, the directions of change in gene expression are variable 
for both ductal and alveolar genes. For example, while Pgr and Areg are down-
regulated in P16.5 compared to Sca1neg cells, Prlr and Esr1 are more highly 
expressed (Fig. 4.1C). As well, the expression of the alveolar genes Csn3, Xdh and 
Elf5 are further enriched, as expected, but Ltf is down-regulated. The common 
luminal genes in both comparisons are down-regulated. These data show a clear 
distinction in the gene expression of Sca1pos cells and P16.5 alveolar cells, 
demonstrating their unique lineage identity, whereas no clear trend is apparent 
between Sca1neg cells and P16.5, suggesting that they are more closely related cell 
types. 
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Figure 4.1 Flow cytometric profile and gene expression analysis of 
P16.5 (day 16.5 of pregnancy) luminal cells. (A) Schematic diagram (top 
row) and representative dot plots (bottom row) depicting the gating strategy 
used to isolate Sca1neg luminal cells from P16.5 pregnant mice (termed as 
P16.5). Cells were first gated on scatter to obtain singlets. Then lineage 
(CD31, CD45, Ter119) positive cells were excluded, and Linneg cells were 
selected based on CD29 expression. CD29pos cells were then evaluated for 
CD24 and CD49f expression. CD24hiCD49flo cells were further subdivided 
based on Sca1 expression. (B) The expression of the ductal-specific and 
alveolar-specific genes identified in Figure 2.7 was assessed in P16.5 
luminal cells. The normalized, annotated, filtered expression values are 
shown as the ratio between the average P16.5 (n=4) and virgin Sca1pos (n=3) 
values after log2 transformation. (C) Same as in (B), except that P16.5 
expression values were compared with virgin Sca1neg rather than Sca1pos. 
Abbreviations: SSC, side scatter; FSC, forward scatter; SSC-A, side scatter 
area; Lin, lineage; 7-AAD, 7-aminoactinomycin-D. 
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4.4.2 Optimization of C/EBPβ chromatin immunoprecipitation  
 
To provide insight into how C/EBPβ regulates alveolar lineage specification, the 
genome-wide occupancy of C/EBPβ was investigated in ductal and alveolar 
progenitors, as well as in P16.5 alveolar cells using chromatin immunoprecipitation 
sequencing. An overview of the method is shown in Figure 4.2A. Following cell 
sorting as described previously (Chapter 2), the cells were fixed with 1 % 
formaldehyde, lysed and sonicated. Optimization of the SDS concentration of the 
sonication buffer is shown in (Appendix 5). To obtain fragmented chromatin with an 
average DNA length of 200-400 base pairs (bp), which is optimal for deep 
sequencing, different sonication conditions were tested (data not shown). The 
optimal sonication condition for mammary epithelial cells was determined to be 50 
cycles of 30 seconds on/30 seconds off on a high setting using a Bioruptor 
Diagenode waterbath sonicator (Fig. 4.2B).  
 
Next, in order to validate the chromatin immunoprecipitation experiment, a known 
C/EBPβ target gene was needed as a positive control. Due to the lack of known in 
vivo C/EBPβ target genes, in silico analysis (TRANSFAC) was used to identify 
putative C/EBPβ binding sites in the three published in vitro target genes (Xdh, Id2, 
Csn2) and an additional predicted target gene (Gata3) (Fig. 4.3A). These analyses 
were then used to design quantitative PCR (qPCR) assays (colored bars below gene 
schematics) against the genomic regions where C/EBPβ binding has been 
demonstrated (red triangles), or was expected based on the bioinformatics analyses 
(orange triangles). Quantitative PCR assays were also designed to screen unbound 
regions within the same gene to serve as intralocus negative controls. Quantitative 
PCR assays were successfully designed for screening bound regions in three of the 
four genes (Xdh, Id2, Gata3). However, although a qPCR assay was designed against 
the published binding sites in Csn2, this assay failed during initial testing, and 
because an alternate assay could not be designed in the same genomic region, it was 
excluded in subsequent experiments. 
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Figure 4.2 Overview of the C/EBPβ chromatin immunoprecipitation 
(ChIP) method. (A) Flow chart showing the steps in ChIP-Seq. (B) 2 % 
agarose gel shows the fragmented chromatin from sorted Sca1neg and 
Sca1pos luminal cells after optimization of sonication conditions. 
Abbreviations: M, marker. 




Figure 4.3 Screening of published C/EBPβ target genes in Sca1neg 
luminal cells. (A) Schematic diagram (not to scale) showing the 3 published 
(Xdh, Id2, Csn2) and one putative (Gata3) target genes of C/EBPβ. The 
transcription start site is indicated by a black arrow for each gene. Exons are 
indicated as thicker lines, with black exon comprising untranslated regions 
and grey exons comprising the coding regions for each gene. Published (red 
arrow heads) and putative (orange arrow heads) C/EBPβ binding sites are 
indicated. Quantitative PCR assays for each gene are shown as colored bars 
below each gene schematic. (B) Quantitative PCR assessment of C/EBPβ 
ChIP using chromatin from sorted Sca1neg luminal cells form 10-week old 
virgin females. Chromatin was immunoprecipitated with C19 anti-C/EBPβ or 
non-immune rabbit IgG. The bar graph represents fold enrichment between 
input-standardized C/EBPβ and IgG ChIP (2-ΔΔCp). Colors correspond to the 
qPCR assays shown in (A). 
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The initial ChIP experiments were performed using Sca1neg cells isolated from 10-
week old virgin females. Each sample tube contained fragmented chromatin from 
100,000 Sca1neg luminal cells, and was immunoprecipitated using an anti-C/EBPβ 
antibody (C19) or control IgG (rabbit, of equal µg quantity to the anti-C/EBPβ 
antibody). The amount of antibody used in each sample tube was first titrated 
(Appendix 5) using the published binding sites in Xdh, and the optimal concentration 
(0.5 µg) was then used to assess binding in the other target genes (Fig. 4.3B). To 
calculate fold enrichment, the 2-ΔCp and 2-ΔΔCp methods were used, which compare 
the input-standardized Cp values of the C/EBPβ ChIP and the control IgG ChIP. 
Optimization of the washing and elution conditions was then conducted to increase 
the signal to noise ratio (data not shown). These experiments led to the observation 
that in Sca1neg cells, C/EBPβ binds to the Xdh promoter, but not to the Id2 or Gata3 
promoters (Fig. 4.3B). Binding in Csn2 could not be determined because of the 
inability to design qPCR assays near the binding sites. The ChIP method was 
validated by 5 independent experiments, which reproducibly showed significant 
enrichment in the Xdh promoter (Xdhbound) compared to the intralocus negative 
control (Xdhunbound) and an interlocus negative control (Hbb-b1 encoding β-globin) 
(Fig. 4.4). 
 
An overview of the sequencing library sample preparation is shown in Figure 4.5A. 
Each sequencing library was prepared from 5 tubes of ChIP-ed DNA (2 ng of input 
material) and was verified by qPCR (Fig. 4.5C,D). The enrichment in C/EBPβ 
binding to the promoter of Xdh is highest in P16.5, followed by Sca1neg cells then 
Sca1pos cells, which correlates with increasing levels of Xdh expression in these cells 
(Fig. 4.5B). An example of an electropherogram from a sequencing library is shown 
in Figure 4.6A. Electropherograms were generated by the University of Edinburgh 
Genepool to verify the quality of each sequencing library. The quality of the 
sequencing libraries was assessed based on the distribution of DNA fragments, the 
size range and concentration of the DNA (Fig. 4.6B). All of the sequencing libraries 
displayed symmetrical distribution of the DNA fragments, had an appropriate size-
range of 150-400 bp for Solexa sequencing, and had sufficient DNA concentration to 
pass the initial quality checks.  
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Figure 4.4 C/EBPβ ChIP in Sca1neg luminal cells from five independent 
experiments. (A) Quantitative PCR assessment of C/EBPβ ChIP using 
chromatin from sorted Sca1neg luminal cells form 10-week old virgin females 
performed as in Fig. 4.3 from 5 independent experiments. The bar graph (E) 
represents fold enrichment between input-standardized C/EBPβ and IgG 
ChIP (2-ΔΔCp). Error bars indicate standard deviations. P-values were 
calculated using an unpaired, one-tailed Student’s T-test, and significance is 
shown as a star in the graph and as a value in the table below (F). Hbb-b1 
(encoding β-globin) was used as an additional negative control. 
Supplementary information related to this figure (further optimization 
experiments) is shown in Appendix 5. Abbreviations: SD, standard 








Figure 4.5 DNA sequencing library preparation. (A) General flow chart 
showing the steps in preparing DNA sequencing libraries using the Illumina 
ChIP-Seq Sample Preparation kit. (B) Average (RMA normalized) expression 
values (log2) of Xdh from the microarray analysis for Sca1pos (n=3), Sca1neg 
(n=3) and P16.5 cells (n=4). Values represent the mean, and error bars 
indicate standard deviations. (C) Quantitative PCR assessment of C/EBPβ 
ChIP using chromatin from sorted Sca1pos and Sca1neg (10-week old virgin 
females) and from sorted P16.5 alveolar cells (day 16.5 of pregnancy). 
Chromatin was immunoprecipitated with C19 anti-C/EBPβ or non-immune 
rabbit IgG. The bar graph represents fold enrichment between input-
standardized C/EBPβ and IgG ChIP (2-ΔΔCp). (D) Quantitative PCR 
assessment of DNA sequencing libraries prepared from samples in (C) using 
the method shown in (A). The bar graph represents fold enrichment between 
input-standardized C/EBPβ and IgG ChIP (2-ΔΔCp). Abbreviations: ChIP, 
chromatin immunoprecipitation; dA, deoxyadenine; P16.5, pregnant day 16.5 











Figure 4.6 Size distribution of DNA sequencing libraries. (A) 
Representative bioanalyzer trace using an HS CHIP showing the size range 
and distribution of DNA fragments in the sequencing library. (B) Table 
showing the average fragment length and concentration of each sequencing 
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4.4.3 Analysis of genome-wide C/EBPβ occupancy in three mammary gland cell 
populations 
 
The ChIP-Seq and microarray data were curated by Dr. Simon Tomlinson using 
Geneprof, and the workflow is shown in Figure 4.7. The datasets contained between 
4-8x107 aligned reads, with approximately 60 % of reads uniquely aligning to the 
mouse genome (Appendix 6). The chromosomal distribution of the reads was similar 
between the C/EBPβ and control IgG ChIP (Appendix 7). The data presented in 
Figure 4.8A shows that C/EBPβ binding occurs throughout the genome. 
Approximately a quarter of C/EBPβ binding occurs in regions between 0-5 kilobase 
(kb) upstream from the transcription start site (narrow promoter [±500 bp], wide 
promoter [±2000 bp], 5 kb upstream), a quarter in regions between 10-50 kb 
upstream of the transcription start site (distal regulatory elements), a quarter in 
introns, and a quarter of binding sites could not be mapped to known genes. The 
most highly enriched binding motif found in the C/EBPβ peaks is TTGCGCAA (Fig. 
4.8B), which is in agreement with the consensus C/EBP binding motif of 
RTTGCGYAAY, where R=A/G and Y=C/T (Osada et al., 1996). The number of 
C/EBPβ binding sites increases from Sca1pos cells (1502) to Sca1neg cells (6976) to 
P16.5 (14,118) (Fig. 4.8C). As well, almost all of C/EBPβ binding events in Sca1pos 
cells are present in Sca1neg cells (94.5 %) and P16.5 (96.3 %). Furthermore, most of 
the binding events in Sca1neg cells are also present in P16.5 (95.8 %), whereas 
approximately half of the binding events in P16.5 are unique (52.4 %). These 
observations demonstrate a correlation between the frequency of genome-wide 
C/EBPβ occupancy and alveolar lineage commitment, as the more committed the cell 
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Figure 4.7 Schematic diagram depicting the work flow used in the 
analysis of the ChIP-Seq data sets. Fifty base pair single-end reads were 
trimmed to remove adapter sequences and aligned to the mouse genome 
(Ensembl 58 Mouse genome NCBIM37 Assembly) using Bowtie. For quality 
control, the mean quality score was calculated for each data set by summing 
up all of the quality scores for each read and dividing the sum by the length 
of the read. A mean quality score of ≥8 passed the quality control filter. Peak 
calling was performed using MACS, and transcription factor binding sites 
(TFBS) were annotated to genes using the default parameters on Geneprof. 
To compare C/EBPβ binding with gene expression, the annotated binding 
peaks were compared to RMA-normalized and quality-filtered expression 
values from the mouse exon arrays. Supplementary information related to 
this figure (quality control analyses of ChIP-Seq data sets) is shown in 
Appendices 6&7. Abbreviations: MACS, model-based analysis of ChIP-
Seq; TFAS, transcription factor associated score; TFBS, transcription factor 
binding site. 




Figure 4.8 Genome-wide binding characteristics of C/EBPβ. (A) C/EBPβ 
occupancy in different genomic regions in Sca1pos cells, Sca1neg cells and 
P16.5 alveolar cells. Transcription factor binding sites were annotated to 
genomic regions based on the distance of the binding peak from known 
transcription start sites. (B) Motif analysis showing that the canonical C/EBPβ 
binding site is the most highly enriched motif in the binding peaks. (C) The 
Venn diagram depicts the total number of C/EBPβ binding events in Sca1pos, 
Sca1neg and P16.5 alveolar cells. Almost all Sca1pos binding events are 
shared with Sca1neg and P16.5, and almost all Sca1neg binding events are 
shared with P16.5. About one half of P16.5 binding events are unique. 
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To further investigate how C/EBPβ occupancy correlates with lineage commitment, 
the pattern of C/EBPβ binding within each gene signature was assessed. The 
frequency of C/EBPβ occupancy is low within the ductal gene signature in Sca1pos 
cells, with approximately 7.5 % of ductal-lineage specific genes bound by C/EBPβ 
(Fig. 4.9). In Sca1neg cells, the frequency of C/EBPβ occupancy within the alveolar-
lineage specific gene signature is 43.1 %, and in P16.5 alveolar cells, C/EBPβ 
binding within the mature alveolar gene signature is 48 %. Functional annotation 
clustering analysis of the C/EBPβ bound genes within Sca1pos cells did not generate 
any clusters that met the enrichment score cutoff of ≥2, whereas the unbound genes 
formed the same functional clusters as described in Chapter 2 (Fig. 4.10A). In 
Sca1neg cells, one functional annotation cluster passed the enrichment score cutoff of 
≥2 for genes not bound by C/EBPβ (Fig. 4.10B). This cluster included the gene 
ontology (GO) terms: cell motion/migration/localization/motility and receptor 
tyrosine kinase/protein/cell surface signalling. For C/EBPβ-bound genes, two 
clusters emerged that contain genes involved in functions related to 
glycoproteins/signal peptide/disulfide bonding and extracellular matrix interactions 
(GO terms: carbohydrate/pattern/polysaccharide /glycosaminoglycan binding and 
cell surface) (Fig. 4.10C). In pregnant alveolar cells, eight clusters emerged for 
unbound genes (Fig. 4.11A). These genes encode extracellular matrix/basement 
membrane/collagen components, mitotic factors, proteins involved in microtubule-
based processes and GTPase regulators. Genes bound by C/EBPβ in P16.5 are also 
enriched in mitotic factors, extracellular matrix components and proteins involved in 
secretion/glycosylation/disulfide bond formation (Fig. 4.11B). In addition to these 
shared processes, C/EBPβ bound genes are also involved in ATP-binding, 
cytoskeleton organization, preparation of chromosomes for cell division, and 
inflammatory responses. These analyses reveal that C/EBPβ target genes have 
distinct functions from non-targets within the two alveolar cell populations, but not 
in ductal progenitor cells.  
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Figure 4.9 C/EBPβ occupancy within the gene signatures of Sca1pos, 
Sca1neg and P16.5 alveolar cells. Lineage-specific gene lists for Sca1pos 
and Sca1neg luminal cells were generated by performing a pair-wise 
comparison between the normalized expression values from the microarrays. 
Differential expression was considered significant if the false detection rate 
(FDR) was ≤0.01. The lineage-specific gene list for P16.5 was generated by 
performing two pair-wise comparisons (P16.5 vs virgin Sca1pos and P16.5 vs 
virgin Sca1neg) using normalized expression values (differential expression 
was considered significant in FDR ≤0.01) and extracting the common unique 
genes from each comparison. Each gene signature was then compared 
against the annotated C/EBPβ target genes, and the frequency of C/EBPβ 
binding is shown as a bar graph (bound + unbound = 100 %). 
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Figure 4.10 Functional annotation clustering analysis of C/EBPβ bound 
and unbound genes in Sca1pos and Sca1neg luminal cells. (A) Functional 
clusters were generated from ductal-lineage specific genes. The transcript 
cluster IDs of differentially expressed genes (from Fig. 2.7) were grouped 
based on C/EBPβ binding (bound and unbound genes), and these gene lists 
analyzed using the DAVID Bioinformatics Resource using default 
parameters. Functional clusters were included in the figure if they had an 
enrichment score of ≤2. No functional clusters passed this enrichment score 
cut-off for C/EBPβ-bound genes in Sca1pos cells. (B&C) Functional clusters 
were generated from alveolar-lineage specific genes using the same analysis 
as in (A). Supplementary information related to this figure (complete list of 
functional clusters) is shown in Appendix 8-10. 
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Figure 4.11 Functional annotation clustering analysis of C/EBPβ bound 
and unbound genes in P16.5 alveolar cells. (A&B) Functional clusters 
were generated from mature alveolar genes using the same analysis as in 
Fig. 4.10. Supplementary information related to this figure (complete list of 
functional clusters) is shown in Appendix 8-10. Abbreviations: P16.5, 
pregnant day 16.5 alveolar cells. 
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To further demonstrate that C/EBPβ occupancy is important in alveolar 
development, wiggle tracks were generated for the ductal and alveolar gene 
signatures shown in Figure 4.1. The ductal genes Pgr, Areg and Foxa1 are not bound 
by C/EBPβ in any of the three cell types (Fig. 4.12B,C,E). Whereas Prlr and Esr1 
(Fig. 4.12A,D), both of which are ductal genes in the virgin mammary gland but 
have known functions in alveolar development during pregnancy and lactation, are 
bound by C/EBPβ, with increased occupancy (higher peaks=increased number of 
reads) observed in the progression towards differentiated alveolar cell identity (i.e., 
lowest/no peak in Sca1pos, mid-size peak in Sca1neg, large peak in P16.5). On the 
other hand, all of the alveolar genes from Figure 4.1 (Csn3, Xdh, Ltf, Elf5) are bound 
by C/EBPβ (Fig. 4.12F-I). The same general pattern of binding can be observed for 
most of the C/EBPβ target genes, whereby small or no binding peaks are seen in 
Sca1pos cells, medium-sized binding peaks are seen in Sca1neg cells, and large binding 
peaks are present in P16.5. As well, several of the genes acquire new binding sites in 
P16.5 alveolar cells (e.g., Prlr, Csn3, Xdh) that are not present in the progenitor cells. 
These examples, together with the bioinfomatics analysis of global C/EBPβ 
occupancy in each gene signature (Fig. 4.9) further demonstrate that C/EBPβ 
preferentially binds alveolar genes, and the level of C/EBPβ occupancy is correlated 
with the level of differentiation in alveolar cells. 
 
Some of the common luminal genes were also bound by C/EBPβ, although the 
pattern of binding is more variable. For example, Krt18 and Sox9 are only bound in 
P16.5, with no binding observed in Sca1neg and Sca1pos cells (Fig. 4.12J,K). Klf5 is 
bound by C/EBPβ in all three populations, albeit the peak in Sca1pos cells is very 
small (Fig. 4.12L). There is one small binding peak in Sca1neg cells and two small 
binding peaks in P16.5 for Gata3, albeit not in the proximal promoter region of the 
gene (Fig. 4.12M). It is possible that these peaks correspond not to Gata3, but to 
another gene located in this genomic region (930412013Rik), whose transcription 
start site is near the position of the two small peaks. Two other distinct peaks are also 
observed within Gata3 in Sca1pos cells, but these peaks are present in the IgG control 
as well, therefore they would not be considered real binding events. Id2, a gene 
demonstrated to be a target of C/EBPβ in vitro (using NIH3T3 cells), is not bound in 
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Sca1pos, Sca1neg or P16.5 cells (Fig. 4.12N), consistent with the results obtained from 
the ChIP experiments presented in Figure 4.3B. Csn2, on the other hand, is bound by 
C/EBPβ in P16.5 (Fig. 4.12O) but is not bound in Sca1pos and Sca1neg cells. The 
absence of C/EBPβ binding in Sca1neg cells was corroborated by the qPCR assay 
presented in Figure 4.3B that was initially designed as a negative control for Csn2 in 
the region near these binding sites (between exons 3 and 4). The number of genes 
bound by C/EBPβ in Sca1pos cells is fewer than in Sca1neg cells and P16.5, and only a 
few unique genes were found that contain a C/EBPβ binding peak. One such 
example, shown in Figure 4.12P, is the gene encoding the V-type proton ATPase 
subunit B (Atp6v1b1). 
 
Four target genes were chosen thus far for qPCR validation of the Solexa sequencing 
results. Quantitative PCR assays were designed against the newly identified C/EBPβ 
binding sites (bound) and another region within each of the genes where binding was 
not observed (unbound). These qPCR assays were then tested on ChIP-ed DNA from 
Sca1pos, Sca1neg and P16.5 alveolar cells (Fig. 4.13). These qPCR data corroborate 
the binding patterns observed in the wiggle tracks. For example, the level of 
enrichment for Prlr is highest in P16.5, then Sca1neg, and lowest in Sca1pos. This 
same pattern is observed for Csn3 and Csn2, while the opposite pattern is observed 
for the ductal-specific binding of Atp6v1b1, consistent with the wiggle track in 
Figure 4.12P.  
 
Overall, these data demonstrate that C/EBPβ binds alveolar genes, and C/EBPβ 
occupancy in these genes increases as the cells progress towards alveolar 
differentiation. These observations support the hypothesis that C/EBPβ directs 
alveolar lineage specification and commitment. The role of C/EBPβ in the ductal 
lineage is equivocal, as almost all of the genes bound by C/EBPβ in the ducts are 
shared with Sca1neg cells and P16.5, and querying the C/EBPβ-bound genes in the 
ductal gene signature did not identify a role in any unique cellular functions. 
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Figure 4.12 Examples of C/EBPβ binding in Sca1pos, Sca1neg and P16.5 
alveolar cells. Wiggle tracks were generated using Geneprof to illustrate the 
pattern of C/EBPβ binding in ductal-lineage and alveolar-lineage genes (from 
the genes used as examples in Fig. 2.7). A schematic diagram for each gene 
is shown at the top (to scale), followed by wiggle tracks of the ChIP-Seq data 
for non-immune IgG (C=control) and C/EBPβ (IP=immunoprecipitation) for 
Sca1pos, Sca1neg and P16.5 alveolar cells. The orientation for each gene is 
denoted by a plus (+) or minus (-) sign after the gene name, where plus (+) 
indicates forward orientation, and minus (-) indicates reverse orientation. (A-
E) Ductal lineage genes. (F-I) Alveolar lineage genes. (J-M) Common luminal 
genes. (N-O) Published C/EBPβ target genes. (P) Example of a gene that is 
bound by C/EBPβ only in Sca1pos cells. Abbreviations: C, IgG 
immunoprecipitation; IP, C/EBPβ immunoprecipitation; P16.5, pregnant day 
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Figure 4.13 Validation of C/EBPβ binding. Quantitative PCR assays were 
designed against newly identified binding sites and intralocus negative 
controls for four C/EBPβ target genes (Prlr, Csn3, Csn2, Atp6vb1). 
Enrichment for C/EBPβ-binding was assessed using DNA sequencing 
libraries prepared with the Illumina ChIP-Seq Sample Preparation kit for 
Sca1pos, Sca1neg and P16.5 alveolar cells. The bar graphs represent fold 
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4.4.4 Elf5 is a direct C/EBPβ target gene in vivo 
 
The observations that Elf5 expression in down-regulated in Cebpb-/- mice (Fig. 3.8), 
and that Elf5 is a direct target of C/EBPβ in vivo (Fig. 4.12I), led us to propose that 
C/EBPβ may regulate alveolar priming and differentiation, at least in part, by direct 
activation of Elf5 expression. The Elf5 gene is transcribed from two distinct 
promoters (Fig. 4.14A). The wiggle track in Figure 4.12I and the follow-up ChIP 
experiment shown in Figure 4.14A demonstrate that C/EBPβ binds the downstream 
proximal promoter (variant 1, TSS1) of Elf5, with no enrichment observed at the 
upstream promoter (variant 2, TSS2). To demonstrate that C/EBPβ binding activates 
Elf5 transcription, in vitro luciferase reporter assays were performed. The promoter 
region of the Elf5 variant 1 containing the C/EBPβ binding site was cloned into a 
luciferase reporter vector and co-transfected with an expression vector encoding 
C/EBPβ (pcDNA3-Cebpb). Four-fold higher Elf5 promoter-driven luciferase activity 
was measured with co-transfection of 100 ng of the C/EBPβ expression vector 
compared to the empty vector control (Fig. 4.14B), demonstrating that C/EBPβ 
binding is sufficient to activate Elf5 gene transcription.  
 
To further investigate the relationship between C/EBPβ and ELF5 downstream 
signalling, C/EBPβ binding was assessed in several known ELF5 target genes. 
Ccnd2, Muc4 and Igfbp4 were recently identified as direct in vivo targets of ELF5 in 
unfractionated pregnant (P17.5) mammary tissue (Escamilla-Hernandez et al., 2010). 
C/EBPβ binding was found in Ccnd2 and Muc4 in P16.5 alveolar cells, but not in 
Sca1neg or Sca1pos cells (Fig. 4.15A-B). Igfbp4 was also found to be a C/EBPβ target 
in P16.5 cells and Sca1neg cells, but not in Sca1pos cells (Fig.4.16A). These data 
suggest that C/EBPβ and ELF5 may co-regulate the expression some target genes. 
However, due to the limited number of known Elf5 target genes in the mammary 
gland, these investigations were not exhaustive. To address this shortcoming, the 
ChIP method was optimized for ELF5 to globally identify its target genes in Sca1pos, 
Sca1neg and P16.5 cells. A preliminary ELF5 ChIP experiment is shown in Figure 
4.16B. Using two commercially available anti-ELF5 antibodies (H62 and AP7394C), 
a high level of enrichment is observed in the bound promoter of Ifgbp4, whereas no  
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Figure 4.14 Elf5 is a C/EBPβ target gene. (A) Schematic diagram (not to 
scale) showing the alternative first exons of the Elf5 gene, giving rise to 
variant 1 (TSS1) and variant 2 (TSS2). Both transcripts encode the same 
protein. Underneath the schematic diagram, the position of the seven 
amplicons used for ChIP analysis is indicated by black boxes/numbers. 
Numbering is relative to TSS1, where TSS1=1. The graph below show a 
representative ChIP experiment performed on sorted Sca1neg cells from 10-
week old virgin females. Chromatin was immunoprecipitated with C19 anti-
C/EBPβ or non-immune rabbit IgG. The values represent fold enrichment   
(2-ΔCp) after standardization against non-immunoprecipitated gDNA (input) 
and normalization against Hbb-b1 (encoding β-globin). Xdh was used as a 
positive control. (B) Schematic diagram (left) showing the design of the firefly 
luciferase reporter vector using the promoter region of Elf5 variant 1. The 
numbering in the schematic diagram is relative to TSS1. The firefly luciferase 
reporter construct was co-transfected with pcDNA3-Cebpb expression vector 
and phRL-CMV (renilla luciferase internal control), and promoter activation 
was assessed using the DLR kit (Promega). The values in the bar graph 
represent the mean firefly-to-renilla ratio from 3 experimental wells, each 
read in triplicate, after background subtraction (empty vector signal), and 
setting the baseline value to 1. Error bars indicate standard deviation 
between replicate wells. The p-value was calculated using an unpaired, one-
tailed Student’s T-test, and significance is shown as a star and value above 
the graph. Abbreviations: TSS, transcription start site; Luc, firefly luciferase. 
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Figure 4.15 Co-regulation of Ccnd2 and Muc4 by C/EBPβ and ELF5. 
(A&B) Wiggle tracks were generated using Geneprof to illustrate the pattern 
of C/EBPβ binding in two published ELF5 target genes. A schematic diagram 
for each gene is shown at the top (to scale), followed by wiggle tracks of the 
ChIP-Seq data for non-immune IgG (C=control) and C/EBPβ 
(IP=immunoprecipitation) for Sca1pos, Sca1neg and P16.5 alveolar cells. The 
orientation for each gene is denoted by a plus (+) or minus (-) sign after the 
gene name, where plus (+) indicates forward orientation, and minus (-) 
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Figure 4.16 Co-regulation of Igfbp4 by C/EBPβ and ELF5. (A) The wiggle 
track was generated using Geneprof to illustrate the pattern of C/EBPβ 
binding in Igfbp4, a published ELF5 target gene. A schematic diagram is 
shown at the top (to scale), followed by wiggle tracks of the ChIP-Seq data 
for non-immune IgG (C=control) and C/EBPβ (IP=immunoprecipitation) for 
Sca1pos, Sca1neg and P16.5 alveolar cells. The orientation for Igfbp4 is 
denoted by a plus (+), and indicates forward orientation. (B) Preliminary 
ELF5 ChIP experiment performed on sorted alveolar cells from day 1 of 
lactation. Chromatin was immunoprecipitated with anti-ELF5 antibodies (H62 
and AP7394C) or non-immune rabbit IgG. The values represent fold 
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enrichment is observed in the unbound intralocus control. ChIP-Seq experiments to 
assess genome-wide ELF5 binding are currently ongoing and will be continued in 




4.5.1 Comparison of gene signatures in Sca1pos, Sca1neg and P16.5 cells 
 
While mature ductal cells are present in the mammary gland around puberty, alveolar 
cells only mature during mid to late pregnancy and become fully differentiated 
secretory cells following parturition (Richert et al., 2000; Anderson et al., 2007). 
Therefore, to assess the molecular mechanisms through which C/EBPβ regulates 
alveolar development, a second time point in late pregnancy (P16.5) was chosen. 
Choosing this time point in late pregnancy rather than after birth (when alveoli are 
fully differentiated) was based on the observations that C/EBPβ is most highly 
expressed during pregnancy, with low levels of expression observed in the virgin and 
lactating mammary gland (Gigliotti and DeWille, 1998; Robinson et al., 1998; 
Sabatakos et al., 1998).  
 
To investigate C/EBPβ function in P16.5 luminal cells, we first analyzed their global 
gene expression profile. The flow cytometric strategy used to isolate P16.5 cells is 
similar to that used to isolate luminal progenitors in the adult virgin gland, except 
that singlets were selected for based on the FACSJAZZ-specific parameters trigger 
pulse width and SSC-488 rather than FCS-A and FCS-H, as on the FACSAriaII (Fig. 
4.1A). While the intention was to isolate Sca1pos and Sca1neg luminal cells from the 
pregnant mammary gland, the Sca1pos cells were almost completely absent (Fig. 
4.1A). During early pregnancy, alveolar progenitor cells rapidly proliferate, and 
during mid to late pregnancy, they begin to differentiate (Anderson et al., 2007). 
These in vivo morphological and functional changes are consistent with the alteration 
in the cellular composition of the luminal compartment (compare Fig. 2.5A and Fig 
4.1A), which shows that by day 16.5 of pregnancy, almost all of the luminal cells 
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have a Sca1neg phenotype (Fig. 4.1A), which we have previously shown to be 
associated with an alveolar cell identity (Chapter 2). 
 
P16.5 luminal cells differentially express 1198 unique genes when compared to 
Sca1neg and Sca1pos cells (FDR ≤0.01). The expression of alveolar genes is highly 
upregulated in P16.5 (e.g., Csn3, Xdh), while the expression of ductal genes (e.g., 
Prg, Areg) is further suppressed (Fig. 4.1B,C). Prlr and Esr1 are exceptions to this 
pattern, as they are more highly expressed in P16.5 than in Sca1neg cells. However, 
this is consistent with their established biological role (discussed in Chapter 1) in 
alveolar differentiation during pregnancy (Brisken et al., 1999; Mallepell et al., 
2006). Interestingly, the expression of the alveolar gene Ltf is down-regulated in 
P16.5 cells when compared with Sca1pos and Sca1neg cells (Fig. 4.1B,C). Lactoferrin 
is an iron-binding protein found in milk, with known functions in innate immunity 
(Clarkson et al., 2004). In unfractionated mammary tissue, Ltf is expressed at low 
levels in the virgin and pregnant gland, with a sharp, but moderate increase at 
parturition, and a substantial increase during involution (Molenaar et al., 1996; 
Clarkson et al., 2004). Its role as a soluble innate defense factor is consistent with an 
increase in Ltf expression during periods when the mammary gland is most 
vulnerable to infections (lactation) or when immune cells are known to be active 
(involution) (Clarkson et al., 2004). In reference to Ltf expression in ewes and cows, 
Molenaar noted that overall expression appears to be inversely related to the degree 
of alveolar differentiation (i.e., secretory alveolar cells have lower Ltf expression 
than pre-secretory alveolar cells) (Molenaar et al., 1996). However, these findings 
are inconsistent with Clarkson’s observation showing that Ltf expression is 
approximately 2-fold higher in lactating mammary glands than during pregnancy 
(Clarkson et al., 2004). Our gene expression arrays (n=3 for Sca1neg and Sca1pos 
cells, n=4 for P16.5) show that Ltf expression is higher in Sca1neg and Sca1pos cells 
than in P16.5, but we did not assess Ltf expression in the lactating mammary gland, 
therefore the relationship between our findings and the published studies is not clear 
(Fig. 4.1C). At present, the functional significance of our observation that Ltf 
expression is lower in P16.5 mammary glands than in virgin progenitor cells is 
unclear, and provides an interesting area for future investigation.  
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In summary, these data show that P16.5 luminal cells are enriched in genes required 
for alveolar function, which is consistent with the biological function of the 
mammary gland at this developmental time point. As well, together with the analyses 
of the virgin mammary gland described in Chapter 2, these data confirm the 
hypothesis that the alveolar cell identity is contained within the Sca1neg luminal cell 
compartment. 
 
4.5.2 C/EBPβ ChIP-Seq 
 
Due to the lack of known C/EBPβ target genes in the mammary gland, and the need 
to identify unique gene targets in Sca1pos, Sca1neg and P16.5 alveolar cells, a ChIP 
method was developed and optimized for use on low numbers of primary mouse 
mammary cells. When these experiments were started in 2008, most ChIP protocols 
were optimized for use on high numbers of cultured cells (≥106 cells). One ChIP 
protocol assessing epigenetic modifications from sorted hematopoietic stem cells 
was available for low cells numbers (10,000 cells/ChIP) (Attema et al., 2007). 
However, after extensive testing and optimization (not included in this thesis), I was 
unsuccessful in adapting this protocol to my experiments with lower occupancy 
transcription factor binding in mammary gland progenitors. Therefore, I set out to 
develop a ChIP-Seq method based on a ChIP-ChIP protocol developed for use with 
Drosophila embryos (Sandmann et al., 2007), where systemic optimization was 
performed for each step including: cross-linking, sonication, preclearing, antibody 
binding, washing conditions and DNA elution steps. The overall aim was to develop 
a method that would allow us to perform ChIP-Seq from primary mammary gland 
cells that could be sorted from a small number of adult mice.  
 
An overview of the standard steps in ChIP are shown in Figure 4.2A. First, 
optimization of the sonication condition was undertaken, where the concentration of 
sodium dodecyl sulfate (SDS) (Appendix 5) and the required number of sonication 
cycles were determined (data not shown). Testing of 0.1 % and 1 % SDS 
concentrations for sonication was based Dr. Pablo Navarro work, who noted that 
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some transcription factor antibodies did not work when chromatin is sonicated in the 
presence of 1 % SDS (unpublished observations). However, for the anti-C/EBPβ 
antibody C19, 1 % SDS in the sonication buffer is optimal (Appendix 5), and the 
number of cycles required to obtain DNA fragments between 200-400 bp, which is 
the optimal size range for Solexa sequencing (Schmidt et al., 2009), is 50 cycles of 
30 seconds on/30 seconds off on a high setting using a Bioruptor Diagenode 
waterbath sonicator (Fig. 4.2B). Next, the conditions for antibody binding and 
capture were optimized using the published C/EBPβ binding sites in the Xdh 
promoter. The quantity of chromatin for each ChIP was chosen based on two 
considerations. First, previous experience with Attema’s method of using 10,000 
cells/ChIP was unsuccessful; therefore, to improve the possibility of a positive result, 
the number of cells/ChIP was increased. Second, it was important to limit the amount 
of cells/ChIP to a number that could be sorted from one or a few adult mice 
(consistent with NC3R recommendations). The number of Sca1neg and Sca1pos cells 
that can be sorted from one adult mouse varies between experiments, but on average, 
it is between 1-2x105 cells/mouse. Therefore, I chose 100,000 cells/ChIP as a starting 
point for the optimization of the ChIP method. The amount of C/EBPβ antibody 
added to each ChIP was tested, as well as the effects of preclearing the chromatin 
prior to ChIP with protein A beads, and the use of different combinations of washing 
buffers after the ChIP. These experiments are summarized in Appendix 5, and show 
that preclearing the chromatin prior to antibody binding improves the signal and 
reduces the background, whereas increased washing leads to loss of antibody 
binding, as shown by the reduced signal in the Xdhbound qPCR assay (Appendix 5). 
The amount of antibody used for each immunoprecipitation was also optimized, and 
0.5 µg C19/100,000 cells was chosen based on the level of enrichment in the bound 
compared to the unbound region in Xdh, as well as based on the reproducibility of 
the results between biological replicates from independent experiments (Fig. 4.4). 
Finally, reverse cross-linking was optimized by comparing two methods and 
determining the yield of DNA from each (Attema et al., 2007; Sandmann et al., 
2007). The first method involves incubating each ChIP sample with SDS and 
proteinase K overnight at 37 oC with moderate agitation, followed by a 6-hour 
incubation at 65 oC. The DNA is then purified using phenol chloroform, and 
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precipitated in the presence of glycogen (Sandmann et al., 2007). The second method 
involved incubating each ChIP sample with SDS and proteinase K at 68 oC for 2 
hours with vigorous shaking, followed by DNA purification using phenol chloroform 
and precipitation in the presence of linear acrylamide and glycogen (Attema et al., 
2007). The quantity of DNA obtained from the two methods is comparable (data not 
shown), therefore the second (shorter) method was chosen for the de-crosslinking of 
C/EBPβ-bound DNA.  
 
The optimized ChIP method was then used to generate samples for the preparation of 
DNA sequencing libraries, which were verified by qPCR and the DNA quality was 
assessed by Bioanalyzer analysis prior to Solexa sequencing (Fig. 4.6A). The ChIP-
Seq data were curated by Dr. Simon Tomlinson using Geneprof, a software program 
developed by Florian Halrbitter, a PhD Candidate in Dr. Tomlinson’s laboratory 
(Halbritter et al., 2012). 
 
4.5.3 Genome-wide C/EBPβ occupancy correlates with alveolar cell fate 
 
Most studies investigating C/EBPβ binding have focused primarily on promoter-
proximal regions (Karaya et al., 2005; Seymour et al., 2006; Wang et al., 2012). 
However, our analysis of the genome-wide binding of C/EBPβ reveals that less than 
¼ of binding events occurs within 5 kb of known transcription start sites, and more 
than 50 % map to previously unknown genomic regions (Fig. 4.8A). These findings 
are consistent with the observations by Schmidt and Wilson, who characterized the 
genome-wide occupancy of another C/EBP family member, C/EBPα, in liver tissue, 
and showed that less than ¼ of the C/EBPα binding events localized to within 3 kb of 
known transcription start sites (Schmidt et al., 2010). In their study, the role of distal 
binding events was not investigated, although the authors noted that the binding 
events closest to the TSS were the most highly conserved between the five vertebrate 
species studied, and were highly enriched in genes known to be up-regulated in liver 
organogenesis, suggesting that the most proximal binding events may be the most 
functionally relevant (Schmidt et al., 2010). Further investigations into the 
characteristics of distal and proximal C/EBPβ binding sites will provide pertinent 
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information about the complex mechanisms underlying C/EBPβ action in the 
mammary gland. Unlike C/EBPα, whose function is conceptually clear-cut (inhibits 
proliferation, promotes differentiation, suppresses tumorigenesis), C/EBPβ function 
is more complex and highly context-dependent (Nerlov, 2007). For example, 
C/EBPβ is an important anti-proliferative agent in promyelocytic leukemia cells, 
where it promotes differentiation towards the granulocytic lineage (Duprez et al., 
2003). On the other hand, it has pro-proliferative properties in keratinocytes, where it 
is required for RAS-mediated tumourigenesis (Zhu et al., 2002). Furthermore, 
Cebpb-/- females have proliferation and differentiation defects in the mammary 
gland (Robinson et al., 1998; Seagroves et al., 1998), whereas over-expression of 
C/EBPβ in a human mammary epithelial cells line (MCF10A) leads to hyper-
proliferation and induces epithelial to mesenchymal transition, a hallmark of cancer 
(Bundy and Sealy, 2003). C/EBPβ has also been linked to human epithelial cancers 
in vivo, and was shown to be an essential effector of cyclin D1-driven mammary 
tumour formation (Lamb et al., 2003). In mice, over-expression of LIP, the 
predominant C/EBPβ isoform expressed during pregnancy, led to the development of 
alveolar hyperplasia, which was subsequently attributed to the cells re-entering S-
phase (Zahnow et al., 2001). These studies demonstrate that the in vivo C/EBPβ 
target genes have critical functions in regulating the cell cycle, and de-repression or 
inhibition of these genes by LIP during pregnancy promotes alveolar cell 
proliferation. This hypothesis is also supported by the observation that genome-wide 
C/EBPβ occupancy increases as cells progress towards the differentiated alveolar cell 
fate (Fig. 4.8C, Fig. 4.9). Few unique binding events are observed in the ductal cell 
lineage, whereas an increasing number of unique binding events are seen in alveolar 
progenitor cells and differentiating alveolar cells (P16.5) (Fig. 4.8C), particularly in 
genes that are alveolar-specific (e.g., Csn3, Xdh, Fig. 4.12). As shown in Figure 4.9, 
the overall frequency of C/EBPβ binding in the regulatory region of alveolar lineage-
specific genes is significantly higher than that of ductal lineage-specific genes. The 
acquisition of new binding sites within genes is also likely involved in the 
specification and proliferation of alveolar cells (Fig. 4.12).  
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4.5.4 C/EBPβ targets genes perform distinct functions in alveolar cells 
 
Functional annotation clustering revealed that Sca1pos genes bound by C/EBPβ do 
not have a clear role in ductal morphogenesis. However, these preliminary analyses 
require further investigation, as it is probable that some of these unique target genes 
have roles in ductal development that were previously unrecognized. Ongoing 
analyses not yet available to present in this thesis are assessing the functional role of 
unbound genes in Sca1pos cells that acquire C/EBPβ binding in the alveolar cell 
types. These genes are particularly interesting, because they may provide the first 
direct mechanism for the development of the alveolar lineage from ductal-primed 
luminal progenitor cells, and would demonstrate that this process is directly 
controlled by C/EBPβ. If empirical evidence supports this hypothesis, a model could 
be generated where Sca1pos cells are positioned in the cellular hierarchy upstream of 
Sca1neg cells, and therefore would be considered common luminal progenitor cells 
that, upon C/EBPβ binding (thereby inhibiting ductal genes and/or activating 
alveolar genes), differentiate into Sca1neg and alveolar cells, and in the absence of 
C/EBPβ binding, would generate mature ductal cells.  
 
Further to these analyses, the genes that display C/EBPβ binding in the alveolar 
lineage gene signature (Sca1neg) are generally involved in extracellular matrix-
associated functions (Fig. 4.10C). These include MET (hepatocyte growth factor 
receptor), whose function was discussed in Chapter 2, and CD44, a type I 
transmembrane adhesion receptor that mediates interactions between mammary 
epithelial cells, as well as between epithelial cells and stroma (Louderbough et al., 
2011). CD44 expression has been associated with cancer stem cells, and prospective 
isolation and transplantation of CD24loCD44pos cells has shown that this population 
is highly enriched in tumour forming activity (Al-Hajj et al., 2003). However, 
contrary to this, the involvement of CD44 in reducing the progression of mammary 
carcinomas was also shown using a mouse model of spontaneously metastasizing 
breast cancer (MMTV-PyV mT) (Lopez et al., 2005). These studies demonstrated 
that loss of CD44 promotes tumour metastasis, and that the interaction of CD44 and 
its ligand hyaluronan, expressed on stromal cells, restricts tumour invasion (Lopez et 
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al., 2005). Therefore, the role of CD44 is cancer formation requires further 
investigation. ESR1neg luminal progenitor cells have been proposed to be the 
initiating cell type for basal-like breast cancer through MET-induced de-
differentiation (Gastaldi et al., 2012), and my work has shown that Met is a marker of 
Sca1neg cells (Chapter 2). Cd44 expression is also enriched in Sca1neg cells, and both 
Cd44 and Met are direct C/EBPβ targets in these cells. Interestingly, the expression 
of Cd44 is comparable in Sca1neg luminal cells and MaSCs, and approximately 4- 
and 10-fold higher than in Sca1pos cells and P16.5, respectively (data not shown). 
The expression of Cd44 in myoepithelial cells has previously been observed, and its 
role in mediating the organization of the luminal and myoepithelial cells layer was 
demonstrated in the Cd44-/- mouse (Louderbough et al., 2011). Cd44-/- mice have 
impaired ductal elongation and TEB formation during puberty, as well as disrupted 
organization of the two epithelial cell layers, as demonstrated by the intermixing of 
luminal and myoepithelial cells (Louderbough et al., 2011). The biological 
importance of C/EBPβ-mediated regulation of Cd44 expression in Sca1neg cells is 
intriguing. The role of Met and Cd44 in tumorigenesis, and the observation that they 
are directly regulated by C/EBPβ in Sca1neg cells, should prompt further 
investigations into the potentially directive role of C/EBPβ in the development of 
basal-like breast cancers. As well, these observations corroborate the findings that 
ESR1neg luminal progenitor cells (i.e., Sca1neg cells) are the most likely cells-of-
origin that generate basal-like breast tumours (Gastaldi et al., 2012). 
 
The genes not bound by C/EBPβ in Sca1neg cells are involved with cell 
migration/motility and receptor protein signalling, and include the two chemokine 
ligands Cxcl2 and Cxcl3 (Fig. 4.10B). CXCLs are secreted chemokines that attract 
neutrophils, and CXCL3 was shown to be a normal component of milk (Rainard et 
al., 2008). However, the biological reason for the constitutively high expression of 
Cxcl3 in the mammary gland in the absence of inflammation remains unclear 
(Rainard et al., 2008). Another gene found in this cluster is the forkhead box 
transcription factor FOXC1. Recently, the role of FOXC1 in the formation of basal-
like breast cancer was demonstrated (Tkocz et al., 2011). These studies showed that 
co-operative repression of Foxc1 expression by GATA3 and BRCA1 is required for 
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normal breast differentiation, and failure to repress Foxc1 expression contributes to 
drug resistance and increased tumour aggressiveness in in vitro models of basal-like 
breast cancer (Tkocz et al., 2011). Ectopic FOXC1 expression can also induce de-
differentiation of mature mammary epithelial cells into a progenitor-like state 
(Bloushtain-Qimron et al., 2008). Like CXCL3, the function of FOXC1 during 
normal mammary gland development is unknown. As these examples demonstrate, 
most of the information available for many of the lineage-specific genes identified 
are related to cancer formation, and little is known about their biological function 
during normal mammary gland development.  
 
During pregnancy, the mammary gland undergoes significant structural changes that 
result not only from the proliferation and differentiation of alveolar cells, but also 
from restructuring of extracellular matrix interactions between epithelial cells, as 
well as between the epithelium and stroma, to enable the gland to transform into a 
secretory organ. The genes involved in these processes are clearly reflected in the 
functional annotation clusters for both C/EBPβ bound and unbound genes in P16.5 
alveolar cells (Fig. 4.11). The most highly enriched clusters are involved in mitosis, 
and a significant portion of C/EBPβ-mediated genes are directly involved in the 
preparation and stabilization of chromosomes for cell division, such as Ncaph 
(chromosome condensation), Nusap1 (microtubule assembly at metaphase), Cenpa 
(formation of centromere) and Sgol1 (stabilization of centromeres). C/EBPβ also 
regulates genes involved in inflammation, defense response and wound healing, such 
as members of the complement pathway (e.g., C1qb, C3, C5ar1, Cd55), Lat (T-cell 
antigen receptor signalling), and Ptafr (platelet activating factor receptor). The 
binding of C/EBPβ to genes involved in immunity is not surprising, as its role as an 
essential regulator of acute phase proteins in the liver in response to inflammation is 
well described (Poli, 1998). However, C/EBPβ-mediated expression of immune 
genes in other tissues (e.g., fat, brain, ovaries, mammary gland) suggests that it may 
have a general role in regulating immune-response genes that is not related to 
inflammation. 
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The role for C/EBPβ-regulated expression of immune molecules in the mammary 
gland may have evolutionary origins. Vorbach posits that the mammary gland 
developed from mucosal epithelium, whose primary function was to protect the 
animal from pathogens (Vorbach et al., 2006). Evidence to support this hypothesis 
stems from the observation that several molecules that originate from the immune 
system have acquired novel functions in the mammary gland. For example, XDH is a 
highly conserved enzyme with a role in innate immunity (Vorbach et al., 2003), and 
it is also an essential component of the milk fat globule, and is required for lactation 
(Vorbach et al., 2002). The regulation of Xdh by C/EBPβ in immune cells may have 
been critical for response to infections. However, as XDH acquired new roles in 
mammary gland development, so too have it’s transcriptional regulators, including 
C/EBPβ. Lysozyme is another example of a factor with antimicrobial properties that 
is also found in milk (Vorbach et al., 2006). Furthermore, the α-lactalbumin gene, 
which encodes a nutritional component of milk, evolved from the lysozyme gene 
following a gene duplication event that occurred at the start of mammalian evolution 
approximately 200 million years ago (Prager and Wilson, 1988). Further support for 
this hypothesis that the mammary gland evolved from mucosal epithelium is 
provided by the observation that inflammatory signalling pathways are key 
regulators of mammary gland development (Vorbach et al., 2006). For example, the 
RANKL/NF-κβ pathway is conserved from invertebrates to mammals, and functions 
primarily to control the expression of antimicrobial molecules, cytokines and co-
stimulatory molecules (Vorbach et al., 2006). In the mammary gland, this signalling 
axis has developed a novel function, whereby it is required for the development of 
the secretory epithelium (Srivastava et al., 2003), and for restructuring the mammary 
gland following lactation (Ormandy et al., 2003; Baxter et al., 2006).  
 
Together, these analyses demonstrate that C/EBPβ regulates specific cellular 
functions during alveolar development, including signal transduction through 
regulating the expression of genes involved in extracellular matrix functions, and 
chromosomal packaging for cell division by regulating genes involved in 
microtubule assembly, chromosome condensation and centromere formation. As 
well, C/EBPβ regulates genes that have traditionally been associated with immune 
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functions. However, as exemplified by XDH, novel roles for C/EBPβ-regulated 
genes in alveolar development are being identified. 
 
4.5.5 C/EBPβ promotes alveolar development in part through regulation of Elf5  
 
Several novel C/EBPβ targets were identified in luminal progenitor cells that have 
key roles in alveolar development, and this prompted a deeper investigation of their 
relationship with C/EBPβ. One of these target genes is Elf5. ELF5 is essential for 
alveolar differentiation during late pregnancy (Oakes et al., 2008), and recently, it 
was also shown to play a critical role in specifying the luminal cell fate and 
regulating progenitor/stem cell function (Chakrabarti et al., 2012). Conditional 
deletion of Elf5 from the mammary gland leads to a block in luminal progenitor cell 
specification, as shown by the loss of CD61pos luminal cells, along with a 
concomitant increase in myoepithelial-like cells that co-express both basal (K14) and 
luminal (K8) keratins. As well, the expression of several Notch signalling 
components is significantly altered (e.g., Notch4, Hes1, Hey1, Cbf1) upon deletion of 
Elf5 (Chakrabarti et al., 2012). Over-activation of Notch signalling was previously 
shown to lead to differentiation of MaSCs towards the ductal luminal fate, whereas 
inhibition of the canonical Notch effector Cbf1 led to expansion of MaSCs and 
increased stem cell activity (Bouras et al., 2008). In Cebpb-/- mice, Elf5 expression 
is also significantly decreased (Fig. 3.8), and the resultant changes in Notch 
signalling may be the underlying mechanism for the reprogramming we observed in 
alveolar progenitor cells (Chapter 3). Further to this, the ChIP-Seq data also shows 
that some Notch signalling components are direct targets of C/EBPβ (e.g., Hey1, 
Jag2I, data not shown), as well as some known ELF5 target genes (e.g., Ccnd2, 
Muc4, Igfb4, Figs. 4.15 & 4.16). These observations raise the possibility that 
C/EBPβ mediates alveolar lineage specification in part through the direct regulation 
of Elf5 and (some of) its target genes, and in part directly through the regulation of 
Notch signalling components. A preliminary experiment to lend support to this will 
be the assessment of the changes in the expression of Hey1, Jag2 Ccnd2, Muc4 and 
Igfb4 in Cebpb-/- mammary tissue.  
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In addition to C/EBPβ and ELF5, STAT5 is also likely to play a central role in 
luminal lineage specification. Activation of STAT5 is essential for the polarization of 
alveolar cells as well as their up-regulation of milk protein gene expression, and their 
survival (Cui et al., 2004; Anderson et al., 2007). More recently, it was demonstrated 
that STAT5 is required for the generation and maintenance of luminal progenitor 
cells (Yamaji et al., 2009). The expression of Stat5 in Cebpb-/- mice is not 
significantly affected (data not shown), and the ChIP-Seq data demonstrated that 
C/EBPβ is not bound to Stat5a, the isoform most pertinent in mammary gland 
development (data not shown). However, ELF5 is involved in the direct regulation of 
Stat5 expression (Choi et al., 2009), and may provide a point of convergence for 
these three essential regulators of luminal specification and alveolar development.   
 
In summary, this chapter described the genome-wide binding characteristics of 
C/EBPβ in Sca1pos cells, Sca1neg cells and P16.5 alveolar cells. These experiments 
revealed that genome-wide C/EBPβ occupancy is correlated with alveolar cells fate, 
and that C/EBPβ target genes perform distinct cellular functions in alveolar cells, but 
not in ductal cells. Furthermore, direct regulation of Elf5 by C/EBPβ may be one 
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In this thesis, I have begun to investigate the molecular mechanisms through which 
C/EBPβ regulates postnatal mammary gland development. In Chapter 2, I have 
described the development and optimization of a flow cytometric staining strategy 
that enabled a more precise isolation of Sca1pos and Sca1neg luminal progenitor cells. 
This strategy was then employed in the isolation and characterization of these 
progenitor cells, and analysis of their global gene expression pattern demonstrated 
that Sca1pos luminal progenitor cells contain ductal luminal progenitor cells (DLPs), 
and Sca1neg luminal progenitor cells contain alveolar luminal progenitor cells 
(ALPs). Furthermore, the in vivo genetic priming of Sca1pos and Sca1neg luminal 
progenitor cells was maintained when the cells were cultured under differentiation 
conditions in vitro, and their colony morphology was consistent with their in vivo 
genetic priming, demonstrating the functional importance of lineage priming in 
progenitor cells. In Chapter 3, I have shown flow cytometric analyses that 
demonstrate that C/EBPβ is required for the appropriate specification of ductal and 
alveolar lineages in the luminal cell compartment. Furthermore, through gene 
expression analysis, I have described that in the absence of C/EBPβ, alveolar lineage 
priming is lost, and ductal lineage priming is up-regulated in both Sca1pos and Sca1neg 
luminal cells, demonstrating that C/EBPβ is important for alveolar-lineage 
specification. Preliminary data also shows that in addition to severe proliferation 
defects, the changes in in vivo lineage priming in Cebpb-/- mice also affect the in 
vitro differentiation potential of Cebpb-/- Sca1pos and Sca1neg luminal progenitor 
cells. Lastly, in Chapter 4, I have described the genome-wide binding characteristics 
of C/EBPβ in Sca1pos, Sca1neg and P16.5 alveolar cells through ChIP-Seq 
experiments. These experiments revealed that genome-wide C/EBPβ occupancy is 
correlated with alveolar cells fate, and that C/EBPβ target genes perform distinct 
cellular functions in alveolar cells throughout their development. Furthermore, I 
showed that Elf5, a master regulator of alveolar development, is directly regulated by 
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C/EBPβ, and posit that direct regulation of Elf5 by C/EBPβ may be one mechanism 
through which C/EBPβ exerts its alveolar cell fate programming. 
	  
The work presented in this thesis contributes significantly to our understanding of 
mammary gland development. The identification of ductal- and alveolar-
programmed luminal cell populations will allow for better definition of the lineage 
commitment process and its regulation by extrinsic and intrinsic factors, including 
C/EBPβ, PRL, STAT5 and ELF5. In addition, studies of mammary carcinoma cells-
of-origin will now be better informed, as specific lineage tracing of luminal 
progenitor subsets can be achieved based on the genes differentially expressed in 
Sca1pos and Sca1neg luminal cells. As well, the work in this thesis makes a significant 
contribution to our understanding of C/EBPβ function during mammary gland 
development. The identification of direct, in vivo target genes in three luminal cell 
populations has enabled us to begin to investigate the mechanisms through which 
C/EBPβ regulates luminal lineage commitment and alveolar specification. For 
example, the identification of Elf5 as a direct C/EBPβ target gene has already 
prompted further investigations into the relationship between C/EBPβ and ELF5. 
ChIP-Seq experiments to identify ELF5 target genes in Sca1pos, Sca1neg and P16.5 
alveolar cells in the presence and absence of C/EBPβ (Cebpb-/- mice) are currently 
in progress (one preliminary ChIP experiment was shown in Chapter 4) and will be 
pursued in my next post with Prof. Nerlov. Further to these experiments, preliminary 
ChIP experiments to optimize immunoprecipitation of STAT5 and GATA3 have also 
been initiated, and will be continued. Although Stat5 and Gata3 are not direct 
C/EBPβ target genes, their critical role in alveolar development suggests that they 
may function within the same regulatory network as C/EBPβ and ELF5. In fact, 
STAT5 was recently shown to regulate Elf5 expression (Yamaji et al., 2009), 
supporting this hypothesis. Elucidating the relationship between these transcription 
factors (and perhaps others), and their target genes, will provide critical insight into 
the regulatory networks that govern alveolar development. Establishing the 
transcriptional hierarchy, and understanding the regulatory relationships between 
each of these transcription factors provides an exciting challenge for the future. 
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6.1.1 Mouse strains 
 
Mice designated as wild type (WT) are strain C57 black 6 CGR obtained from the 
Roger Land and Scottish Centre for Regenerative Medicine (SCRM) animal units. 
Cebpb-/- mice have been described (Sterneck et al., 1997). Briefly, chimeras were 
generated from embryonic stem cells in which part of the Cebpb promoter and the 
full Cebpb coding region were replaced by a neomycin resistance gene. Adult virgin 
female mice were analyzed between the ages of 10-14 weeks, whereas pregnant mice 
were taken on day 16.5 following plug confirmation. 
 
6.1.2 Genotyping of Cebpb mice 
 
Genomic DNA was extracted from tail samples using 700 µl of Tail Lysis Buffer (50 
mM Tris pH 8.0, 100 mM ethylenediaminetetraacetic acid [EDTA], 100 mM NaCl, 1 
% (weight to volume [w/v]) SDS, 10 units Proteinase K [Sigma]) for 12 to 16 hours 
at 56 oC. Following lysis, 200 µl of NaCl was added, briefly mixed, and centrifuged 
for 10 minutes at maximum speed (≥ 16,000 x g) at room temperature. The 
supernatant was transferred to a new 1.5 ml Eppendorf tube, 800 µl of isopropanol 
was added, the sample was briefly mixed, and centrifuged for 10 minutes at 
maximum speed at 4 oC. The DNA pellet was washed with 500 µl of 70 % ethanol 
and centrifuged for 5 minutes at maximum speed at 4 oC, and then dired for 10 
minutes. The DNA sample was resuspended in 100 µl of sterile water. 
 
The genotyping PCR reaction was comprised of 4 µl of genomic DNA, 1 µl of each 
of the following 10 µM primers: G22 5’acgagactagtgagacgtgctac, G23                     
5’ gcttcgaacccgcggactgcaa and G24 5’catctttaaggtgattactcagggc, 2 µl of 2 mM 
deoxyribonucleotide triphosphates [dNTPs] (Roche), 4 µl of 5x Colorless GoTaq 
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Flexi Buffer (Promega), 1.2 µl of 25 mM MgCl2 (Promega), 2.5 units (0.5 µl) of 
GoTaq DNA polymerase (Promega), 2 µl of dimethyl sulfoxide [DMSO], and 3.3 µl 
of sterile water. Amplification was performed using a DNA Engine Thermal Cycler 
(BioRad) as follows: denaturation for 5 minutes at 95 oC, 5 cycles of: 1 minute at   
95 oC, 1 minute at 50 oC and 1 minute at 72 oC, followed by 35 cycles of: 1 minute at 
95 oC, 1 minute at 55 oC and 1 minute at 72 oC, and a final extension for 5 minutes at 
72 oC. Amplicons were separated on a 2 % (w/v) agarose gel and visualized on a 
Syngene G:BOX (Fisher). The wild type allele generated a 771 bp amplicon, and the 
mutant allele generated a 530 bp amplicon. 
 
6.2 Flow cytometry 
 
6.2.1 Mammary gland dissection and single cell preparation 
 
The four limbs of a female mouse killed by a Schedule 1 method were pinned, and a 
midline incision was created from the vagina to the jaw. After pulling back the skin 
to expose the subcutaneous mammary fat pads, all five glands were dissected from 
each side of the animal and placed in 4 ml of cold Dulbecco’s Modified Eagle 
Medium (DMEM)/F-12 (Gibco). The tissue was transferred onto a glass plate, 
minced to 1-2 mm fragments using two scalpels, transferred to a 15 ml conical tube, 
and digested in 4 ml of DMEM/F-12 containing 2 mg/ml Collagenase D (Roche) and 
6 units Dispase II (Roche) for 1-2 hours at 37 oC on a rotating shaker (40 to 50 rpm). 
The sample was then washed with 10 ml of sterile, cold HEPES buffer, pH 7.5 (20 
mM HEPES, 140 mM NaCl, 10 mM KCl, 0.1 % (w/v) D-glucose, 0.5 % (w/v) 
bovine serum albumin [BSA], 2 mM EDTA, 2 mM CaCl2) and centrifuged for 5 
minutes at 300 x g at 4 oC. The cell pellets were resuspended in 1 ml of GEY 
solution, pH 7.0 (150 mM NH4Cl, 10 mM KHCO3, 0.1 mM EDTA), incubated for 3 
to 5 minutes at room temperature, washed with 14 ml of cold HEPES buffer, and 
centrifuged for 5 minutes at 300 x g at 4 oC. The sample was resuspended in 1 ml of 
HEPES buffer, filtered using a 40 µm Filcon filter (Becton Dickinson) to obtain a 
single-cell suspension, and the cells counted with a hemocytometer.  
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6.2.2 Antibody staining 
 
All incubation steps were carried out at 4 oC for 20 minutes in the dark. To wash the 
cells following each incubation, the suspension was diluted between 1:10 to 1:20 
with cold HEPES buffer, centrifuged for 5 minutes at 300 x g at 4 oC, and the 
supernatant was discarded. Dissociated mammary gland cells were first incubated 
with lineage antibodies (CD31, CD45, Ter119), then a goat anti-rat secondary 
antibody, followed by a blocking step with normal rat serum. The cells were then 
incubated with CD29-biotin, and lastly with a cocktail containing streptavidin (SA), 
CD24, CD49f, Sca1 and CD49b. Further information about the antibodies is found in 
Table 6.1. After completion of the staining protocol, the cells were resuspended in 
cold HEPES buffer containing the viability marker 7-AAD (1 ng/ml, Cambridge 
Bioscience) and filtered with a 40 µm Filcon filter (Becton Dickinson) prior to flow 
cytometric analysis or cell sorting.  
 
Table 6.1 Antibodies used for flow cytometry.  
The table lists the antibodies used for the detection of cell surface antigens 
using flow cytometry. The incubation steps in the protocol are indicated on 
the left, followed by the antibody name and directly conjugated fluorophore. 
The lineage antibodies (step 1) are unconjugated, and were detected with a 
goat anti-rat secondary antibody (step 2). The dilution of each antibody is 
shown, as well as clone name, supplier, stock concentration and isotype 
control. 
 
Step Antibody & fluorophore Clone Supplier Stock Dilution Isotype 
1 CD31 Pure 390 eBioscience 0.5 mg/ml 1:450 Rat IgG2a 
 CD45 Pure 30-F11 eBioscience 0.5 mg/ml 1:450 Rat IgG2b 
 Ter119 Pure TER119 eBioscience 0.5 mg/ml 1:450 Rat IgG2b 
2 Goat anti-rat IgG F(ab’)2 PE-Cy5 
- SCBT 0.4 mg/ml 1:100 - 
3 Normal rat serum - Sigma - - - 
4 CD29 Biotin Ha2/5 BD 0.5 mg/ml 1:100 Hamster IgM 
5 SA AF750-APC - Invitrogen 1 mg/ml 1:300 - 
 CD24 FITC or PB M1/69 Biolegend 0.5 mg/ml 1:150 Rat IgG2b 
 CD49f PE or FITC GoH3 Biolegend 0.2 mg/ml 1:150 Rat IgG2a 
 Sca1 PE-Cy7 D7 eBioscience 0.2 mg/ml 1:300 Rat IgG2a 
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6.2.3 Cell sorting and analysis 
 
Single cell suspensions stained as described above were analyzed using an 
LSRFortessa II cell analyzer (Becton Dickinson), or sorted using either a FACSAria 
II (Becton Dickinson) or FACSJAZZ (Becton Dickinson). All flow cytometric data 
analyses were performed using FlowJo version 8.7.1 (Tree Star Inc). 
 
6.3 Mouse mammary colony-forming cell assay 
 
6.3.1 Preparation of fibroblast cell layer 
 
NIH3T3 fibroblast cells (ATCC) were plated on a 48-well plate (Iwaki, 10,000 
cells/well) in 400 µl of complete Iscove’s Modified Dulbecco’s Medium (IMDM) 
(IMDM [Gibco], 5 % fetal calf serum (FCS) [Gibco], 10 units/ml penicillin and 10 
µg/ml streptomycin [P/S, Invitrogen]), and incubated in a tissue culture incubator (37 
oC, 5 % CO2). After 24 hours, the medium was removed and replaced with complete 
IMDM containing 4 µg/ml of mitomycin-C (Sigma). The cells were incubated with 
mitomycin-C for 4 hours at 37 oC with 5 % CO2, then washed 3 x with 400 µl of 
warm phosphate buffered saline (PBS, Gibco) and 1 x with 400 µl of complete 
IMDM. Alternately, cells were irradiated using standard methods. Finally, the cells 
were incubated for 24 hours in complete IMDM medium at 37 oC with 5 % CO2. 
 
6.3.2 Three-dimensional extracellular matrix assay 
 
Two thousand (2000) sorted mammary gland cells were embedded in 100 µl of 
chilled Matrigel (Becton Dickinson) and plated on top of the mitomycin-C treated 
fibroblast cell layer. To promote solidification of the Matrigel, the plate was 
incubated for 10 minutes at 37 oC with 5 % CO2. For assessing alveolar 
differentiation and ductal branching, the cells were incubated with 400 µl of mouse 
Epicult-B medium [Stem Cell Technologies], 1x Epicult supplement [Stem Cell 
Technologies], 1x B27 supplement (Gibco), 10 ng/ml recombinant human epidermal 
growth factor [rh EGF, Stem Cell Technologies], 10 ng/ml recombinant human basic 
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fibroblast growth factor [rh bFGF, PeproTech], 2 mM glutamax, 10 µM ROCK 
inhibitor Y-27632 (Calbiochem), 5 % FCS, 1x gentamycin. Fresh medium was added 
after 24 hours without ROCK inhibitor and FCS and changed at 3-day intervals. 
From day 7-15 of culture, the medium was supplemented with prolactin (3 µg/ml, 
Sigma) and RANKL (200 ng/ml, R&D Systems). Colonies were scored on day 15 of 
culture. For assessing ductal morphogenesis, the cells were incubated with 400 µl of 
mouse Epicult-B medium, 1x Epicult supplement, 10 ng/ml rh EGF, 10 ng/ml rh 
bFGF, 4 µg/ml Heparin [Stem Cell Technologies], 5 % FCS, 10 units/ml P/S. The 
medium was changed at three days intervals, and the colonies were scored after 21 
days in culture. 
 
6.4 Chromatin immunoprecipitation sequencing 
 
6.4.1 Cross-linking, lysis and sonication of mammary cells 
 
Sorted cells (see Section 6.2) were centrifuged for 10 minutes at 300 x g at 4 oC, and 
the supernatant was removed. The cell pellets were gently resuspended in 1 ml of 
DMEM/F-12 containing 1 % formaldehyde (Sigma) and incubated for 10 minutes 
with gentle agitation at room temperature. The fixation was stopped with 125 mM 
glycine for 5 minutes with gentle agitation at room temperature. The samples were 
then centrifuged for 5 minutes at 300 x g at 4 oC, and washed 2 x with 1 ml of 
Hank’s Balanced Salt Solution (HBSS, Invitrogen) containing cOmplete Mini 
EDTA-free Protease Inhibitor Cocktail Tablet (PIC, Roche, prepared according to 
the manufacturer’s instructions).  
 
The cell pellets were resuspended in ChIP Lysis Buffer (50 mM Tris, pH 8.0, 10 mM 
EDTA, 1 % SDS, PIC) and incubated for 20 minutes on ice. For pellets containing 
less than 5x105 cells, 200 µl of ChIP Lysis Buffer was used, and for pellets 
containing between 5x105 to 2x106 cells, 500 µl of ChIP Lysis Buffer was used.  
 
The samples were sonicated on a high setting for 50 cycles of 30 seconds on and 30 
seconds off using a Bioruptor NextGen Sonicator (Diagenode) to obtain DNA 
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fragments between 200-400 base pairs in size. The sheared chromatin was diluted 
with RIPA Buffer (10 mM Tris pH 7.5, 1 mM EDTA, 1 % Triton X-100, 0.1 % SDS, 
0.1 % sodium deoxycholate, 100 mM NaCl, PIC) so that 400 µl contained chromatin 
from 1x105 cells. Aliquots of chromatin from 1x105 cells/tube were prepared in 1.5 
ml low retention tubes (Axygen), and either frozen and stored at -80 oC, or used 
immediately for preclearing and antibody binding. 
 
6.4.2 Preclearing, antibody binding and antibody capture 
 
Magnetic Dynabeads Protein A (Invitrogen) was used for the removal of non-
specific binding to protein A beads (preclearing). To prepare the beads for chromatin 
preclearing, 20 µl of slurry per sample was washed three times with cold RIPA 
Buffer, resuspended in the original volume with RIPA Buffer, added to each aliquot 
of sonicated chromatin, and incubated for one hour with moderate rotation (20 
rotations per minute [rpm] on a Stuart SB3 rotator) at 4 oC. The beads were then 
captured with a DynaMag-2 magnetic tube holder (Invitrogen), and the cleared 
chromatin (supernatant) was transferred to a new 1.5 ml low-retention tube.  
 
Immunoprecipitation was performed with 0.5 µg of anti-C/EBPβ (C19, Santa Cruz 
Biotechnology), 0.5 µg of anti-Elf5 (H62, Santa Cruz Biotechnology; AP7394C, 
Abgent), or 0.5 µg of rabbit IgG (Santa Cruz Biotechnology) for 12-14 hours 
(overnight) at 20 rpm at 4 oC. Concomitantly, another aliquot of Dynabeads Protein 
A beads (20 µl/sample) was blocked in 1 ml of RIPA Buffer containing 10 µg of 
BSA for 12-14 hours with 20 rpm rotation at 4 oC. The following day, the 
supernatant was removed from the beads, and they were resuspended in their original 
volume with RIPA Buffer. The blocked beads (20 µl/sample) were then incubated 
with the samples for 2 hours with 20 rpm rotation at 4 oC to capture the 
immunocomplexes.  
 
Subsequently, the protein A-captured immunocomplexes were washed 3 x with cold 
RIPA Buffer, 4 x with cold RIPA500 Buffer (RIPA buffer containing 500 mM 
NaCl), 1 x with cold Lithium Chloride Buffer (250 mM LiCl, 10 mM Tris, pH 8.0,   
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1 mM EDTA, 0.5 % nonyl phenoxypolyethoxylethanol [NP40], 0.5 % SDS), and 2 x 
with cold TE Buffer (10 mM Tris, pH 8.0, 10 mM EDTA). Each wash was incubated 
for 4 minutes at 20 rpm at room temperature. Finally, RNA contaminants were 
removed by incubation with 50 µg/ml RNAse A (Sigma) for 30 min at 37 oC. 
 
6.4.3 Reverse cross-linking and DNA purification 
 
Following the washes and RNAse-A treatment, the protein A-bound 
immunocomplexes were resuspended in 200 µl of ChIP Elution Buffer (20 mM Tris, 
pH 7.5, 5 mM EDTA, 50 mM NaCl, 1 % SDS, 50 µg/ml Proteinase K [Roche]) and 
incubated for 2 hours at 68 oC and 1300 rpm on an Eppendorf Thermomixer. The 
supernatant containing immunoprecipitated genomic DNA was transferred to a new 
low-retention tube (Axygen), and the beads were incubated with a further 100 µl of 
ChIP Elution Buffer for 10 minutes to remove any remaining DNA. The supernatant 
was pooled with the previous aliquot for each sample, and the beads were discarded. 
 
One additional chromatin sample (referred to as ‘input'), which did not undergo 
immunoprecipitation, was reverse cross-linked by supplementing the RIPA Buffer 
with Proteinase K (to a final concentration of 50 µg/ml) and SDS (to a final 
concentration of 1 %) and incubating for 2 hours at 68 oC and 1300 rpm on an 
Eppendorf Thermomixer along with the ChIP samples. The volumes of the reagents 
used in the subsequent phenol-chloroform extraction were also adjusted for the input 
sample to reflect its larger volume of approximately 440 µl. 
 
The reverse cross-linked genomic DNA was purified by phenol-chloroform 
extraction. To begin, samples were mixed with one volume (300 µl) of phenol-
chloroform-isoamyl-alcohol (Invitrogen), transferred to 2 ml phase-lock tubes 
(VWR), and centrifuged for 5 minutes at maximum speed at room temperature. The 
aqueous phase, separated from the organic phase by the phase-lock gel in the tubes, 
was then mixed with one volume (300 µl) of chloroform (Invitrogen) and centrifuged 
for 5 minutes at maximum speed at room temperature. The remaining aqueous phase 
was transferred to a fresh 1.5 ml low-retention tube, and the DNA was precipitated 
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overnight at -20 oC with 2.5 volumes (750 µl) of ethanol in the presence of 50 µg 
glycogen (Ambion) and 30 µl of 3 M sodium acetate, pH 5.2. The following day, the 
samples were centrifuged for 20 minutes at maximum speed at 4 oC, washed with 
500 µl of 70 % ethanol, centrifuged for 5 minutes at maximum speed at 4 oC, air 
dried for 10-15 minutes, and resuspended in 20 µl of sterile water. 
 
6.4.4 ChIP validation using qPCR 
 
Published and putative C/EBPβ and ELF5 target genes were used for initial 
validation of chromatin immunoprecipitation. In silico analysis of putative C/EBPβ 
and ELF5 binding was performed using TRANSFAC/ExPlain 3.0 (BioBase). qPCR 
assays were designed against published/putative bound and unbound regions in each 
gene using the Universal ProbeLibrary (UPL) Assay Design Centre (Roche) (Table 
6.2).  
 
Each qPCR reaction contained 2 µl of gDNA, 5 µl of 2 x Probes Master (Roche),   
2.6 µl of Probes Water (Roche), 0.2 µl of 10 µM sense and antisense primer mix, and 
0.2 µl of 10 µM mouse UPL probe (assay specific). Amplification was performed on 
a LightCycler 480 (Roche) with the following conditions: denaturation for 10 
minutes at 95 oC, 45 cycles of: 30 seconds at 95 oC, 10 seconds at 60 oC and              
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Table 6.2 qPCR assays for validation of C/EBPβ and ELF5 ChIP. 
The qPCR primers listed in the table were designed using the Roche UPL 
assay design centre. The table lists the primer ID (which includes the gene 
name), the primer sequences  (5’ to 3’) and the accompanying UPL probe. 
As well, the genomic position of each qPCR assay relative to the 
transcription start site (TSS) is listed, along with the reference that identified 
the target gene. Whether the transcription factor of interest is expected to be 











Xdh-1 F: acagagtaggatctgtggattgg R: ggcaagagtcacaggtttgc 93 -149/-84 C/EBPβ + 
 Seymour et 
al., 2006 
Xdh-2 F: tgcaaacctgtgactcttgc R: tgaaacaaagttagccaatgagaa 1 -108/-31 C/EBPβ + 
 
Xdh-3 F: cagagctagcaggcaatctga R: tcttgaagaaggaaatgaatctga 99 
+4734/ 
+4804 C/EBPβ - 
 
Xdh-4 F: cgagaaatggcacactaaggt R: ggcaaataaaaatgacccaaa 79 
+6595/ 
+6660 C/EBPβ - 
 
Id2-1 F: ttcgcctggtatgatggac R: gcgtcttttatgtgcactcg 31 -72/-18 C/EBPβ + 
 Karaya et 
al., 2005 
Id2-2 F: ctcgcgcttcattctgaac R: tgaaggctttcatgctgct 69 -8/+95 C/EBPβ + 
 
Id2-3 F: cttactatgaaggtgtcaggacca R: ggttaccacctcagtgtaccg 5 
+1011/ 
+1084 C/EBPβ - 
 
Id2-4 F: gaaacgcaacacacctagca R: cgtttaaaatctagtcccaatgc 21 
+2438/ 
+2498 C/EBPβ - 
 
Gata3-1 F: ggcgccgtcttgatagttt R: tgtctcgctctctcagtctctct 55 
+25/ 
+125 C/EBPβ + 
Unpublished 
Gata3-2 F: atagagagctacgcaatctgacc R: acctgagtagcaaggagcgta 63 
+125/ 




R: tacttctccgaggccctctc 42 +2727/ +2794 ELF5+ 
 Escamilla-
Hernandez  
et al., 2010 






R: gaaggggtctgagaaagctctac 7 +994/ +1069 ELF5+ 
Escamilla-
Hernandez  
et al., 2010 








Stat5a-1 F: ccaagcagaactcagataggtg R: tcccagcaagtgtttgtgtc 108 
-2907/ 
-2813 ELF5- 
Choi et al., 
2009 








Stat5a-4 F: tactgcccatgccaacttc R: aagtctgccatcccctttg 82 -8/+67 ELF5+ 
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Table 6.2 Continued 
Gene/ 
Primer ID 







Elf5-1 F: gccctgactgtctggctaaa R: cagagcttgtcagcacttca - 
-12541/ 
-12387 C/EBPβ - 
Unpublished 
Elf5-2 F: tattgccctccctctctcag R:gagcacaggagaaatgtgtca - 
-12463/ 
-12364 C/EBPβ - 
 
Elf5-3 F: ctcactttttatgaataacgta R: aatttaaataatcactgtggag - 
 -6995/ 
-6846 C/EBPβ - 
 
Elf5-4 F: tcactttttatgaataacgtat R: gcctatcaatttaaataatcac - 
-6994/  
-6839 C/EBPβ - 
 
Elf5-5 F: tggcactgctcttctttcct R: ccaagtcccgaacctctgta - 
-370/ 
-301 C/EBPβ + 
 
Elf5-6 F: caaaggctgcaatgaacaga R: tggagcagttctcgttgag - 
-290/ 
-220 C/EBPβ + 
 
Elf5-7 F: acccaggaaatgagcagaga R: agcttgctcaacggagactg - 
-244/  
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6.4.5 Preparation of DNA sequencing libraries 
 
Immunoprecipitated DNA from 5-6 sample tubes (equivalent to chromatin from      
5-6x105 cells) was pooled for preparation of each DNA sequencing library. The 
starting material and sequencing libraries were quantified using the Quant-iT dsDNA 
HS Assay (Invitrogen) on either a Nanodrop 3000 (Fisher) or Qubit (Invitrogen) 
fluorospectrometer.  
 
DNA sequencing libraries were prepared using the Illumina ChIP-Seq Sample 
Preparation Kit (Illumina) according to the manufacturer’s instructions with the 
exception of the following three changes: 1) Two ng of DNA were used for library 
preparation instead of 10 ng. 2) Each Qiagen column purification step was modified 
at the elution stage to maximize DNA recovery. The modification includes heating of 
Buffer EB to 65 oC, 3 minutes incubation of Buffer EB on the column prior to 
centrifugation for 1 minute at maximum speed at room temperature. Reapplication of 
the eluate onto the column for another 3 minutes incubation, followed by a final spin 
for 1 minute at maximum speed at room temperature. 3) During the library size 
selection step, the excised gel fragments were incubated in 6 volumes of Buffer QG 
for 30 minutes at room temperature instead of 3 volumes of Buffer QG for 10 
minutes at 50 oC.  
 
6.4.6 Solexa sequencing and bioinformatics analysis 
 
DNA sequencing libraries were submitted to the University of Edinburgh GenePool 
(Edinburgh, Scotland) for Solexa sequencing using the GAIIx Sequencer (Illumina). 
Samples were verified using the High Sensitivity DNA Chip (Agilent) on a 
Bioanalyzer 2100 (Agilent) prior to Solexa sequencing. Dr. Simon Tomlinson 
curated the ChIP-Seq data using Geneprof. Fifty base pair single-end reads were 
trimmed to remove adapter sequences and aligned to the mouse genome (Ensembl 58 
Mouse genome NCBIM37 Assembly) using Bowtie. For quality control, the mean 
quality score was calculated for each data set by summing up all of the quality scores 
for each read and dividing the sum by the length of the read. A mean quality score of 
	   144	  
≥8 passed the quality control filter. Next, peak calling was performed using MACS 
(Zhang et al., 2008), and peaks were annotated to genes using the criteria of -20 kb to 
+1 kb of TSS (default parameters on Geneprof) (Halbritter et al., 2012). Functional 
annotation clustering analyses were performed using DAVID bioinformatics 
resource (http://david.abcc.ncifcrf.gov) using the functional annotation tool with 
default parameters. 
 
6.5 Microarray and qRT-PCR analysis 
 
6.5.1 RNA extraction from sorted mammary epithelial cells  
 
Mammary gland cells (10,000 per array) prepared as described in section 6.2 were 
sorted directly into 800 µl of Trizol Reagent (Invitrogen). Total RNA was extracted 
according to the manufacturer’s instructions, with the exception that during the 
precipitation step, 10 µg of linear polyacrylamide (Ambion) were added. RNA was 
quantified using the Quant-iT RNA Assay (Invitrogen) on a Qubit (Invitrogen) 
fluorospectrometer. Three biological replicates for Sca1pos and Sca1neg cells, and four 
biological replicates for P16.5 were used for microarray analysis. 
 
6.5.2 Gene expression using microarray and bioinformatics analysis 
 
RNA samples were submitted to the RH Microarray Center (Copenhagen, Denmark) 
for analysis on a GeneChip Mouse Exon 1.0 ST Array (Affymetrix). Dr. Simon 
Tomlinson curated the microarray data using GeneProf (Halbritter et al., 2012). 
Intensity data were background corrected and normalized at the gene level (core 
probe sets only) using Robust Multiarray Analysis (RMA), and transcript clusters 
were annotated using Expression Console. The resulting signals were filtered to 
exclude Transcript Cluster IDs with minimal variation across samples. Filtered data 
were tested for differential expression using Limma in the BioConductor framework 
(Gentleman et al., 2004). Transcript cluster IDs with a false detection rate of p ≤0.01 
were considered differentially expressed. Functional annotation clustering analyses 
were performed using DAVID bioinformatics resource 
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(http://david.abcc.ncifcrf.gov) using the functional annotation tool with default 
parameters. 
 
6.5.3 Gene expression using qRT-PCR 
 
Following RNA extraction as described in section 6.5.1, cDNA was synthesized 
using the Superscript VILO cDNA Synthesis Kit (Invitrogen) according to the 
manufacturer’s instructions. Gene expression was analyzed either using the UPL 
system on a LightCycler 480 (Roche) (described in section 6.4.4 with the exception 
that cDNA was used instead of gDNA), or a BioMark 48.48 Dynamic Array 
(Fluidigm) on a BioMark Genetic Analyzer (Fluidigm) using the manufacturer’s 
instructions. 
 
6.6 Luciferase assays 
 
H293T cells were plated on a 12-well plate (Iwaki) and cultured in DMEM (Gibco) 
containing 10 % FCS for 24 hours at 37 oC, 5 % CO2. After 24 hours, the cells were 
transfected with pGL3-Elf5-promoter (50 ng), pcDNA3-Cebpb (10-100 ng) or empty 
vector (pcDNA3, 10-100 ng), and phRL-CMV (500 pg) (Promega) as a transfection 
control, using the calcium phosphate method. For this, the DNA plasmids were 
combined with 0.25 M CaCl2, mixed in a 1:1 volume to volume (v/v) ratio with 2x 
HBS Buffer (50 mM HEPES, 1.5 mM Na2HPO4, 280 mM NaCl), and added drop-
wise to each well. Transfected cells were harvested after 24 hours, and assayed using 
the Dual Luciferase Reporter (DLR) Assay (Promega). The cells in each well were 
lysed in 200 µl of Passive Lysis Buffer (Promega), and 10 ml of lysate was assayed 
for Renilla and firefly luciferase activity using a GloMax 96 microplate luminometer 
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Appendix 1. Accompaniment to Figure 2.1-2.5. (A) Representative 
fluoresence minus one controls used in flow cytometry. (B) Assessment of 
Sca1 expression of CD49fhi cells in Sleeman’s (top) and Li (bottom) gating 
strategies (Sleeman et al., 2007; Li et al., 2009). 
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Appendix 2. Accompaniment to Figure 2.8A. Complete functional annotation 
clustering analysis of differentially expressed genes in Sca1pos and Sca1neg 
luminal progenitor cells. Functional clusters generated by enriched genes in 
Sca1pos luminal progenitors. The transcript cluster IDs of differentially 
expressed genes (from Fig. 2.7) were analyzed using the DAVID 
Bioinformatics Resource using default parameters. Functional clusters were 
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Appendix 3. Accompaniment to Figure 2.8B. Complete functional annotation 
clustering analysis of differentially expressed genes in Sca1pos and Sca1neg 
luminal progenitor cells. Functional clusters generated by enriched genes in 
Sca1neg luminal progenitors. The transcript cluster IDs of differentially 
expressed genes (from Fig. 2.7) were analyzed using the DAVID 
Bioinformatics Resource using default parameters. Functional clusters were 
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Appendix 4. Accompaniment to Figure 3.7. C/EBPβ in luminal progenitor 
cell specification. Bar graph and accompanying tables showing the 
frequency of the parent population (LinnegCD29posCD24hiCD49flo) for Sca1pos 
cells and Sca1neg cells in Cebpb+/+ (n=4), Cebpb+/-, (n=4) and Cebpb-/- 
(n=10) mice. The values in the bar graph and accompanying tables show the 
mean frequency for each population. Error bars indicate standard deviation. 
Significance (p-value) was calculated using an unpaired, one-tailed Student’s 
T-test. The level of significance is shown by stars in the graphs, and 
numerically in the tables. Abbreviations: SD, standard deviation; n, number; 
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Appendix 5. Accompaniment to Figure 4.4. Development of the C/EBPβ 
chromatin immunoprecipitation (ChIP) method. Top bar graph depicts the 
optimization of the SDS concentration during sonication (1 % vs. 0.1 %), the 
inclusion of preclearing with Dynabeads Protein-A (± precl), and the inclusion 
of an additional washing step using a modified RIPA buffer that contains 500 
mM NaCl and 0.5 % sodium deoxycholate (± wash). The optimal condition 
chosen was 1 % SDS concentration during sonication, and inclusion of a 
preclearing step, but not an additional wash step. Bottom bar graphs show 
the antibody titration of C19 (anti-C/EBPβ) (2 experiments). The optimal 
concentration was chosen as 0.5 µg based on the level of enrichment. If less 
than 0.5 µg of C19 was used, then the level of enrichment is lower than with 
0.5 µg of C19, whereas using 1 µg did not improve the signal. These 
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Appendix 6. Accompaniment to Figure 4.7. Quality control analysis of ChIP-
Seq data sets prior to analysis. (A) Bar graph show the total number of 
aligned reads for each sequencing library, and the proportion of distinct 
regions. (B) Bar graph shows the percentage of unique and not unique reads 
(unmapped or mapped to more than one genomic region) for each 
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Appendix 7. Accompaniment to Figure 4.7. Quality control analysis of ChIP-
Seq data sets prior to analysis. Chromosomal distribution of reads for each 
sequencing library. All libraries have equal coverage of all chromosomes 
(except Y and MT). Abbreviations: P16.5, pregnant day 16.5 alveolar cells; 
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Appendix 8. Accompaniment to Figure 4.10A. Complete functional 
annotation clustering table of C/EBPβ bound (Appendix 8A) and unbound 
(Appendix 8B) genes in Sca1pos luminal cells generated using the DAVID 
bioinformatics resource with default parameters. Functional clusters were 
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Appendix 9. Accompaniment to Figure 4.10B&C. Complete functional 
annotation clustering table of C/EBPβ bound (Appendix 9A) and unbound 
(Appendix 9B) genes in Sca1neg luminal cells generated using the DAVID 
bioinformatics resource with default parameters. Functional clusters were 
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Appendix 10. Accompaniment to Figure 4.11. Complete functional 
annotation clustering table of C/EBPβ bound (Appendix 10A) and unbound 
(Appendix 10B) genes in P16.5 alveolar cells generated using the DAVID 
bioinformatics resource with default parameters. Functional clusters were 
included in the figure if they had an enrichment score of ≥2. 
 
 
 
 
 
 
 
 
 
 
